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GENERAL INTRODUCTION
Adapted from: Helminths, Hygiene Hypothesis and Type 2 Diabetes
Karin de Ruiter*, Dicky L. Tahapary*, Erliyani Sartono, Pradana Soewondo, 
Taniawati Supali, Johannes W.A. Smit and Maria Yazdanbakhsh





1A SHORT INTRODUCTION TO HELMINTHSHelminths, or parasitic worms, are multicellular organisms and represent one of the most 
prevalent infectious agents affecting nearly one-third of the population worldwide (1). 
Helminth infections are widely distributed in tropical and subtropical regions, primarily 
in rural areas where sanitation is poor. Soil-transmitted helminths (STHs) (main species: 
Ascaris lumbricoides, Trichuris trichiura, hookworm) represent the most common species 
infecting humans, followed by schistosomes and filarial nematodes (1). Helminths have 
varied life cycles, and routes of infection can vary from direct penetration (schistosomes, 
hookworms), entrance via a mosquito bite (filarial worms) or through ingestion (A. 
lumbricoides, T. trichiura). Also the location of adult worms within the human body differs 
from the peripheral blood (schistosomes), the lymphatics (filarial worms), the intestine 
(STHs), or other tissues.
It was estimated that 1.45 billion people worldwide were infected with at least one 
species of STHs in 2010, with the majority of infections and highest burden occurring in 
Asia (2). When expressing the burden of helminth infections in disability-adjusted life years 
(DALYs), 5.2 million DALYs were attributable to STHs, 3.3 million to schistosomiasis and 2.8 
million to lymphatic filariasis, meaning that helminths contribute, to the greatest extent, 
to the total burden of neglected tropical diseases (26 million DALYs) (2, 3). Despite this 
worldwide burden and presumed helminth-associated morbidities such as malnutrition, 
poor growth, cognitive deficits and anaemia among children with heavy and chronic STH 
infections (4, 5), most infections are often clinically asymptomatic and mortality due to 
STHs is rare (6). Interestingly, a recent analysis of the Cochrane database demonstrated 
that mass treatment of all children in endemic areas does not improve average nutritional 
status, haemoglobin, cognition, school performance or survival, although it might have 
nutritional benefits among helminth-infected children (7). 
The high prevalence of helminth infections, and its chronic and often asymptomatic 
nature of infection therefore suggests a long evolutionary co-adaptation between 
helminths and their human host. Indeed, there seems to be an immunological interaction 
between helminths and their host in which helminths polarize the immune system towards 
a strong type 2 immune response that is believed to be associated with tissue repair (8), 
as well as establishment of a regulatory network, which can contribute to the control of 
overt immune responses to allow longer term survival of the parasite while restricting 
inflammation that might otherwise lead to pathology (9). 
HELMINTH-ASSOCIATED TH2 RESPONSES AND IMMUNE 
REGULATORY NETWORK
Helminth parasites are strong inducers of type 2 immunity which involves activation and 
expansion of CD4+ T helper 2 (Th2) cells producing the cytokines interleukin (IL)-4, IL-5, 
IL-9, IL-10 and IL-13, systemic and localized eosinophilia, expansion of basophils and mast 
cells, goblet-cell hyperplasia and the production of IgE (10). Moreover, the presence of 
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alternatively activated macrophages (AAMs), induced by IL-4 and/or IL-13, is a characteristic 
feature of the polarized Th2 response (11). The type 2 response is host protective by 
controlling the number of parasites through direct killing or expulsion, and inducing tissue 
repair, necessary to protect against the damage caused by tissue-migrating helminths (12). 
Cellular immune hyporesponsiveness in individuals infected with helminths was first 
observed in the 1970s, when lymphocytes isolated from subjects chronically infected 
with Schistosoma mansoni showed a diminished proliferative response upon stimulation 
with schistosome antigens (13). Subsequently, several human studies demonstrated that 
chronic helminth infections, such as schistosomiasis and filariasis, result in parasite-antigen-
specific immune suppression (14-17). As the responsiveness is restored after anthelmintic 
treatment (18-22), a causal relationship between the presence of helminths and suppression 
of the immune system was considered likely (23). This T-cell hyporesponsiveness is thought 
to be mediated by a helminth-induced regulatory network involving regulatory T cells 
(Tregs) and their associated regulatory cytokines IL-10 and transforming growth factor 
(TGF)-β (14, 24). Tregs, the subset of T cells that maintains self-tolerance in humans 
(23), can dampen both Th1 and Th2 cell activation (9) and can be activated during many 
infections, such as parasitic, viral, fungal and bacterial infections (25). Several studies in 
animal models and humans show that helminth infections are associated with increased 
Treg frequencies and/or functional capacity (26-28). Moreover, the finding that mice were 
cleared of parasites after the administration of antibodies to Treg surface markers (GITR 
and CD25) supported the concept that the induction of Tregs is part of the helminths’ own 
survival strategy (29).  
T-cell hyporesponsiveness, as observed in helminth-infected populations, is not 
restricted to parasite antigens but extends to bystander antigens, such as vaccines, 
allergens or autoantigens (9). This “spillover suppression” seems to be present particularly 
with increasing intensity of infection (30) and has several consequences, one of them being 
that infected subjects develop a regulatory network which helps to control inappropriate 
inflammation. Indeed, areas where helminths are endemic have been associated with 
a reduced prevalence of immunopathologies such as Th2-mediated allergic-diseases 
(reviewed in (6, 31, 32)), and Th1-mediated autoimmune diseases (33, 34). 
HELMINTHS AND TYPE 2 DIABETES: AN INVERSE 
ASSOCIATION?
There has been an alarming increase in the worldwide burden of diabetes, especially 
in low- to middle-income countries (35). Rapid socioeconomic development in these 
countries has led to a shift in dietary habits and infrastructure that promotes overnutrition 
and decreased physical activity, ultimately increasing the risk for type 2 diabetes (T2D) (36). 
Obesity-induced chronic low-grade inflammation has been shown to be a key feature in 
the development of insulin resistance (IR; a decrease in insulin-stimulated glucose uptake), 
which is a strong predictor for the development of T2D (37, 38). Initiation of inflammation in 
obesity involves inflammation of visceral adipose tissue and the liver, as well as the release 
of free fatty acids, which then promote systemic inflammation, reflected by increased levels 
of pro-inflammatory cytokines (37). As helminths can skew the immune system towards an 
anti-inflammatory profile, it is possible that the inflammation leading to IR is decreased, 
which would translate into a protective role of helminths in the development of T2D. This 
hypothesis is supported by the notion that there is little overlap between the proportion 
of children per country requiring preventive chemotherapy for STH and the prevalence of 
diabetes (39, 40). However, it should be noted that potential confounding factors such as 
relative wealth, diet and physical activity are likely to play a role in this observation. 
Interestingly, a number of epidemiological studies in different populations, listed in 
Figure 1, have reported an inverse association between helminths and metabolic diseases 
(Reviewed in more detail in (41)), and a recent meta-analysis showed that individuals 
with a previous or current helminth infection were 50% less likely to manifest metabolic 
dysfunction (hyperglycaemia, T2D, metabolic syndrome or insulin resistance) compared to 
those uninfected (OR 0.50; 95% CI 0.38-0.66) (42). Moreover, it was shown by a study in 









Hams et al55: Helminth T2 Rnase ω1 promotes metabolic 
homeostasis in an IL-33- and ILC2- dependent mechanism.
Berbudi et al54: Filarial infection or antigen administration 
improves glucose tolerance in diet-induced obese mice. 
Shen et al61: PSI correlated with a lower prevalence of metabolic 
syndrome and its components, including central obesity, 
hypertriglyceridemia and low HDL-C.
Hays et al62: Subjects with previous S.stercoralis infection were 
61% less likely to have a diagnosis of T2D than those uninfected.
Wiria et al43: STH infected subjects had lower BMI and lower 
HOMA-IR compared to those uninfected.
Chen et al60: PSI associated with a lower prevalence of diabetes, 
metabolic syndrome and insulin resistance.
Aravindhan et al59: Reduced prevalence of lymphatic filariasis 
among diabetic individuals compared to non-diabetic and pre-
diabetic individuals. 
Mendonca et al58: Positive association between positive S. 
stercoralis serology and T2D.
Nazligul et al57: First report of an inverse association between STH 
prevalence and diabetes.
Yang et al52: Parasitic nematode-induced modulation of body 
weight and associated metabolic dysfunction in mouse models of 
obesity.
Wu et al46: Eosinophils sustain adipose AAM associated with 
glucose homeostasis. 
Hussaarts et al53: Chronic helminth infection and helminth-derived 
egg antigens promote adipose tissue M2 macrophages and 
improve insulin sensitivity in obese mice.
Bhargava et al56: Immunomodulatory glycan LNFPIII alleviates 
hepatosteatosis and insulin resistance through direct and indirect 
control of metabolic pathways.
2012
Figure 1. Overview of experimental and epidemiological landmark studies investigating 
the association between helminth infections or administration of helminth-derived molecules and 
metabolic outcomes. (AAM, alternatively activated macrophage; ILC2, innate lymphoid type 2 
cells; T2D, type 2 diabetes; STH, soil-transmitted helminths; PSI, previous schistosome infection; 
HDL-C, high-density lipoprotein cholesterol; BMI, body mass index; HOMA-IR, homeostatic model 
assessment of insulin resistance).
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HOMA-IR, indicating that STH-infected subjects were more insulin sensitive compared to 
uninfected subjects (43). A significant negative association was found between the number 
of helminth species a subject was infected with and HOMA-IR, even after adjustment 
for age, sex and BMI (43). However, cross-sectional studies provide no information 
on the causal relationship between helminths and metabolic diseases and therefore 
longitudinal studies are needed.
HELMINTHS’ IMMUNOMODULATORY EFFECTS 
ASSOCIATED WITH IMPROVED METABOLIC HOMEOSTASIS
A number of landmark studies have provided evidence for the beneficial effects of helminths 
and helminth-derived molecules on metabolic homeostasis (Figure 1), and shed light on 
the immunomodulatory mechanisms that could explain the link between helminths and 
T2D. It was demonstrated that the maintenance of AAMs in white adipose tissue (WAT), 
necessary to maintain glucose homeostasis partly through secretion of IL-10 (44, 45), 
depends on the presence of IL-4 secreting eosinophils (46). Helminth infections promote 
WAT eosinophilia (46) and this accumulation is highly dependent on type 2 cytokines, 
particularly IL-5 (47-49). Innate lymphoid type 2 cells (ILC2s) are widely distributed in 
tissues, including WAT, lack antigen-specific receptors and are capable of producing type-2 
cytokines in response to alarmins such as IL-25 and IL-33 (50). By functional deletion of 
these cells it was shown that ILC2s are required to sustain eosinophils and AAMs in WAT as 
they are the major source of IL-5 and IL-13 (51). These findings indicate that the presence 
of eosinophils, AAMs and ILC2 immune cells in WAT have beneficial effects on obesity-
induced inflammation and improve glucose homeostasis in obese mice.
Recent studies have provided further evidence by demonstrating that the type 2 
environment induced by infection with Nippostrongylus brasiliensis (52), S. mansoni (53) or 
the filarial nematode Litomosoides sigmodontis (54) improves glucose tolerance and insulin 
sensitivity in diet-induced obese mice. In addition, similar insulin-sensitizing effects have 
been attributed to the administration of helminth-derived (egg) antigens (53-55). Despite 
the different experimental models used, increased numbers of eosinophils and AAMs 
in WAT of helminth-infected HFD-fed mice are consistently found (52-54). By infecting 
eosinophil-deficient mice, it was shown that the improvement in glucose tolerance by L. 
sigmodontis infection depended on eosinophils (54). As expected, infection induced Th2 
cytokine responses (IL-4, IL-5, IL-13) in WAT with IL-4 being the key cytokine consistently 
upregulated after infection. 
In addition, S. mansoni-soluble egg antigen (SEA) (53), S. mansoni egg-derived 
omega-1 (ω1) (55) and L. sigmodontis antigen (54) administration enhanced the number 
of group 2 innate lymphoid cells (ILC2s) in WAT and resulted in slightly increased IL-5 (not 
IL-13) production (53). Recently, Hams et al. showed that ω1 induces the release of IL-33, 
a potent inducer of ILC2s, from adipocytes in both mice and humans (55). In the absence 
of ILC2s, ω1 failed to induce the infiltration of eosinophils and AAMs in WAT and was 
unable to improve glucose tolerance in obese mice (55). This indicates a causative role of 
ILC2s in alteration of the immune cell environment in WAT.
Taken together, these findings show that in experimental animal models, helminths 
influence metabolic homeostasis, at least partly, by changing the immune cell composition 
in the adipose tissue (Figure 2). Whereas obesity-induced, chronic low-grade inflammation 
is characterized by the accumulation of CD8+ T cells, CD4+ Th1 cells, CAMs, B cells and 
mast cells in the adipose tissue, chronic helminth infections or helminth-derived molecules 
induce increased numbers of CD4+ Th2 cells, eosinophils, AAMs, Tregs and ILC2s, 
dampening the inflammation and improving glucose tolerance. 
SCOPE AND OUTLINE OF THIS THESIS
Although previous studies strongly suggest that there is an association between helminth 
infections and metabolic homeostasis, the causality of this relationship in humans has 
not been demonstrated as yet. Therefore, the main objective of this thesis is to improve 
the understanding of the role of helminth infections in the development of insulin 
resistance, hence T2D, and to gain insight into the immunological mechanisms underlying 
this possible association. 
To this end, we initiated a large scale cluster randomized controlled trial (RCT), 
described in Chapter 2, assessing the effect of anthelmintic treatment on insulin resistance 
























IL-4, IL-5, IL-13, IL-10
Figure 2. The effects of helminths and obesity on the immune cell composition in adipose tissue. 
Along with epidemiological transition, the prevalence of obesity is higher and exposure to helminth 
infections is lower in urban areas compared to rural areas. With obesity, the immune cell composition 
in the adipose tissue shifts towards a Th1 and pro-inflammatory profile associated with insulin 
resistance. Helminths or helminth-derived molecules are thought to prevent and/or reverse this shift 
by inducing a Th2 and anti-inflammatory immune cell environment, which is associated with insulin 
sensitivity. AAM, alternatively activated macrophages; CAM, classically activated macrophages.
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This area is endemic for STH and has been previously reported to have a low prevalence 
of insulin resistance and T2D. 
In chapter 3, we analyze the outcomes of this RCT with respect to the effects of 
anthelmintic treatment on STH prevalence, adiposity, insulin resistance and Th2 responses 
(e.g. eosinophil counts and total IgE levels). 
Omega-1 (ω1) is a glycoprotein that was previously identified as the major 
immunomodulatory component in S. mansoni-soluble egg antigen (SEA) and in chapter 
4, we study the effects of plant-produced recombinant ω1 treatment on whole-body 
glucose homeostasis and insulin sensitivity in a mouse model of diet-induced obesity. To 
investigate whether ω1 has a beneficial effect on metabolic homeostasis and the underlying 
mechanisms, we perform in-depth metabolic profiling and analyze the immune cell 
composition of metabolic organs.
Whereas field studies in endemic areas may be complicated by logistic challenges, there 
is no substitute for real-life biological settings of infection and it provides opportunities to 
study the underlying immunological processes that might explain the possible beneficial 
effects of helminth infections. Chapter 5 describes the method that was developed to 
study granulocyte activation by flow cytometry in the field with only basic laboratory 
infrastructure. This method is applied in our RCT conducted in Indonesia in order to study 
the effect of anthelmintic treatment on eosinophil and neutrophil activation by assessing 
activation markers, the responsiveness to stimuli and circulating levels of eosinophil 
granule proteins, the outcomes of which are described in chapter 6. 
Chapter 7 describes the effect of anthelmintic treatment on Th2-mediated responses in 
a large scale RCT in Indonesia. It measures two different components of the Th2 mediated 
response, namely IgE and IL-5 response to a mitogen, PHA.
To fully understand immune modulation by helminths and identify specific cells that 
might be important in this process, we applied mass cytometry in chapter 8, allowing high-
resolution dissection of the cellular composition of the immune system by the simultaneous 
measurement of 37 cellular markers at a single-cell level. The effects of deworming on 
type 2 and regulatory immune responses are studied by performing unbiased immune 
profiling of Indonesian adults before and after anthelmintic treatment.
Finally, chapter 9 summarizes the main findings presented in this thesis and provides 
directions for future research towards understanding the link between helminth infections, 
their immunomodulatory effects and inflammatory diseases such as T2D. 
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Insulin resistance is a strong predictor of the development of type 2 diabetes mellitus. 
Chronic helminth infections might protect against insulin resistance via a caloric restriction 
state and indirectly via T-helper-2 polarization of the immune system. Therefore, 
the elimination of helminths might remove this beneficial effect on insulin resistance.
Methods/Design
To determine whether soil-transmitted helminth infections are associated with a better 
whole-body insulin sensitivity and whether this protection is reversible by anthelmintic 
treatment, a household-based cluster-randomized, double blind, placebo-controlled trial 
was conducted in the area of Nangapanda on Flores Island, Indonesia, an area endemic for 
soil-transmitted helminth infections. The trial incorporates three monthly treatment with 
albendazole or matching placebo for one year, whereby each treatment round consists 
of three consecutive days of supervised drug intake. The presence of soil-transmitted 
helminths will be evaluated in faeces using microscopy and/or PCR. The primary 
outcome of the study will be changes in insulin resistance as assessed by HOMA-IR, while 
the secondary outcomes will be changes in body mass index, waist circumference, fasting 
plasma glucose, 2h-glucose levels after oral glucose tolerance test, HbA1c, serum lipid 
levels, immunological parameters, and efficacy of anthelmintic treatment.
Discussion
The study will provide data on the effect of helminth infections on insulin resistance. It will 
assess the relationship between helminth infection status and immune responses as well 
as metabolic parameters, allowing the establishment of a link between inflammation and 
whole-body metabolic homeostasis. In addition, it will give information on anthelmintic 
treatment efficacy and effectiveness. 
Trial registration
This study has been approved by the ethical committee of Faculty of Medicine Universitas 
Indonesia (ref: 549/H2.F1/ETIK/2013), and has been filed by the ethics committee of 
Leiden University Medical Center, clinical trial number: ISRCTN75636394. The study is 
reported in accordance with the CONSORT guidelines for cluster-randomised trials.
BACKGROUND 
The number of people with diabetes mellitus is increasing worldwide (1-3). At present, 
8.3% of adults (382 million people) have diabetes mellitus (4) and Asia is a major site 
of this rapidly emerging epidemic (5). In many Asian countries, including Indonesia, 
rapid socio-economic development has led to a shift in infrastructure, technology and 
introduction of Western style diets, which promotes overnutrition and sedentary lifestyles 
(5-8). These changes have already led to an increasing prevalence of diabetes mellitus in 
Indonesia (9-12).
A strong predictor for the development of type 2 diabetes mellitus (DM2) is insulin 
resistance (13,14), which is caused by complex disturbances in multiple biological systems. 
There is now abundant evidence that inflammation (15) plays a role in the development of 
DM2, in addition to the more established relationship between an altered energy balance 
resulting from excess consumption of high-energy foods and/or decreased physical activity. 
In DM2 subjects, chronic low-grade inflammation is a common feature (15) which results, 
at least in part, from the activation of inflammatory pathways by fatty acids in multiple 
organs (16-18). However, the fundamental molecular mechanisms are still incompletely 
understood (19). 
In developing countries, infectious pressure might be one particular modifier of insulin 
resistance. Helminth infections, which are still endemic in many low to middle income 
countries, may therefore affect whole-body and tissue-specific insulin sensitivity owing 
to their immunomodulatory properties (20). Previous studies have shown that helminth 
infections can adopt an immune evasion strategy by inducing regulatory T cells (21-26). 
Hereby helminth infections may decrease systemic inflammation and subsequently 
the development of inflammatory diseases, including DM2 (27-30). Studies examining 
the relationship between helminth infections and DM2 in both humans (31,32) and murine 
modelss (33,34) support this hypothesis. At a molecular level, mTOR, a serine/threonine 
protein kinase located downstream of insulin signalling, plays an essential role in immune 
cell energy metabolism and function (35,36). Furthermore, it has been shown that STAT6 
signalling downstream of IL-4, as well as Th2 responses induced by helminths, improve 
glucose metabolism and insulin signalling (33,37). Intriguingly, in humans, immune 
intervention with IL-1 receptor antagonist (Anakinra) has also been shown to influence 
glucose metabolism (38).
Helminths are also known to reduce energy intake and thereby change the energy 
balance (39), which may be beneficial in terms of insulin resistance (39,40). Helminths 
may therefore both directly improve insulin sensitivity via a caloric restriction state and 
indirectly via Th2 activation. It appears, the immune system which has evolved with 
helminths (41) and under conditions of low energy intake, seems to be out of balance 
in situations of nutritional overload and decreasing exposure to parasites (23,42). In line 
with the proposed beneficial effects of helminth infections on glucose metabolism, our 
previous unpublished cross sectional study in Flores Island, Indonesia, has shown that 
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subjects infected with intestinal helminths have a significantly lower insulin resistance as 
expressed by HOMA-IR.
Although aforementioned studies strongly suggest that there is an association between 
helminth infections, systemic inflammation and glucose metabolism, the causality in these 
relationships has not been demonstrated as yet. Therefore, we have initiated a large scale 
cluster randomized controlled trial (RCT) with the aim to assess the effect of anthelmintic 
treatment on insulin resistance, the hypothesis being that reduction of worm load to 
undetectable levels will lead to a higher degree of insulin resistance. While study outcomes 
will be analysed at the individual participant level, a household cluster randomization was 




The study area is located in Nangapanda, a sub-district of the Ende District of Flores 
Island, Indonesia (43,44). Nangapanda is a semi-urban coastal area with a population of 
approximately 22.000 people being divided over 29 villages. Our study area includes 
three of these villages (Ndeturea, Ndorurea 1, Ndorurea, with a total population of 3698 
people, from which most of the adult population are farmers. Previous studies have shown 
that this area is endemic for soil-transmitted helminth (STH) infections (45). A detailed map 
of the study area has been published (43).
Trial design
The study is designed as a household-based cluster-randomized, double-blind trial with 
two arms. In one arm treatment is given with albendazole (single dose of 400 mg) on 
3 consecutive days, while the other arm consists of matching placebo treatment (both 
albendazole and placebo are manufactured by PT Indofarma Pharmaceutical, Bandung, 
Indonesia). The treatment is provided every three months for a period of 1 year (total 4 
rounds) to all household members except children below 2 years of age, while subjects 
aged 16 or above will undergo clinical and laboratory examination. Subjects with 
active treatment for diabetes mellitus, serious concomitant disease and pregnancy will 
be excluded.
The population was randomised by JWAS and JJH using  computer aided block 
randomization at household level, utilizing Random Allocation Software to assign 
treatment groups. Both study investigators and patients are blinded for treatment codes. 
The treatment code will be unblinded when all data needed for analysis are cleaned and 
entered into the database. An additional randomization was performed in a subgroup of 
individuals, who will undergo an oral glucose tolerance test and immunological studies 
in order to study glucose metabolism and immune mechanisms in more detail. For this 
subgroup, we aimed to select one subject per household and stratified by age group 
(16-36 years of age, 36-56 years of age, and >56 years of age) to ensure that sufficient 
numbers of all age groups are participating. Randomization was based on households.
Well trained community workers were recruited and trained to distribute the drugs. 
These workers were also trained to assist during clinical examination and sample collection 
and were involved in health promotion within the population. Community workers and 
research team members will directly supervise the study participants while taking the study 
medication, and will collect empty drug canisters at each visit to confirm compliance. 
Furthermore, assessment of side effects will take place during these visits and migration 
and death will be noted. Adverse events spontaneously reported by the patient or 
observed by the investigators, will be monitored throughout the study. After completion 
of the study, the whole study population will be treated with a single dose of albendazole 
(400 mg) for 3 consecutive days.
Outcomes
As this study aims to assess the effect of anthelmintic treatment on whole-body insulin 
sensitivity, our primary outcome is a change in insulin resistance as assessed by HOMA-IR 
between both treatment arms after one year of treatment. Secondary outcomes are changes 
in body mass index and waist circumference, fasting plasma glucose, 2h-glucose levels 
after oral glucose tolerance test, HbA1c, serum lipid levels, immunological parameters, 
and efficacy of anthelmintic treatment.
Sample size 
Sample size is calculated according to intention to treat analysis in which we will need 
1580 subjects in total. Based on our previous study (45) we assume that the average 
household size is 4 and that around 20% will be lost to follow up after one year. We use 
a significance level of 5% and a power of 80%. Correlations within households are taken 
into account by using the correction factor 1 + (m-1) ICC, with m being the household size 
and ICC the intra-class correlation. The sample size is computed for a difference in mean 
between the two treatment groups of 0.18 and an ICC of 0.1.
For the subgroup of individuals undergoing an oral glucose tolerance test, a sample 
size of 335 subjects in total is calculated assuming that around 20% will be lost to follow 
up after one year and using a significance level of 5% and a power of 80%. The sample size 
is computed for a difference in mean of 10.3 mg/dL and a standard deviation of glucose 
level of 30 mg/dL.
METHODS
Sample collection
At baseline all eligible subjects, aged 16 and above will be invited to visit the examination 
centre after an overnight fasting and to provide stool, blood and first morning urine 
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samples. During this visit, participant’s education level and profession will be registered. 
After 1 year of treatment, follow-up sample collection will take place as shown in Table 1. 
Clinical anthropometry assessment
Anthropometric measurements of body weight, height, waist and hip circumference are 
obtained using the National Heart, Lung, and Blood Institute (NHLBI) practical guidelines. 
To measure body weight a flat scale for mobile use (SECA Model 876, Seca Gmbh Co, 
Hamburg, Germany) is used, while a portable stadiometer (SECA Model 213, Seca 
Gmbh Co, Hamburg, Germany) is used to measure height. Waist and hip circumference 
are measured using ergonomic circumference measuring tape (SECA Model 201, Seca 
Gmbh Co, Hamburg, Germany). In addition, body fat composition is measured using 
a Tanita body composition analyser (TBF-300A, Tanita Corp, Tokyo, Japan). Three blood 
pressure measurements (left arm, sitting upright position, after resting 5 minutes) are taken 
from each subject, using a digital sphygmomanometer (HEM-7200, Omron Healthcare 
Co, Ltd, Kyoto, Japan), and calibrated using a Riester nova-presameterH-Desk model 
mercury sphygmomanometer (Gerhard Glufke Rudolf Riester GmbH & Co, Jungingen, 
Germany) and a 3MTM LittmannH Classic II S.E. Stethoscope (3M, St. Paul, Minnesota, 
USA). The average of three systolic/diastolic blood pressure measurements will be used 
for analysis.
Parasitological examination
To assess intestinal helminth infection, stool containers are distributed and collected by 
health workers. Stool samples are examined by the Kato Katz method (46) for identification 
and quantification of STH eggs using 2 slides for each sample. An aliquot of the fresh 
stool samples is frozen at -20oC in the field and subsequently at -80oC in laboratories 
of the Departments of Parasitology at Leiden University Medical Center, Leiden, 
The Netherlands and Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia for 
DNA extraction (43). Part of the stool sample will be saved for potential future analysis of 
the microbiome. 
DNA isolation and helminth real-time PCR
DNA isolation from stool will be performed as described elsewhere (43), with some minor 
modifications. Real-time PCR will be performed to detect the presence of A. duodenale, 
N. americanus (hookworm), A. lumbricoides and T. trichiura using a method described 
previously (43) with some modifications. 
Blood collection 
Peripheral blood is collected into EDTA and SST Vacutainers (BD, Franklin Lakes, NJ, USA). 
Giemsa-stained peripheral blood smear is prepared to evaluate neutrophil and eosinophil 
count. In a subset of the study population, additional blood is collected in PAXgene 
Blood RNA Tubes (PreAnalytiX GmbH, Hombrechtikon, Switzerland) and Sodium Heparin 
Vacutainers (BD). Blood collected in PAXgene Blood RNA Tubes will be used to study RNA 
expression profiles, while blood collected in Sodium Heparin Vacutainers will be used 
for detailed immunological measurements as described below (section Immunological 
methods). All samples deriving from EDTA and SST Vacutainers (serum, plasma, cell 
pellet and whole blood) and all PAXgene Blood RNA Tubes are kept at -200C at the Field 
Clinical Research Centre (FCRC) and will be sent on dry ice to the University’s laboratory 
for storage at -800C. 
Metabolic parameters
Fasting blood glucose is measured in capillary blood using Breeze®2 glucose meters 
(Bayer Health Care LLC, Basel, Switzerland). An oral glucose tolerance test is performed in 
a subset of the study population according to the WHO protocol (47,48). Glucose levels 
are measured in capillary blood using Breeze®2 glucose meters after overnight fasting 
and 2 hours after ingesting 75g of anhydrous glucose dissolved in 200 cc of water. Insulin, 
HbA1c and lipid profiles will be measured in an internationally accredited laboratory. 
HOMA-IR, a well-validated measure of insulin resistance will be calculated to estimate 
insulin resistance (49). 
Immunological methods
The immunological parameters that will be studied are 1) Total IgE levels as one of 
the markers of a Th2 response and its relation to metabolic parameters, 2) Circulating 
pro- and anti-inflammatory cytokines in order to study their relationship to metabolic 
parameters, 3) Antigen specific IgE and IgG to Ascaris lumbricoides to monitor antibody 
responses to one of the helminths studied as a marker of changing immune responses as 
a result of anthelmintic treatment, 4) Granulocyte (neutrophil and eosinophil) frequencies 
and their activation to assess whether granulocytes, in particular eosinophils which are 
associated with a Th2 response, are linked to helminth infections and metabolic parameters, 
5) Peripheral blood mononuclear cells (PBMC) subset analysis and polarisation by flow 
cytometry in order to assess the relationship between immune cell frequencies (T cell 




follow up1st 2nd 3rd 4th
Clinical Anthropometry X X
Parasitological examination X X
Metabolic parameters X X
Immunological parameters X X
Assessment of side effects X X X X X
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subsets, B cell subsets, monocyte subsets, NK cells and myeloid suppressor cells) in situ as 
well as after activation and metabolic parameters.
Total IgE
Total IgE will be measured using ELISA with rabbit anti-human IgE antibodies (Dako, 
Glostrup, Denmark) and goat anti-human IgE biotinylated antibodies (Vector Laboratories, 
Burlingame, CA, USA) as capture and detection antibodies, as described previously (43). 
The World Health Organization standard of human serum IgE was used as a reference 
(National Institute for Biological Standards and Control). The results will be expressed in 
International Units (IU).
Circulating cytokines
Pro- and anti-inflammatory cytokines (TNFα, IFNγ, IL-1, IL-6, IL-10, TGFβ) will be measured 
in serum samples using cytokines kit with high sensitivity.
Ascaris-specific IgE
Ascaris antigen will be prepared from Ascaris lumbricoides worms as described previously 
(50). Maxisorp plates (Thermo Fisher Scientific, Roskilde, Denmark) will be coated overnight 
with 5 µg/ml Ascaris antigen in 0.1 M carbonate buffer (pH 9.6). Plates will be blocked for 
1 hour with PBS containing 2% bovine serum albumin. Samples will be diluted 1/60 in 0.1 
M Tris-HCl containing 0.05% Tween-20 and incubated overnight together with a pool of 
positive standard plasma containing 1 x 106 arbitrary units (AU) parasite specific IgE. After 
a washing step, goat anti-human IgE biotinylated antibodies (Vector) will be incubated 
followed by streptavidin-HRP (Sanquin, Amsterdam, the Netherlands). The color is 
developed by adding 3,3’,5,5’ tetramethylbenzidine (TMB) (KPL, Gaithersburg, MD, USA). 
The reaction will be stopped by adding 1.8 M H2SO4 and absorbance will be read at 450 
nm in an automated plate reader. 
Ascaris-specific IgG isotypes
Maxisorp plates will be coated with Ascaris antigen as described for Ascaris specific IgE 
above. Blocking will be done using PBS containing 5% bovine serum albumin. Samples 
will be diluted 1/1000, 1/10, 1/5 or 1/25 for IgG1, IgG2, IgG3 and IgG4 respectively, and 
a pool of positive standard plasma containing 1 x 106 arbitrary units (AU) parasite specific 
IgG isotypes will be included in each plate. After overnight incubation, HRP-labelled 
anti human IgG isotypes (Sanquin) in PBS 0.05% Tween-20 will be added for 4 hours 
incubation at 370C using the following dilutions: 1/3000 for anti IgG1 (HP6188) and anti 
IgG4 (HP6196); 1/1000 for anti IgG2 (HP6014) and anti IgG3 (HP6095). TMB substrate will 
be used to develop the color and the reaction will be stopped as described above.
Whole blood stimulation and fixed granulocyte cryopreservation
To study the expression of activation markers on granulocytes, 600 μl of heparinised 
venous blood is divided over 3 polystyrene tubes (200 μl/tube). After a pre-incubation of 5 
minutes in a 37°C waterbath, a 5 minutes stimulation at 37°C is performed with N-Formyl-
Met-Leu-Phe (FMLP, 10-5 M; Sigma, Saint Louis, MO, USA) or eotaxin (10-7 M; R&D systems, 
Abingdon, UK). Subsequently, 4 ml of FACS lysing solution (BD) is added and after an 
incubation period of 15 minutes at room temperature the red blood cells are lysed while 
white blood cells, including granulocytes, become fixed. Cells are washed with RPMI 1640 
containing 10% heat-inactivated FCS and then resuspended in RPMI 1640 containing 10% 
of heat-inactivated foetal calf serum (FCS) and 10% dimethyl sulfoxyde (DMSO). Cryovials 
containing the cell suspension are placed at -80°C for minimum of 4 hours, followed by 
storage in liquid nitrogen until further analysis.
PBMC cryopreservation
Peripheral blood mononuclear cells (PBMCs) are isolated from heparinised venous blood 
using Ficoll density gradient centrifugation within 12 hours after blood collection. After 
isolation, cells are cryopreserved in RPMI 1640 containing 20% of FCS and 10% DMSO. 
Cryovials containing the cell suspension are transferred to a freezing unit which is placed 
in a -80°C freezer for minimum of 4 hours. Subsequently, vials are stored in liquid nitrogen 
until analysis.
Metabolomics for metabolic profiling
Urine samples and blood samples from heparinized blood are kept at -200C at the FCRC 
and subsequently stored at -800C at the University’s laboratory for possible future 
metabolomics measurements. The exploratory metabolomics analysis will be performed 
by 1H-NMR and LC-MS metabolomics, a combination of NMR and LC-MS proposed for 
this study provides a comprehensive coverage of metabolome and as such increases 
the probability of finding physiologically meaningful associations within the data. 
Data management and statistical analyses
A centrally accessible database designed in Microsoft Access is established and the data 
is entered by well-trained data entry personnel. Descriptive data will be summarized for 
continuous variables as mean +/- SD for normally distributed data and median (range) for 
non-normally distributed data. Categorical data will be expressed as proportions.
The effect of anthelmintic treatment on insulin resistance (HOMA-IR) as our primary 
outcome will be assessed using an intention to treat approach after 1 year of treatment 
using mixed models to account for the correlation within households, in which relevant 
confounders (including age, gender, BMI, village) are entered. The characterization of 
immune responses to helminth infections and systemic inflammation will be assessed by 
measuring cytokine profiles. Moreover, for these analyses multilevel modelling will be 
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used and the use of longitudinal data will take repeated measurement into account (51). 
The mediation of helminth’s effects on insulin resistance via immune responses will also 
be assessed.
Ethical approval, trial registration and consent
This study has been approved by The Health Research Ethical Committee, Faculty of 
Medicine, Universitas Indonesia Cipto Mangunkusumo Hospital, Jakarta, Indonesia 
(reference number:549/H2.F1/ETIK/2013). It has also been filed by the ethics committee of 
Leiden University Medical Center and is registered as a clinical trial ref: ISRCTN75636394 
(http://www.controlled-trials.com/isrctn/pf/75636394). The local health authorities have 
been informed about this study and have given their approval and support. The study, 
its benefits and risks are explained to the population and consent forms are distributed 
to be signed by the subjects who are willing to participate in this study. They are 
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Figure 2. Age pyramid. Age pyramid of all individuals living in the study area in Nangapanda, Flores 
island, Indonesia (n=3698 subjects, 52% female) (A), and of study participants (n=1669 subjects, 60% 
female) (B).
Figure 1. Flow diagram of the Sugarspin project.
Description of the population recruited
So far, the study has provided the following data (Figure 1). At baseline, a total of 3698 
individuals were registered in 752 households. Of the 2428 subjects aged 16 years or older, 
1669 subjects were eligible with consent for examination. For the oral glucose tolerance 
test and immunological studies 339 subjects were randomly selected and gave approval. 
Figure 2 shows the age pyramid of both the total population in the study area and 
the study population. In the study population farming and fishing are the traditional source 
of income, while some individuals engage in jobs at government offices or in the private 
sector (Figure 3). A similar distribution is seen in the total population. The education level 
of the majority of subjects in the study population is elementary school (33%), followed by 
senior high school (22%), and junior high school (16%), while 11% has college or university 
degrees. Moreover, 18% of the subjects is illiterate, either not educated at all or dropped 
out from elementary school (Figure 4). A similar distribution of education levels is seen in 
the total population.




The SUGARSPIN trial is the first and currently the only longitudinal study investigating 
the effects of anthelmintic treatment on whole-body insulin sensitivity. This placebo-
controlled trial enables us for the first time to investigate the causal relationship between 
helminth infections, systemic inflammation and glucose metabolism in humans. In addition, 
this study will provide data on anthelmintic treatment efficacy and effectiveness in a large 
population in a developing country like Indonesia. 
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Figure 4. Education level. At baseline, education level was assessed for study participants 
(n=1669 subjects).
Figure 3. Job distribution. At baseline, profession was assessed for study participants 
(n=1669 subjects).
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Emerging evidence suggests that helminth infections are associated with lower insulin 
resistance (IR). Current deworming programs might remove this helminth-associated 
protective effect. Therefore, we evaluated the anthelmintic treatment effect on changes 
in IR.
Methods
We conducted a double-blind, household-cluster-randomized, placebo-controlled clinical 
trial on Flores island, Indonesia, an area endemic for soil-transmitted helminths (STHs). All 
subjects received four rounds of albendazole or matching placebo with 3-month intervals, 
for 3 consecutive days. The primary outcome was the change in homeostatic model 
assessment of IR (HOMA-IR) in those aged >16 years. An intention-to-treat analysis was 
performed involving all subjects and ad hoc in the helminth-infected subjects. 
Results
We examined 797 (in 329 households) and 872 (in 353 households) subjects, who were 
assigned randomly into the albendazole and placebo arm, respectively. Albendazole was 
associated with a significant reduction in STH prevalence, total Immunoglobulin E (IgE) 
and eosinophil count. Whereas albendazole had no effect on IR (estimated treatment 
effect, 0.006 (95% confidence interval, -.010 – .021), P = .48) at the community level, it 
was associated with a significant increase in IR (estimated treatment effect, 0.031 (95% 
confidence interval, .004 – .059), P = .04) (P value for interaction = .01) among helminth-
infected subjects as detected by microscopy. Pathway analysis suggested that this might 
in part be due to an increased body mass index or a reduced eosinophil count.
Conclusions
Anthelmintic treatment reduces STH prevalence, total IgE and eosinophil count but has no 
effect on IR at the community level. In helminth-infected subjects, treatment significantly 





The increasing prevalence of type 2 diabetes mellitus (DM2) is a major health concern 
worldwide, in particular in low- and middle-income countries (1). Rapid socioeconomic 
development in these countries has led to a shift in dietary habits and infrastructure 
that promotes overnutrition and decreased physical activity (2), ultimately increasing 
the risk for DM2. DM2 is characterized by increased insulin resistance (IR). Although 
the pathophysiology of DM2 is complex and involves several defects (3), there is evidence 
that in addition to an altered energy balance, chronic low-grade systemic inflammation 
plays a key role, linking the immune system and the impairment in metabolic homeostasis (4).
Helminth infections, which are still endemic in many low- and middle-income countries 
(5), are associated with skewed immune responses toward type 2 and regulatory immune 
responses (6). This may lead to a decreased systemic inflammation and consequently 
increased whole-body and tissue-specific insulin sensitivity (7). In addition, helminths 
are associated with a lower body mass index (BMI) (8), which may be beneficial in terms 
of IR. Helminths may therefore improve insulin sensitivity via immunological and non-
immunological pathways (6, 9, 10). 
Interleukin 4 (11) and interleukin 10 (12), key cytokines in helminth infections, have 
been shown to regulate peripheral nutrient metabolism and insulin sensitivity (11). Recent 
studies in animal models of diet-induced obesity (13-17) have also shown that helminth 
infections (13, 15-17) and helminth-derived molecules (14, 16-18) can increase insulin 
sensitivity through direct and indirect control of metabolic pathways (18). Furthermore, 
several population-based studies have reported a lower DM2 risk in subjects with previous 
(19, 20) or current (21, 22) chronic helminth infections. In a previous study on Flores island 
in Indonesia, we reported that chronic soil-transmitted helminth (STH) infections were 
associated with lower whole-body IR, independent of BMI (8). 
However, all human studies performed so far have been cross-sectional, preventing any 
insight on a causal relation between helminth infections and IR. Therefore, we performed 
a cluster-randomized controlled trial of anthelmintic treatment in an area endemic for 




We conducted a household-based, cluster-randomized, double-blind trial in 3 villages 
in Nangapanda, Ende, Flores island, Indonesia. The trial was approved by the ethics 
committee of Faculty of Medicine, Universitas Indonesia (FKUI), filed by the ethics 
committee of Leiden University Medical Center (LUMC), and registered as a clinical trial 
(http://www.isrctn.com/ISRCTN75636394). The protocol was published previously (23).




All subjects in the study area, except children <2 years of age and pregnant women, were 
included in the trial to avoid cross-contamination between household members. Subjects 
aged ≥16 years underwent clinical and laboratory examination, excluding subjects with 
active treatment for diabetes mellitus and serious concomitant diseases. 
Study Design and Treatments
After obtaining written informed consent, the population was randomized by household 
blocks using random allocation software for assignment to treatment. Both study 
investigators and participants were blinded for the treatment code. After randomization, 
all study subjects received a tablet of albendazole (400 mg) or matching placebo (both 
manufactured by PT Indofarma Pharmaceutical, Bandung, Indonesia) for 3 consecutive days 
with direct supervision. This treatment regimen was given 4 times with 3-month intervals 
(weeks 9-10, 21-22, 33-34, and 45-46). Clinical measurements, as well as blood and stool 
sample collection, were performed during the first 8 weeks before the start of the drug 
administration (baseline or t=0) and 6 weeks after the last drug administration (follow-up 
or t=52 weeks) (Supplementary Figure 1). After completion of the study, the whole study 
population was treated with a tablet of albendazole (400 mg) for 3 consecutive days.
Study Procedures and Outcomes
All clinical measurements and blood sample collections were performed after an overnight 
fast. Detailed information on study procedures are available in the Supplementary 
Appendix. In brief, body weight, height, waist circumference, and hip circumference were 
measured, from which BMI and waist-to-hip-ratio were calculated. Fasting blood glucose 
was determined in capillary blood. All sera, plasma, whole blood, and stool samples were 
frozen at −20°C and subsequently stored at −80°C. Insulin, hemoglobin A1c (HbA1c), total 
cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides and high-sensitivity 
C-reactive protein (hs-CRP) were measured pairwise (baseline and follow-up) in the same 
analytical runs at the LUMC. A Giemsa-stained peripheral thin blood smear was read at 
FKUI to assess the differential white blood cell count, resulting in a relative percentage of 
basophils, eosinophils, neutrophils, lymphocytes and monocytes. Total immunoglobulin E 
(IgE) was measured at LUMC as described previously (24).
Fresh stool samples were examined by microscopy using the Kato-Katz method to 
detect STHs (hookworm, Ascaris lumbricoides, and Trichuris trichiura). Multiplex real-time 
polymerase chain reaction (PCR) was performed to simultaneously detect the presence of 
hookworm (Ancylostoma duodenale, Necator americanus), A. lumbricoides, T. trichiura, 
and Strongyloides stercoralis. Stool samples were considered positive by PCR when cycle 
threshold (Ct) values were <50, and further grouped into 3 categories: Ct <30, 30 to <35, 
and ≥35 representing a high, moderate and low DNA load, respectively (25). 
Primary outcome was IR, assessed using the homeostatic model assessment of IR 
(HOMA-IR), a well-validated measure of whole body IR in humans (HOMA-IR = fasting 
serum insulin x fasting glucose / 22.5) (26). Secondary outcomes included BMI, waist 
circumference, fasting blood glucose, HbA1c, lipid levels, total IgE, eosinophil count, 
hs-CRP and prevalence of STHs as assessed by microscopy and stool PCR. Adverse events 
reported by subjects or observed by the investigators were monitored during the trial.
Statistical Analysis
The sample size was calculated according to intention-to-treat analysis. Based on our 
previous study (27), we assumed that the average household size is 4 and that around 20% 
of participants would be lost to follow-up after one year. We used a significance level of 
5% and a power of 80%. Correlations within households were taken into account by using 
the correction factor 1 + (m-1) ICC, with m being the household size and ICC the intra-
class correlation. The sample size was calculated to aim at a difference in mean HOMA-IR 
between the 2 treatment groups of 0.18 and an ICC of 0.1, indicating 1580 subjects 
in total. 
For continuous variables, normally distributed data were summarized as mean and 
standard deviation (SD), whereas non-normally distributed data (HOMA-IR, insulin, hs-CRP, 
total IgE and eosinophil count) were summarized as geometric mean and 95% confidence 
interval (CI), and log-transformed for analyses. HOMA-IR and hsCRP were log transformed 
as log10(1+(value)). Categorical data were expressed as proportions. 
The effect of anthelmintic treatment on HOMA-IR was assessed at community level using 
an intention-to-treat approach, using mixed models to account for the correlation within 
households. As an ad hoc analysis, we stratified by infection status by including helminth 
infection status (no infection, any infection) at baseline and its interaction with treatment 
into the model. We also stratified by the number of helminth species a subject was infected 
with, by including the number of helminth species (no infection, single infection, multiple 
infection) at baseline and its interaction with treatment into the model. Two random effects 
were used: To model clustering within households, a random household specific intercept 
was used, and to model correlation within subjects, random subject-specific intercept was 
used. Parameter estimates for treatment effect and 95% CIs were reported. The reported 
P values were obtained using a likelihood ratio test comparing the model with and without 
the treatment effect. We used the same model for secondary outcomes. For the binary 
outcome (helminth infection status), a logistic model was used with random household 
effects and random subject effects. All models were fitted using the lme4 package 
(R software).
RESULTS
Between 1 April 2014 and 3 June 2014, we initially included 752 households with 3566 
subjects in the trial. Randomization resulted in 1825 subjects assigned to placebo and 1741 
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subjects to albendazole (377 and 375 households, respectively). The overall trial profile 
is shown in Figure 1, with a total of 1669 subjects aged ≥16 years who were examined at 
baseline (872 subjects (353 households) and 797 subjects (329 households) in the placebo 
and the albendazole groups, respectively). Baseline characteristics were similar between 
both treatment arms (Table 1). 
The overall loss to follow-up, from baseline to 52 weeks, was 18.9%. The main reason 
for loss to follow-up was permanent or temporary movement out of the village for 
Figure 1. Trial profile. #Baseline data (t=0) were collected during the first 8 weeks before the start of 
the drug administration. $Single dose of albendazole or matching placebo was given for 3 consecutive 
days to all household members, except children <2 years of age and pregnant women. *Other reasons 
of lost to follow-up were harvesting crops, working on funeral ceremonies, severely ill, hospitalized, 
and nursing mother. Abbreviations: HH, households; FU, follow-up.
Table 1. Baseline characteristics of the study population
Characteristic No. Placebo No. Albendazole
Age, y, mean (SD) 872 42.5 (15.7) 797 42.5 (15.7)
Sex, female, No. (%) 872 534 (61.2) 797 478 (60.0)
Body mass index, kg/m2, mean (SD) 860 22.4 (4.2) 790 22.4 (4.0)
Waist circumference, cm, mean (SD)
 Female 532 76.5 (12.6) 476 77.0 (12.6)
 Male 333 76.5 (11.6) 317 76.6 (11.3)
Waist-to-hip-ratio, mean (SD)
 Female 507 0.88 (0.07) 473 0.89 (0.08)
 Male 317 0.94 (0.07) 315 0.94 (0.07)
Systolic BP, mmHg, mean (SD) 871 129.3 (23.4) 765 129.5 (23.8)
Diastolic BP, mmHg, mean (SD) 871 76.4 (12.1) 765 76.5 (12.1)
Total cholesterol, mmol/L, mean, (SD) 836 4.9 (1.1) 764 4. 9 (1.1)
HDL  cholesterol, mmol/L, mean, (SD)
 Female 517 1.3 (0.4) 457 1.3 (0.4)
 Male 319 1.1 (0.3) 307 1.1 (0.3)
LDL cholesterol, mmol/L, mean, (SD) 836 3.0 (0.9) 763 3.0 (0.9)
Triglycerides, mmol/L, mean, (SD) 836 1.4 (0.7) 764 1.5 (0.7)
HbA1ca, mmol/mol, mean (SD) 715 32.5 (9.0) 683 32.3 (8.5)
Fasting blood glucose, mmol, mean, (SD) 836 5.5 (1.6) 768 5. 5 (1.6)
Fasting Insulin, mU/L, GM (95%CI) 836 3.5 (3.2 – 3.7) 768 3.5 (3.3 – 3.8)
HOMA-IR, GM (95%CI) 836 1.09 (1.02 – 1.15) 768 1.08 (1.01 – 1.14)
hs-CRP, mg/L, GM (95%CI) 836 1.26 (1.16 – 1.36) 764 1.26 (1.16 – 1.37)
Total IgE, IU/mL, GM (95%CI) 835 557.2 (498.1 – 623.3) 766 601.6 (534.8 – 676.7)
Eosinophil count, %, GM (95%CI) 829 5.9 (5.6 – 6.1) 763 6.1 (5.8 – 6.4)
Helminth infection by microscopy, No. (%) 655 283 (43.2) 602 251 (41.7)
 Single 185 (28.2) 160 (26.6)
 Multiple 98 (15.0) 91 (15.1)
Helminth infection by PCR, No. (%) 783 425 (54.3) 710 393 (55.4)
 Single 256 (32.7) 252 (35.5)
 Multiple 169 (21.6) 141 (19.9)
Abbreviations: BP, blood pressure; CI, confidence interval; GM, geometric mean; HDL, high-density lipoprotein; 
HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment for insulin resistance; hs-CRP, high-sensitivity 
C-reactive protein; IgE, immunoglobulin E; LDL, low-density lipoprotein; PCR, polymerase chain reaction; 
SD, standard deviation. aAfter excluding subjects with unidentified hemoglobinopathy on the Tosoh G8 high-
performance liquid chromatography analyzer (13.9% [116/831] in the placebo group and 10.5% [80/763] in 
the albendazole group).
employment or study. Those who moved out and refused to come for follow-up were 
younger in comparison to the whole population. There were no significant differences 
between both treatment arms in terms of loss to follow-up (Supplementary Table 1). 
With respect to compliance, 87.9% (1189/1353) of the subjects took the maximum of 12 
tablets (87.0% (574/660) vs 88.7% (615/693) in the albendazole and the placebo groups, 
respectively). We collected stool samples from 92.0% (1535/1669) of the subjects at 
baseline and 89.9% (1217/1353) of the subjects at follow-up. Data to calculate HOMA-IR 
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were available for 1604 subjects at baseline, and for 1272 subjects at follow-up. Sixteen 
subjects who were receiving active treatment for DM2 were excluded from analysis.
Effect of Treatment at the Community Level
Albendazole treatment reduced the percentage of subjects with any helminth infection as 
assessed by either microscopy (from 41.7% (251/602) to 5.6% (27/486) in the albendazole 
arm vs 43.2% (283/655) to 34.4% (181/526) in the placebo arm; P < .0001) or PCR (from 
55.4% (393/710) to 11.3% (62/550) in the albendazole arm vs 54.3% (425/783) to 46.8% 
(278/594) in the placebo arm; P < .0001). The highest reduction was seen for hookworm, 
followed by A. lumbricoides and T. trichiura infection (Figure 2). When assessing 
the infection intensity in categories based on PCR, albendazole treatment resulted in 
a reduction in intensity across these 3 helminth species with the least effect on T. trichiura 
infection (Figure 2B). S. stercoralis prevalence, which was already low, was eliminated in 
the albendazole group (Supplementary Table 2).
At the community level, neither HOMA-IR nor BMI, waist circumference, fasting blood 
glucose, HbA1c, total cholesterol, HDL-C, LDL-C, triglycerides, or hs-CRP were found 
to be affected by albendazole treatment (Table 2). However, the significant reduction 
of infection prevalence and intensity by albendazole treatment was accompanied by 
a significant decrease in total IgE level (estimated treatment effect, -0.066 (95% CI, 
-.094 – -.037); P < .0001) and eosinophil count (-0.057 (95% CI, -.086 – -.028); P = .0001) 
(Table 2). 
Effect of Treatment in STH-infected Subjects
Next, the effect of treatment was assessed only in those who were infected with helminths 
at baseline, as detected by microscopy. Albendazole treatment resulted in a significant 
increase in HOMA-IR (0.031 (95% CI, .004 – .059); P = .04) (Figure 3A). This effect was 
greater in comparison to subjects without helminth infections at baseline (P = .01 for 
the interaction between helminth infection status at baseline and treatment). Moreover, 
with an increasing number of helminth species infecting a subject at baseline, there was 
a gradual increase in HOMA-IR after treatment. Thus, whereas we saw no significant effect 
of treatment among those with no infection (-0.013 (95% CI, -.035 – .010); P = .28) or those 
infected with single species (0.017 (95% CI, -.017 – .050); P = .34), treatment in those 
infected with multiple helminth species resulted in a significantly higher HOMA-IR (0.061 
[95% CI, .015 – .106]; P = .02; P value for interaction = .005) (Figure 3A). These effects 
were also reflected for BMI (Figure 3B), eosinophil count (Figure 3C), and total IgE level 
(Figure 3D), but not for HbA1c, total cholesterol, HDL-C, LDL-C, triglycerides or hs-CRP 
level. Pathway analysis showed that adjustment for BMI and eosinophil count, but not total 
IgE level, attenuated the treatment effect on HOMA-IR among helminth-infected subjects 
(Supplementary Table 3).
When using PCR to detect STH infection, a significant increase of HOMA-IR was 
observed only among subjects who were infected with multiple helminth species at 
baseline (Supplementary Figure 2A). A significant increase of BMI was also observed in 
these subjects (Supplementary Figure 2B). The group of subjects infected with multiple 
helminth species had a significantly higher infection intensity in comparison to the group 
of subjects infected with single helminth species (Supplementary Table 4). 
Adverse Events
Adverse events were reported in 3.9% (31/797) and 2.6% (23/872) of subjects in 
the albendazole and the placebo groups, respectively. Abdominal pain was the most 
commonly reported complaint (35% (11/31) vs 13% (3/23) in the albendazole and the placebo 
groups, respectively). Other commonly reported complaints were diarrhea and nausea, 
which were similar in both treatment arms.
Figure 2. The effect of albendazole treatment on the prevalence and intensity of soil-transmitted 
helminths. Percentage of hookworm-, Ascaris lumbricoides-, and Trichuris trichiura-infected subjects 
at baseline (t=0) and following treatment (t=52 weeks), in the placebo and albendazole treatment 
arms, as detected by microscopy (n=1011; A) and polymerase chain reaction (n=1144; B). Albendazole 
treatment was associated with a significant reduction of hookworm, A. lumbricoides and T. trichiura. 
P values were calculated using a logistic model with random household effects and random subject 
effects. *P <.0001.
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Table 2. Effect of albendazole treatment on primary and secondary outcomes at the community level
Outcome Parameter
Placebo Albendazole
Treatment Effect (95%CI) P valueBaseline Follow-up Baseline Follow-up
Insulin resistance HOMA-IR 1.09 (1.02 – 1.15)
n=836
1.16 (1.09 – 1.24)
n=659
1.08 (1.01 – 1.14)
n=768
1.17 (1.13 – 1.25)
n=635
0.006 (-.010 – .021) .48








0.018 (-.105 – .142) .77
Fasting insulin (mU/L) 3.5 (3.2 – 3.7)
n=836
3.8 (3.5 – 4.1)
n=646




0.006 (-.032 – .043) .77








0.051 (-.350 – .452) .80








0.104 (-.011 – .220) .08








-0.229 (-.855 – .397) .47








-0.031 (-.098 – .035) .35








-0.008 (-.031 – .016) .52








-0.032 (-.089 – .024) .26








-0.003 (-.023 – .090) .25
Immune-related Total IgE (IU/mL) 557.2 (498.1 – 623.3)
n=835
441.8 (386.7 – 504.7)
n=651
601.6 (534.8 – 676.7)
n=766
399.0 (347.9 – 457.7)
n=628
-0.066 (-.094 – -.037) <.0001
Eosinophil count (%) 5.9 (5.6 – 6.1)
n=829
5.9 (5.6 – 6.1)
n=641




-0.057 (-.086 – -.028) .0001
hs-CRP (mg/L) 1.26 (1.16 – 1.36)
n=836
1.30 (1.19 – 1.42)
n=659
1.26 (1.16 – 1.37)
n=764
1.34 (1.23 – 1.46)
n=632
0.010 (-.017 – -.038) .46
The estimated treatment effect after 12-months of follow-up for HOMA-IR and other glucose-related parameters, adiposity, 
lipid, and immunological parameters at community level is displayed with corresponding 95% CI. The estimated treatment 
effects were obtained by mixed models and P values are indicated. HOMA-IR, fasting insulin, total IgE, eosinophil count 
and hs-CRP were log transformed. 
Abbreviations: CI, confidence interval; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, 
homeostatic model assessment for insulin resistance; hs-CRP, high sensitivity C-Reactive Protein. IgE, Immunoglobulin E; 
LDL-C, low-density lipoprotein cholesterol.
DISCUSSION 
Here, we report the first cluster-randomized trial in humans investigating the causal 
relationship between helminth infections and whole-body IR in an area endemic for 
STHs. We found that after 12 months of follow-up, 4 rounds of anthelmintic treatment 
with 3-month intervals did not lead to an increase in IR or other parameters such as 
BMI, waist circumference, fasting blood glucose, HbA1c, serum lipid levels and hs-CRP 
at the community level, when all participants irrespective of their helminth status were 
included in the analysis. This despite the fact that the prevalence and infection intensity 
of STHs, as well as their associated type 2 immune responses, measured by total IgE and 
eosinophil count, were significantly reduced in albendazole-treated subjects. 
When considering helminth-infected subjects, we observed that albendazole treatment 
resulted in a significant increase of IR among helminth-infected subjects when infection 
was detected by microscopy. Moreover, the effect of treatment on IR was stronger in 
those infected with multiple STH species at baseline compared to those with a single 
STH infection. We observed a similar pattern of the treatment effect on BMI. Even though 
significant, it is important to note that the magnitude of the effect of 1 year of deworming 
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on IR was modest. The effect of deworming in increasing IR seemed to be partly mediated 
through an increase in BMI, as adjustment for BMI, a strong predictor of IR (28), attenuated 
the treatment effect on IR. Similar to BMI, eosinophil count and total IgE were significantly 
decreased in helminth-infected subjects, and this was stronger in those with multiple 
helminth infections. The possible importance of eosinophils in IR, shown in animal models 
(13, 14, 16, 17) and in 1 epidemiological study (29), is also seen in our study as correction 
for eosinophil count reduced the treatment effect on IR. 
When infection was assessed by PCR, which, in comparison to the Kato-Katz method, 
has a better ability to detect low-intensity infections that may be clinically less relevant 
(25), we only observed a significant increase in IR in the group of subjects who were 
infected with multiple helminth species at baseline. The infection intensity (DNA load) 
in this group of subjects was significantly higher than in those infected with a single STH 
species. Albendazole treatment led to a strong reduction of infection intensity in those 
infected with multiple STH species, which might explain the significant increase in IR 
following albendazole treatment. 
The observed modest increase of IR after treatment among helminth-infected 
subjects, as detected by microscopy, could also contribute to the lack of a significant 
effect of albendazole treatment on IR at the community level. Two recent meta-analyses on 
deworming in children support this notion as they show that although a mass deworming 
approach, thus irrespective of helminth infection status, resulted in no change in weight 
gain, targeted anthelmintic treatment of infected children resulted in a significant weight 
gain (30, 31). 
However, several other explanations for the absence of a treatment effect on IR at 
the community level need to be considered. Although our study design was successful 
in lowering STH infection prevalence and its associated Th2 responses, it is possible that 
longer treatment and follow-up would show stronger effects. It is also possible that both 
immune and non-immune-related effects of helminths on IR are not only associated with 
current helminth infections (8) but also with exposure to helminth infections in the past and 
therefore sustained (13, 19). The causal relationship between helminth infection and IR, 
as found in the subgroup of infected subjects, might have a relatively small contribution 
to the multifactorial pathogenesis of IR (28). Therefore, longer follow-up studies involving 
assessment of other more established factors, such as diet and physical activity (28), will 
be needed to investigate this. 
The use of PCR in our study, in addition to microscopy for detection of helminths, has 
helped us realize that the burden of infections, in terms of the number of helminth species 
as well as the infection intensity (DNA load), might influence the effect of anthelmintic 
treatment on IR. Deworming in subjects with increasing burden of infections resulted in 
an increasing change in IR. In addition, treatment of uninfected subjects, as assessed by 
either microscopy or PCR, did not influence IR, which suggests that an undetectable or 
a low level of helminth infection might be irrelevant for IR. The question whether a high 
burden of helminth infection causes different modulating effects on the immune system or 
energy balance, remains to be answered.
In conclusion, intensive anthelmintic treatment in an STH-endemic area significantly 
reduces both the STH infection prevalence and intensity, as well as its related type 2 
responses. This treatment does not lead to an increase of whole-body IR at the community 
level, but it does increase IR among those with a microscopy-detected STH infection. 
Studies are needed to determine the long term metabolic consequences of anthelmintic 
treatment in communities where STHs are highly prevalent. However, in terms of policy, 
countries implementing helminth control programs need to be aware that this may 
exacerbate or accelerate the deterioration in metabolic health, and that education and 
prevention strategies for noncommunicable diseases such as DM2 need to go hand in 
hand with infectious disease control measures.
Figure 3. Effect of albendazole treatment on homeostatic model assessment for insulin resistance 
(HOMA-IR), body mass index (BMI), total immunoglobulin E (IgE), and eosinophil count, stratified 
by the number of helminth species carried by infected subjects at baseline as detected by 
microscopy. Effect of albendazole treatment on HOMA-IR (n = 1211; A), BMI (n = 1233; B), total 
IgE (n = 1209; C), and eosinophil count (n = 1200; D), stratified by the number of helminth species 
infecting subjects at baseline, as detected by microscopy. The estimated treatment effects are 
displayed with the corresponding 95% confidence interval. Circle, infected with at least 1 helminth 
species; square, no infection; triangle, infected with 1 helminth species; inverse triangle, infected 
with >1 helminth species.
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All clinical measurements and blood sample collections were performed after an overnight 
fast. Anthropometric measurements of body weight (SECA Model 876, Seca Gmbh Co, 
Hamburg, Germany), height (SECA Model 213, Seca Gmbh Co, Hamburg, Germany), 
waist and hip circumference (SECA Model 201, Seca Gmbh Co, Hamburg, Germany) were 
obtained using the National Heart, Lung, and Blood Institute (NHLBI) practical guidelines 
by a team of trained researchers. BMI was calculated as weight in kg divided by square 
of height in meter, while Waist Hip Ratio (WHR) was calculated as waist circumference 
divided by hip circumference. Three blood pressure measurements (left arm, sitting 
upright position, after resting 5 minutes) were taken from each subject, using a digital 
sphygmomanometer (HEM-7200, Omron Healthcare Co, Ltd, Kyoto, Japan). The average 
of all three measurements was used for analysis.
Fasting blood glucose was measured in capillary blood using Breeze®2 glucose 
meters (Bayer Health Care LLC, Basel, Switzerland). All sera, plasma and whole blood 
samples were frozen at −20°C in the field study centre and subsequently stored at −80°C 
at the Department of Parasitology of FKUI and LUMC. Insulin, HbA1c, total cholesterol, 
high-density lipoprotein (HDL)-cholesterol, triglycerides and high-sensitive C-reactive 
protein (hsCRP) were measured pairwise (baseline and follow-up) in the same analytical 
runs at the Department of Clinical Chemistry and Laboratory Medicine at LUMC, which 
is ISO 15189:2012 accredited. Accuracy of test results is periodically and independently 
verified in EQA-schemes organized by the Dutch EQA-organization, the SKML.
Serum insulin concentrations were determined by a solid-phase, enzyme-labeled 
chemiluminescent immunometric assay (Siemens IMMULITE 2000XPi). The measuring 
range of the insulin assay was 2–300 mU/L (CVa <7% at all levels). IR was assessed by 
HOMA-IR, a well-validated measure of whole body IR in humans (HOMA-IR = fasting 
serum insulin x fasting glucose / 22.5) (26). HbA1c was measured using a cation-exchange 
chromatography (IC)-based high performance liquid chromatogtaphy (HPLC) assay (Tosoh 
G8 HPLC Analyzer, from Tosoh Corporation, Tokyo, Japan and distributed through Sysmex 
in the Netherlands), with a measuring range of 20–125 mmol/mol Hb (CVa<5% at all levels). 
Test results are in accordance to the IFCC Reference Measurement System for HbA1c. 
The non-porous ion exchange HPLC-column and four-steps buffer gradient enables a clear 
separation of HbA1c from other fractions and haemoglobin variants such as HbC, HbD and 
HbS. As these variants can be detected, the software automatically corrects the HbA1c 
results for these variants. However, other variants which may typically be present in non-
Caucasian populations, are not detected and lead to inaccurate HbA1c results. Therefore, 
all chromatograms were visually inspected by experienced technicians in order to detect 
the unidentified Hb-variants. HbA1c results from unidentified Hb-variants were excluded 
as these test results were inaccurate. 
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Total cholesterol, HDL-cholesterol and triglycerides assays were based on enzymatic 
colorimetric methods (Modular P analyzers, Roche Diagnostics, Mannheim, Germany). 
The measuring range of total cholesterol, HDL-cholesterol and triglycerides were 
0.08–20.7 mmol/L (CVa<2%), 0.08–3.10 mmol/L (CVa<2%) and 0.05–11.4 mmol/L 
(CVa<5%), respectively. Lipid test results are standardized to internationally recognized 
CDC Reference Measurement Systems. Low-density lipoprotein (LDL)-cholesterol 
(in mmol/L) was calculated using The Friedewald formula, (LDL-chol, mmol/L) = 
(Total chol) - (HDL-chol) - (0.456 X (TG)). A latex-enhanced immunoturbidimetric method 
was used to measure hs-CRP on Roche Modular P-instrumentation, the measuring range 
being 0.1–20.0 mg/L. hs-CRP test results are ERM-DA470k/IFCC standardized. 
A Giemsa-stained peripheral thin blood smear was read at the Department of Clinical 
Pathology, FKUI to assess differential white blood cell count, resulting in a relative 
percentage of basophils, eosinophils, neutrophils, lymphocytes and monocytes. Total IgE 
was measured at the Department of Parasitology, LUMC using ELISA with rabbit anti-
human IgE antibody (Ab) (Dako, Glostrup, Denmark) as capture Ab and goat anti-human 
IgE biotinylated Ab (Vector Laboratories, Burlingname, CA, USA) as detection Ab (24). 
Fresh stool samples were examined by the Kato Katz method to identify and quantify 
STH (hookworm, Ascaris lumbricoides and Trichuris trichiura) eggs using 2 slides for each 
sample. Aliquots of fresh stool samples were frozen at −20°C in the field study centre and 
subsequently at −80°C at the Department of Parasitology of FKUI and LUMC for DNA 
extraction. Stool DNA isolation and real-time PCR were performed pairwise (baseline and 
follow-up). DNA isolation from stool was performed as described elsewhere (24), with an 
additional step of bead beating (1800 rpm for 3 minutes) inside the Fastprep-96TM system 
to optimize DNA extraction. Multiplex real-time PCR was performed to simultaneously 
detect the presence of hookworm (Ancylostoma duodenale, Necator americanus), 
A. lumbricoides, T. trichiura and Strongyloides stercoralis using a method described 
previously(24) with some modifications, adding the T. trichiura primers and probe, and 
combining the fluorescence of A. duodenale and N. americanus as one reading of 
hookworm. Stool samples were considered positive by PCR when cycle threshold (Ct) 
values were below 50. Positive Ct values were further grouped into 3 categories: Ct<30, 
30≤Ct<35 and Ct≥35 representing a high, moderate and low DNA load, respectively (25), 
An additional grouping was made based on the number of different STH species that 
subjects were infected with: no infection, single infection (one of the four STHs: hookworm, 




















Supplementary Figure S1. Trial time frame. Baseline data (t=0) were collected during the first 8 weeks 
before the start of the drug administration. Treatment regimen was given 4 times with three month 
time intervals (week 9-10, 21-22, 33-34, and 45-46). Follow-up data (t=52 weeks) were collected 6 
weeks after the last treatment round. 
Supplementary Figure S2. Effect of albendazole treatment on HOMA-IR, BMI, total IgE and 
eosinophil count stratified by the number of helminth species carried by infected subjects at 
baseline as detected by PCR. Effect of albendazole treatment on HOMA-IR (n= 1433; A), BMI 
(n= 1464; B), total IgE (n=1430; C), and eosinophil count (n=1422; D) stratified by the number of 
helminth species infecting subjects at baseline, as detected by PCR. The estimated treatment effects 
are displayed with corresponding 95% confidence interval. Circle, infected with at least 1 helminth 
species; square, no infection; triangle, infected with 1 helminth species; inverse triangle, infected with 
>1 helminth species. 
SUPPLEMENTAL DATA
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Supplementary table S1. Summary of subjects lost to follow-up
Died Moved Refused Other Reasons
Total Lost to 
Follow Up



































































*% was calculated from all subjects in each treatment arm (placebo n=872, albendazole n=797). 
Abbreviations: Pla, Placebo; Alb, Albendazole.















Negative 396 (66.7) 385 (70.0) 420 (70.7) 527 (95.8)
Low 98 (16.5) 88 (16) 92 (15.5) 18 (3.3)
Moderate 67 (11.3) 58 (10.5) 62 (10.4) 5 (0.9)
High 33 (5.5) 19 (3.5) 20 (3.4) 0 (0.0)
A. lumbricoides
n (%)
Negative 484 (81.5) 462 (84.0) 517 (87.0) 543 (98.7)
Low 26 (4.4) 14 (2.5) 19 (3.2) 1 (0.2)
Moderate 47 (7.9) 43 (7.8) 32 (5.4) 4 (0.7)
High 37 (6.2) 31 (5.6) 26 (4.4) 2 (0.4)
T. trichiura
n (%)
Negative 436 (73.4) 400 (72.7) 460 (77.4) 505 (91.8)
Low 45 (7.6) 49 (8.9) 40 (6.7) 23 (4.2)
Moderate 80 (13.5) 71 (12.9) 63 (10.6) 19 (3.5)
High 33 (5.5) 30 (5.5) 31 (5.2) 3 (0.5)
S. stercoralis
n (%)
Negative 588 (99.0) 547 (99.5) 589 (99.1) 550 (100.0)
Low 3 (0.5) 1 (0.2) 3 (0.5) 0 (0.0)
Moderate 2 (0.3) 1 (0.2) 1 (0.2) 0 (0.0)
High 1 (0.2) 1 (0.2) 1 (0.2) 0 (0.0)
*Ct value of 50 indicates no infection (negative). Ct values <50 were further grouped into 3 categories: Ct<30, 
30≤Ct<35 and Ct≥35 representing a high, moderate and low DNA load, respectively. 
Abbreviations: Ct=Cycle threshold.
Supplementary table  S3. Pathway analysis of the treatment effect on insulin resistance in helminth-
infected subjects as detected by microscopy
Model Estimated Treatment Effect (95%CI), P value
Unadjusted 0.031 (0.004 – 0.059), p=0.04
Adjusted for BMI changes 0.025 (-0.001 – 0.051), p=0.10
Adjusted for total IgE changes 0.030 (0.002 – 0.057), p=0.06
Adjusted for eosinophil count changes 0.026 (-0.002 – 0.053), p=0.13
Adjusted for BMI and eosinophil changes 0.020 (-0.007 – 0.046), p=0.23
Abbreviations: BMI=Body Mass Index, IgE= Immunoglobulin E.
Supplementary table S4B. Comparison of baseline infection intensity in subjects infected with single 
and multiple helminth species as detected by microscopy
Helminth species
Single (n=334)
[epg, median (IQR), n]
Multiple (n=180)
[epg, median (IQR), n] P value*
Hookworm 96 (48 – 267), n=108 138 (72 – 474), n=108 0.087
A.lumbricoides 360 (72 – 1596), n=103 1980 (432 – 6264), n=143 <0.001
T.trichiura 36 (12 – 120), n=123 84 (36 – 261), n=152 <0.001
This analysis was conducted in subjects analyzed in Figure 3. Infection intensity was assessed using the number of 
egg per gram of stool sample (epg) from Kato Katz method. *Independent-samples Mann Whitney U Test.
Supplementary table S4A. Comparison of baseline infection intensity in subjects infected with single 
and multiple helminth species as detected by PCR
Helminth species
Single (n=491)
[Ct value, mean (SD)]
Multiple (n=296)
[Ct value, mean (SD)]
Mean differences (95%CI), 
P value*
Hookworm 35.9 (4.0), n=259 34.3 (4.4), n=226 -1.6 (-2.3 – -0.8), p<0.0001
A.lumbricoides 32.9 (3.2), n=75 31.0 (3.7), n=179 -1.9 (-2.9 – -0.9), p<0.0001
T.trichiura 33.7 (2.9), n=156 32.3 (3.3) n=247 -1.4 (-2.0 – -0.8), p<0.0001
This analysis was conducted in subjects analyzed in Figure S1. Infection intensity was assessed using Ct values of 
PCR, which represent the amount of DNA in the stool sample. The lower the Ct value, the higher the amount of 
DNA. Number of subjects with S.stercoralis was very low (one within the single infection group and nine within 
the multiple infection group). *Independent t-test.
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Type 2 immunity is involved in the maintenance of metabolic homeostasis and its 
disruption during obesity promotes chronic low-grade inflammation. Helminth parasites 
are the strongest natural inducers of type 2 immunity and we previously reported that 
infection with Schistosoma mansoni or treatment with a mixture of soluble egg antigens 
(SEA) both improved whole-body metabolic homeostasis in insulin-resistant obese mice. In 
the present study, we investigated the effects of two plant-produced glycosylation variants 
of omega-1, a glycoprotein present in SEA that has been shown to trigger dendritic cell-
mediated Th2 polarization by a glycan-dependent mechanism, on whole-body metabolic 
homeostasis. We showed that both recombinant omega-1 glycovariants decreased 
fat mass and improved whole-body metabolic homeostasis in obese mice, an effect 
associated with increased adipose tissue Th2 cells, eosinophils and alternatively-activated 
macrophages. In the liver, omega-1 did not affect hepatic steatosis but increased IL-13-
expressing Th2 cells and expression of fibrotic gene markers. Remarkably, the metabolic 
effects of omega-1 were still observed in obese STAT6-/- mice, although the Th2-mediated 
immune response was completely abolished. Omega-1 did not affect locomotor activity or 
energy expenditure but inhibited food intake in both WT and STAT6-/- mice. Altogether, 
we conclude that the improvement of metabolic homeostasis by omega-1 is independent 
of its Th2-inducing capacity and may be explained by brain-mediated inhibition of food 
intake and/or immune-independent direct interaction of omega-1 with metabolic cells.
INTRODUCTION
Obesity is associated with chronic low-grade inflammation in metabolic tissues (1). This 
so-called meta-inflammation plays a prominent role in the etiology of insulin resistance 
and type 2 diabetes (1-4), and is notably associated with increased numbers of pro-
inflammatory macrophages in white adipose tissue (WAT) (5), liver (6, 7) and skeletal muscle 
(8, 9). In WAT, these macrophages mainly originate from newly-recruited blood monocytes 
that differentiate into pro-inflammatory, classically-activated macrophages (CAMs) upon 
entering the inflammatory milieu (5) and/or being activated by elevated local concentration 
of free fatty acids (10). These pro-inflammatory macrophages produce cytokines, such as 
tumor necrosis factor alpha (TNF-α) and interleukin 1-beta (IL-1β), which directly inhibit 
canonical insulin signaling (as reviewed in (2)) and contribute to tissue-specific insulin 
resistance and whole-body metabolic dysfunction. In the liver, activation of Kupffer cells, 
the resident macrophages (11), promote the recruitment of pro-inflammatory monocytes 
(6) and neutrophils (12) which trigger hepatic inflammation and insulin resistance through 
the production of pro-inflammatory cytokines and elastase, respectively (6, 11-13). While 
obese adipose tissue is thus characterized by pro-inflammatory type 1 cytokines, a type 2 
cytokine environment is present in metabolic tissues under homeostatic, insulin sensitive 
conditions. Indeed, type 2 innate lymphoid cells (ILC2s) and T helper 2 (Th2) cells produce 
the type 2 cytokines IL-4, IL-5 and IL-13 in healthy adipose tissue and sustain a WAT 
eosinophils and alternatively activated macrophages (AAM) axis that is largely driven by 
eosinophil-produced IL-4 (14, 15). According to the current paradigm, AAMs are the final 
effector cells of this type 2 immune response that sustain insulin sensitivity through 
underlying molecular mechanism(s) that are still largely unknown.
Parasitic helminths are the strongest natural inducers of type 2 immunity (16). 
Interestingly, soil-transmitted helminth infection was reported to be associated with higher 
insulin sensitivity in humans (17), suggesting that helminth-induced type 2 immunity could 
protect against metabolic disorders. Moreover, both the short-lived rodent helminth 
Nippostrongylus brasiliensis and human Schistosoma mansoni improved insulin sensitivity 
and glucose tolerance in high-fat diet (HFD)-induced obese mice, an effect associated with 
strong WAT eosinophilia (15, 18). We also showed that chronic treatment with S. mansoni 
soluble egg antigens (SEA) promoted eosinophilia, T-helper 2 cells (Th2), type 2 cytokines 
expression and AAMs in WAT, and improved whole-body metabolic homeostasis (18). 
SEA drives DC-mediated Th2 skewing at least partly through glycosylated molecules 
((19), and reviewed in (20)). More specifically, an unknown Dectin-1/2-ligand in SEA 
(21, 22) and the T2 RNAse glycoprotein omega-1 (ω1; (23, 24)) have been shown to drive 
Th2 skewing. We have previously reported that ω1 is internalized by human DCs through 
an interaction between its glycans and the mannose receptor, and promotes Th2 skewing 
through interfering with protein synthesis (24). Interestingly, acute treatment of HFD-fed 
obese mice with human embryonic kidney 293 (HEK-293)-produced recombinant ω1 was 
recently shown to decrease body weight and improve whole-body glucose tolerance 
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through an IL-33-ILC2-axis (25). In this study, the metabolic effect of ω1 was reported to 
be glycan-dependent, yet we have previously shown that glycans on HEK-293-produced 
ω1 differ significantly from S. mansoni native ω1 (23, 24). Notably, HEK-293-produced 
ω1 glycans did not express the immunogenic Lewis-X (LeX) motifs present on native 
ω1, but rather expressed LDN-F (24), a glycan motif with similar C-type lectin-binding 
properties as LeX. However, as S. mansoni expresses an abundance of complex and 
unique glycans that modulate host immunity (as reviewed in (26)), it is critical to produce 
recombinant immunomodulatory molecules that harbour as similar glycosylation pattern 
as possible to the native ones. By exploiting the flexible N-glycosylation machinery of 
Nicotiana benthamiana plants, we successfully produced large amounts of recombinant 
ω1 carrying a terminal single branch LeX-motif (pLeX-ω1), a carbohydrate structure found 
on native ω1, making this glyco-engineered molecule more potent in Th2 skewing than 
the wild-type plant-glycosylated recombinant ω1 (pWT-ω1) (27). In the present study, we 
therefore investigate the effects and underlying mechanisms of these two plant-produced 
recombinant ω1 molecules on whole-body metabolic homeostasis in HFD-fed obese 
mice. Remarkably, treatment with both molecules improved the metabolic homeostasis of 
obese mice, an effect independent from the Th2 response but associated with a significant 
reduction in food intake. This raises the possibility that these glycoproteins can modulate 
the neuro-immunological axis involved in the control of feeding behaviour in mice. 
MATERIALS AND METHODS
Animals, diet and treatment
All mouse experiments were performed in accordance with the Guide for the Care and Use 
of Laboratory Animals of the Institute for Laboratory Animal Research and have received 
approval from the university Ethical Review Boards (Leiden University Medical Center, 
Leiden, The Netherlands; DEC12199). 8-10 week-old male C57BL/6J mice (Charles River, 
L’Arbresle, France) were housed in a temperature-controlled room with a 12 hour light-
dark cycle. Throughout the experiment, food and tap water were available ad libitum. 
Mice were fed a high-fat diet (HFD, 45% energy derived from fat, D12451, Research Diets) 
or a low-fat diet (LFD, 10% energy derived from fat, D12450B, Research Diets, Wijk bij 
Duurstede, The Netherlands) for 12 weeks, followed by group randomization according to 
body weight, fat mass, and fasting plasma glucose levels. 
Recombinant omega-1 was produced in either wild-type (pWT-ω1) or LeX-glyco-
engineered N. benthamiana plants (pLeX-ω1), as described previously (27). Recombinant 
pWT/pLeX-ω1 (50 μg) and vehicle control (sterile-filtered 0.9% phosphate-buffered saline) 
were injected intraperitoneally every 3 days for 4 weeks, in four independent experiments. 
Short-term effects of pWT/pLeX-ω1 were assessed in LFD- or HFD-fed mice treated every 
2 days with 50 μg pWT/pLeX-ω1 for one week. Dose-dependent effects of pLeX-ω1 
treatment were investigated by treating HFD-fed mice with 10, 25 or 50 μg of pLeX-ω1 
every 3 days for 4 weeks.
To investigate the role of type 2 immunity in the immunometabolic effects of pLeX-ω1, 
8-10 weeks-old male wild-type (WT) and Stat6-/- mice on C57BL/6J background (The Jackson 
Laboratory, Bar Harbor, ME, USA) were randomized based on body weight and fasting blood 
glucose levels, and either put on a HFD (60% energy derived from fat; D12492; Research 
Diets, New Brunswick, NJ, USA) or LFD (10% energy derived from fat; D12450J; Research 
Diets) for 10 weeks. To exclude effects of genotype-dependent microbiota differences 
on metabolic and immunological outcomes, the beddings of LFD- and HFD-fed WT and 
Stat6-/- mice were frequently mixed within similar diet groups throughout the run-in period. 
After 10 weeks, HFD-fed mice were randomized as described above and treated i.p. every 
3 days for 4 weeks with 50 μg pLeX-ω1 or vehicle-control.
Body composition and indirect calorimetry
Body composition was measured by MRI using an EchoMRI (Echo Medical Systems, 
Houston, TX, USA). Groups of 4-8 mice with free access to food and water were subjected 
to individual indirect calorimetric measurements during the initiation of the treatment with 
recombinant ω1 for a period of 7 consecutive days using a Comprehensive Laboratory 
Animal Monitoring System (Columbus Instruments, Columbus, OH, USA). Before the start 
of the measurements, single-housed animals were acclimated to the cages for a period of 
48 h. Feeding behaviour was assessed by real-time food intake. Oxygen consumption and 
carbon dioxide production were measured at 15-min intervals. Energy expenditure (EE) 
was calculated and normalized for lean body mass (LBM), as previously described (18). 
Spontaneous locomotor activity was determined by the measurement of beam breaks.
At sacrifice, visceral white adipose tissue (epidydimal; eWAT), subcutaneous white 
adipose tissue (inguinal; iWAT), supraclavicular brown adipose tissue (BAT) and liver were 
weighed and collected for further processing.
Plasma analysis
Blood samples were collected from the tail tip of 4h-fasted mice (food removed at 9 
am) using chilled paraoxon-coated capillaries. Blood glucose level was determined 
using a Glucometer (Accu-Check; Roche Diagnostics, Almere, The Netherlands) and 
plasma insulin level was measured using a commercial kit according to the instructions of 
the manufacturer (Chrystal Chem, Zaandam, The Netherlands). The homeostatic model 
assessment of insulin resistance (HOMA-IR) adapted to mice was calculated as ((glucose 
(mg/dl)*0.055) × (insulin (ng/ml) × 172.1))/3857 and used as a surrogate measure of whole-
body insulin resistance (28). The plasma concentrations of alanine aminotransferase (ALAT) 
was measured using a Reflotron® kit (Roche diagnostics) using a pool of plasma samples 
from each group (n = 4-6 mice per group) in 2 separate experiments.
Glucose and insulin tolerance tests
Whole-body insulin sensitivity was determined by an i.p. insulin tolerance test (ipITT) at 
week 1 or week 3 of treatment, as described previously (18). In short, after an initial blood 
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collection (t = 0), an i.p. bolus of insulin (1 U/kg (lean) body mass of insulin (NOVORAPID, 
Novo Nordisk, Alphen aan den Rijn, Netherlands)) was administered to 4h-fasted mice. 
Blood glucose was measured by tail bleeding at 20, 40, 60, and 90 min after insulin 
administration using a Glucometer.
Whole-body glucose tolerance was assessed by an i.p. glucose tolerance test 
at week 3 of treatment, as previously reported (18). After an initial blood collection 
(t = 0), a glucose load (2 g/kg total body weight of D-Glucose (Sigma-Aldrich, Zwijndrecht, 
The Netherlands)) was administered to 6h-fasted mice, and blood glucose was measured 
by tail bleeding at 20, 40, 60, and 90 min after glucose administration using a Glucometer. 
In addition, blood was collected at t = 20 minutes post glucose injection for assessing 
glucose-induced insulin secretion.
Isolation of stromal vascular fraction from adipose tissue
Epididymal adipose tissues were collected at sacrifice after a one minute perfusion with 
PBS through the heart left ventricle and digested as described previously (18). In short, 
collected tissues were digested for 1 h at 37°C in HEPES buffer (pH 7.4) containing 0.5 
g/L collagenase type I from Clostridium histolyticum (Sigma-Aldrich) and 2% (w/v) dialyzed 
bovine serum albumin (BSA, fraction V; Sigma-Aldrich). The disaggregated adipose tissue 
was passed through a 100 μm cell strainer that was washed with PBS supplemented with 
2.5 mM EDTA and 5% FCS. After centrifugation (350 x g, 10 minutes at room temperature), 
the supernatant was discarded and the pellet was treated with erythrocyte lysis buffer. 
The cells were next washed with PBS supplemented with 2.5 mM EDTA and 5% FCS, and 
counted manually. 
Isolation of leukocytes from liver tissue
Livers were collected and digested as described previously (18). In short, livers were 
minced and digested for 45 minutes at 37°C in RPMI 1640 + Glutamax (Life Technologies, 
Bleiswijk, The Netherlands) containing 1 mg/mL collagenase type IV from Clostridium 
histolyticum, 2000 U/mL DNase (both Sigma-Aldrich) and 1 mM CaCl2. The digested liver 
tissues were passed through a 100 μm cell strainer that was washed with PBS/EDTA/FCS. 
Following centrifugation (530 x g, 10 minutes at 4°C), the supernatant was discarded, after 
which the pellet was resuspended in PBS/EDTA/FCS and centrifuged at 50 x g to pellet 
hepatocytes (3 minutes at 4°C). Next, supernatants were collected and pelleted (530 x g, 
10 minutes at 4°C). The cell pellet was first treated with erythrocyte lysis buffer and next 
washed with PBS/EDTA/FCS. CD45+ leukocytes were isolated using LS columns and CD45 
MicroBeads (35 µL beads per liver, Miltenyi Biotec) according to manufacturer’s protocol 
and counted manually. 
Processing of isolated immune cells for flow cytometry
For analysis of macrophage and lymphocyte subsets, both WAT stromal vascular cells 
and liver leukocytes were stained with the live/dead marker Aqua (Invitrogen), fixed with 
either 1.9% paraformaldehyde (Sigma-Aldrich) or the eBioscienceTM Intracellular fixation 
and permeabilization kit (Invitrogen), and stored in FACS buffer (PBS, 0.02% sodium azide, 
0.5% FCS) at 4°C in the dark until subsequent analysis. For analysis of cytokine production, 
isolated cells were cultured for 4 hours in culture medium in the presence of 100 ng/
mL phorbol myristate acetate, 1 µg/mL ionomycin and 10 µg/mL Brefeldin A (all from 
Sigma-Aldrich). After culture, cells were washed with PBS, stained with Aqua, and fixed as 
described above. 
Flow cytometry
For analysis of CD4 T cells and innate lymphoid cell (ILC) subsets, SVF cells were stained 
with antibodies against B220 (RA3-6B2), CD11b (M1/70), CD3 (17A2), CD4 (GK1.5), NK1.1 
(PK136) and Thy1.2 (53-2.1; eBioscience, San Diego, CA, USA), and CD11c (HL3) and GR-1 
(RB6-8C5; both BD Biosciences, San Jose, CA, USA). For analysis of ILC2s, antibodies 
against CD25 (PC61.5; eBioscience), T1/ST2 conjugated to biotin (DJ8; MD Bioscience) 
and streptavidin-APC (BD Biosciences) as second staining were additionally included. 
CD4 T cell subsets and cytokine production by ILCs were analyzed following 
permeabilization with either 0.5% saponin (Sigma-Aldrich) or eBioscienceTM Intracellular 
fixation and permeabilization kit. Subsets were identified using antibodies against CD11b, 
CD11c, GR-1, B220, NK1.1, CD3, CD45, CD4, Thy1.2, IL-4 (11B11), IL-13 (eBio13A), Foxp3 
(FJK-16s; all eBioscience), IL-5 (TRFK5) and IFN-γ (XMG1.2; both Biolegend). 
For analysis of macrophages, eosinophils, monocytes and neutrophils, cells were 
permeabilized as described above. Cells were then incubated with an antibody against 
YM1 conjugated to biotin (polyclonal; R&D Systems, Minneapolis, MN, USA), washed, and 
stained with streptavidin-PerCP (BD Biosciences), and antibodies directed against CD45, 
CD11b, CD11c (HL3 (BD Biosciences) or N418 (Biolegend)), F4/80 (BM8; eBioscience or 
Biolegend), SiglecF (E50-2440; BD Biosciences), and Ly6C (HK1.4; Biolegend). 
All cells were stained and measured within 4 days post fixation. Flow cytometry 
was performed using a FACSCanto or LSR-II (both BD Biosciences), and gates were set 
according to Fluorescence Minus One (FMO) controls. Representative gating schemes are 
shown in Figure S1. 
RNA purification and qRT-PCR 
RNA was extracted from snap-frozen adipose tissue samples (~20 mg) using Tripure RNA 
Isolation reagent (Roche Diagnostics, Almere, The Netherlands). Total RNA (1 µg) was 
reverse transcribed and quantitative real-time PCR was then performed with SYBR Green 
Core Kit on a MyIQ thermal cycler (Bio-Rad) using specific primers sets (available on 
request). mRNA expression was normalized to ribosomal protein, large, P0 (RplP0) mRNA 
content and expressed as fold change compared to LFD-fed mice using the ∆∆CT method. 




Liver lipids were extracted as previously described (29). Briefly, small liver samples were 
homogenized in ice-cold methanol. After centrifugation, lipids were extracted by addition 
of 1800 μl CH3OH:CHCl3 (1:3 v/v) to 45 μl homogenate, followed by vigorous vortexing 
and phase separation by centrifugation (14,000 rpm; 15 min at RT). The organic phase was 
dried and dissolved in 2% Triton X-100 in water. Triglycerides concentrations were measured 
using a commercially available enzymatic kit (Instruchemie, Delfzijl, the Netherlands) and 
expressed as nanomoles per mg protein, which was determined using the Bradford protein 
assay kit (Sigma-Aldrich).
Histological analysis
A piece of liver was fixed in 4% paraformaldehyde (PFA; Sigma-Aldrich), paraffin-
embedded, sectioned at 4 μm and stained with Hematoxilin and Eosin (H&E), or Sirius Red 
to visualize collagen. Six fields at 20x magnification (total area 1.68 mm2) were used for 
the analysis of hepatic steatosis in H&E-stained sections. On Sirius Red-stained sections, 
fibrosis was scored on 10 fields at 40x magnification (total area 1.23 mm2) as absent (score 
0), present in the perisinusoidal or periportal area (score 1), present in the perisinusoidal 
and periportal (score 2), bridging fibrosis (score 3) or cirrhosis (score 4) as described 
elsewhere (30).
Statistical analysis
All data are presented as mean ± standard error of the mean (SEM). Statistical analysis was 
performed using GraphPad Prism version 7.04 for Windows (GraphPad Software, La Jolla, 
CA, USA) with ordinary one-way analysis of variance (ANOVA) followed by Bonferroni 
post-hoc test. Differences between groups were considered statistically significant 
at P < 0.05.
RESULTS
Plant-produced recombinant omega-1 glycovariants reduce body weight 
and improve whole-body metabolic homeostasis in obese mice
To study the effects of recombinant ω1 glycovariants on whole-body metabolic homeostasis, 
C57BL/6J mice were fed a LFD or HFD for 12 weeks and next treated biweekly with 
intraperitoneal injections of 50 µg pWT-ω1, pLeX-ω1 or PBS (vehicle-control) for 4 weeks. 
Both ω1 glycovariants induced a rapid and gradual body weight loss in HFD-fed mice 
(Fig. 1A-B), which was exclusively due to a decrease in fat mass (Fig. 1C) whereas lean 
mass was not affected (Fig. 1D). pWT/pLeX-ω1 significantly reduced epididymal white 
adipose tissue (eWAT) mass but had no effect on liver, subcutaneous white adipose tissue 
(iWAT) and brown adipose tissue (BAT) masses (Fig. 1E). Using metabolic cages, we found 
that both ω1 glycovariants induced a significant decrease in cumulative food intake during 
the experimental period (Fig. 1F). Consequently, mean daily energy intake was reduced to 
the same extent while locomotor activity was not affected (Fig. 1G).
We next investigated the effects of pWT/pLeX-ω1 on whole-body metabolic 
homeostasis. As expected, HFD-feeding increased fasting blood glucose, plasma insulin 
and homeostatic model assessment of insulin resistance (HOMA-IR) as compared to 
LFD-fed mice (Fig. 1H-J). Remarkably, treatment with both ω1 glycovariants for 4 weeks 
significantly reduced blood glucose and insulin in obese mice to the levels of LFD-fed 
lean mice (Fig. 1H-I). As a result, HOMA-IR was significantly reduced in ω1-treated mice, 
indicating a better insulin sensitivity with a trend towards a stronger effect induced by 
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Figure 1. Plant-produced recombinant ω1 glycovariants reduce body weight, visceral fat mass and 
food intake in diet-induced obese mice. Mice were fed a LFD or a HFD for 12 weeks, after which they 
were treated i.p. with PBS, or 50 µg pWT-ω1 or pLeX-ω1 once every 3 days for a period of 4 weeks. 
Body weight was monitored throughout the experimental period (A-B). Body composition (C-D) and 
weight of epidydimal WAT (eWAT), inguinal WAT (iWAT), instrascapular brown adipose tissue (BAT) 
and the liver (E) were measured after 4 weeks of treatment. Food intake was assessed using fully 
automated single-housed metabolic cages during the first week of treatment (F). Locomotor activity 
was determined by measuring by beam breaks (G). Blood glucose (H) and plasma insulin levels (I) were 
determined in 4h-fasted mice during week 4 of treatment and HOMA-IR was calculated (J). An i.p. 
glucose tolerance test (2 g/kg body weight) was performed in 6h-fasted mice at week 3 of treatment. 
Blood glucose levels were measured at the indicated time points and the AUC of the glucose 
excursion curve was calculated (K). Blood was also collected for determination of glucose-induced 
insulin secretion at t = 20 minutes post glucose injection (K). An i.p. insulin tolerance test (1U/kg 
lean body mass) was performed in 4h-fasted mice at week 3 of treatment. Blood glucose levels were 
measured at the indicated time points and the area under the curve (AUC) of the glucose excursion 
curve was calculated (L). Data shown are a pool of 2 (D) or 4 (A-E, H-L) independent experiments. 
Results are expressed as means ± SEM. * P<0.05 vs HFD (n = 12-20 animals per group in A-E, K-L, 
and 4-13 animals per group in F-J). 
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the recombinant molecule harbouring single branch LeX (Fig. 1J). Congruent with these 
data, we observed a significant improvement in whole-body glucose tolerance (Fig. 1K) 
and insulin sensitivity (Fig. 1L) in both pWT and pLeX-ω1-treated obese mice. Of note, 
the effects of these two ω1 glycovariants on plasma metabolic parameters and whole-body 
insulin sensitivity were already observed after one week of treatment, although there was 
only marginal impact on body weight and fat mass at this time point (Fig. S2). Furthermore, 
the improvement of metabolic homeostasis was found to be dose-dependent, at least for 
pLeX-ω1 (Fig. S3). Altogether, these data show that both recombinant ω1 glycovariants 
improve whole-body metabolic homeostasis in insulin-resistant obese mice.
Omega-1 glycovariants increase adipose tissue Th2 cells, eosinophils and 
alternatively-activated macrophages, but not ILC2s
An ILC2-eosinophil-AAM axis contributes to the maintenance of adipose tissue insulin 
sensitivity in homeostatic conditions and is disrupted during obesity (14, 15). To investigate 
whether the beneficial metabolic effects induced by ω1 glycovariants could be due to an 
increase in these type 2 immune cells, we isolated the stromal vascular frac tion (SVF) 
from eWAT and analysed the immune cell composition by flow cytometry (Fig. S1). We 
found that both ω1 glycovariants markedly increased WAT CD4 T cells, with pWT-ω1 
being more potent than pLeX-ω1, while total ILCs were unaffected (Fig. 2A). Interestingly, 
ex vivo restimulation revealed a specific increase in IL-4/5/13-expressing Th2 cells, while 
the other CD4 T cell subsets, i.e. reg ulatory T cells (Treg) and Th1 cells, were not affected 
(Fig. 2B). In addition, we confirmed that HFD reduced WAT IL-5+/IL-13+ ILC2s, as previously 
reported (14), an effect that was even further pronounced with ω1 glycovariants (Fig. 2C). 
The type 2 cytokines IL-5 and IL-13 produced by either ILC2s and/or Th2 cells have 
been reported to maintain WAT eosinophils (14). Congruent with our data on Th2 cells, 
we found a potent increase in WAT eosinophils upon ω1 treatment that was of similar 
extent for both glycovariants (Fig. 2D). Finally, both pWT-ω1 and pLeX-ω1 increased WAT 
Ym1+ AAMs while the pro-inflammatory CD11c+ macrophages were not affected, shifting 
the balance of cell polarization towards a M2/M(IL-4)-like phenotype (Fig. 2E-H). A similar 
immune response was already observed after one week of treatment with ω1 glycovariants 
(Fig. S4) and appears to be dose-dependent (Fig. S5). 
Omega-1 glycovariants do not induce WAT beiging
Although the concept was recently challenged (31), AAMs have been suggested to 
trigger WAT beiging through production of catecholamines, thereby increasing energy 
expenditure (32-34). Since WAT AAMs were significantly increased in ω1-treated obese 
mice, we investigated whether the ω1 glycovariants could induce WAT beiging and 
therefore enhance adaptive thermogenesis and energy expenditure. We found that 
the recombinant molecules neither increased Ucp1 or other beiging gene markers mRNA 
expression in both epidydimal and subcutaneous (inguinal) fat pads (Fig. 3A-B), nor 
the whole-body energy expenditure measured in metabolic cages (Fig. 3C), indicating 
that ω1 does not induce canonical or non-canonical WAT beiging in our conditions. 
STAT6-mediated type 2 immunity is not required for the effects of 
pLeX-ω1 on metabolic homeostasis 
Induction of AAM polarization is a classical feature of type 2 immunity which usually occurs 
through IL-4/IL-13 receptor-mediated signalling and requires the transcription factor STAT6 
(35, 36). In order to assess whether type 2 immunity is required for the metabolic effects of 
ω1, we therefore used Stat6-deficient mice. As expected, while pLeX-ω1 increased WAT 
Th2 cells and AAMs in WT mice, this specific type 2 immune response was abrogated 
in Stat6-/- mice (Fig. 4A-B). However, treatment with pLeX-ω1 still reduced body weight 
(Fig. 4C) and food intake (Fig. 4D) in Stat6-/- obese mice to the same extent as in WT 
mice. In addition, while pLeX-ω1 did not significantly affect fasting blood glucose levels, 





















































































































































Figure 2. ω1 glycovariants increase WAT Th2 cells, eosinophils and AAM, without affecting ILCs. 
Mice were fed a LFD or a HFD and were treated with PBS or pWT/pLeX-ω1 as described in the legend 
of Figure 1. At sacrifice (week 4 of treatment), eWAT was collected and the stromal vascular fraction 
(SVF) was isolated. Following fixation and permeabilization, SVF cells were stained and analyzed 
by flow cytometry. The complete gating strategy is shown in Figure S1. Numbers per gram tissue 
CD4 T cells, ILCs (A), eosinophils (D) and macrophages (E) were determined. Intracellular cytokine 
production was analyzed after 4h stimulation with PMA and ionomycin in the presence of Brefeldin 
A. CD4 T cells were identified as Aqua-CD45+Thy1.2+Lineage+CD4+ cells, and ILCs were identified as 
Aqua-CD45+Thy1.2+Lineage-CD3-CD4- cells, in which the lineage cocktail included antibodies against 
CD11b, CD11c, B220, GR-1, NK1.1 and CD3. Frequencies of CD4 T helper subsets (B) and cytokine-
expressing ILCs (C) were determined. Percentages of CD11c+Ym1- (M1-like; F) and CD11c-Ym1+ 
(M2-like; G) in macrophages. Using the percentages of M1-like and M2-like macrophages, M2/M1 
ratios were calculated (H). Data shown are a pool of at least three independent experiments, except 
for C and E, which are a representative experiment of at least two independent experiments. Results 
are expressed as means ± SEM. * P<0.05 vs HFD, $ P<0.05 vs pWT-ω1 (n = 6-19 animals per group 
in A-B, D, F-I, and 3-9 animals per group in C and E).
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To investigate the role of type 2 immunity in the pro-fibrotic effects of pLeX-ω1, we 
used Stat6-deficient mice. As expected, the increase in liver IL-13+ Th2 cells in response 
to pLeX-ω1 was markedly reduced in Stat6-deficient mice (Fig. 5N). In line with this data, 
the increase in hepatic IL-13 gene expression induced by pLeX-ω1 was also significantly 
reduced in obese Stat6-/- mice as compared to WT (Fig. 5O). Although pLeX-ω1 still 
induced expression of fibrotic gene markers in Stat6-deficient mice, there was a marked 
decrease in expression as compared to WT mice (Fig. 5O), suggesting that recombinant 



























































































Figure 3. ω1 glycovariants do not induce WAT 
beiging. Mice were fed a LFD or a HFD and 
were treated with PBS or pWT/pLeX-ω1 as 
described in the legend of Figure 1. At sacrifice, 
mRNA expression in eWAT (A) and iWAT (B) of 
the indicated genes was quantified by RT-PCR 
and expressed relative to the RplP0 gene as 
fold difference compared to the LFD-fed mice. 
Energy expenditure, corrected for lean body 
mass, was measured using fully automated single-
housed metabolic cages during the first week 
of treatment (C). Data shown are a pool of two 
independent experiments. Results are expressed 
as means ± SEM. * P<0.05 vs HFD (n = 4-10 
animals per group).
Moreover, the improvements in whole-body glucose tolerance (Fig. 4H-I) and insulin 
sensitivity (Fig. 4J) was still observed in Stat6-/- mice, indicating that pLeX-ω1 restored 
metabolic homeostasis in obese mice independent of its Th2-inducing capacity. 
Omega-1 glycovariants do not affect hepatic steatosis, but increase 
fibrotic gene markers and liver damage
Similar to WAT, maintenance of hepatic insulin sensitivity is also associated with type 2 
immunity (37). On the other hand, obesity-driven activation of Kupffer cells increases 
the recruitment of pro-inflammatory monocytes and triggers hepatic insulin resistance (2, 
11). In our conditions, while pWT/pLeX-ω1 increased Th2 cells in the liver, we surprisingly 
did not find alternative activation of Kupffer cells (Fig. 5A-D). Instead, the ω1 glycovariants 
increased the number of CD11c+ pro-inflammatory Kupffer cells (Fig. 5E-F) and newly 
recruited monocytes (Fig. 5G). However, ω1 glycovariants did not affect hepatic steatosis, 
as assessed by histomorphologic assessment of hematoxylin and eosin (H&E)-stained liver 
sections (Fig. 5H-I) and tissue triglycerides content (Fig. 5J). 
In addition to ectopic lipid deposition in the liver during NAFLD, increased inflammation, 
hepatocyte damage and fibrosis may characterize progression towards non-alcoholic 
steatohepatitis (NASH) (38). IL-13 has recently also been implicated to play a role in 
the development of liver fibrosis (39, 40), hence we investigated whether ω1 glycovariants 
affect liver fibrosis. pLeX-ω1 significantly increased fibrotic gene marker expression 
(Fig. 5K), while no clinical fibrosis was detected (Fig. 5L). However, we observed an 
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Figure 4. STAT6 is not required for metabolic effects of pLeX-ω1. WT and Stat6-/- mice on a C57BL/6J 
background were fed a LFD or a HFD for 12 weeks before 4 weeks of biweekly intraperitoneal injections 
with PBS or 50 µg pLeX-ω1. At the end of the experiment (week 4 of treatment), eWAT was collected, 
processed and analyzed as described in the legend of Figure 2. The frequencies of cytokine-expressing 
CD4 T cells were determined (A). Abundances of Ym1+ or PD-L2+ (M2-like) macrophages (B) were 
determined. Body weight (C) and food intake (D) was monitored throughout the experimental period. 
Blood glucose (E) and plasma insulin levels (F) were determined and HOMA-IR (G) was calculated as 
described in the legend of Figure 1. An i.p. glucose tolerance test (2 g/kg body weight; H-I) and i.p. 
insulin tolerance test (1U/kg body weight; J) were performed as described in the legend of Figure 1. 
Results are expressed as means ± SEM. *P<0.05 vs HFD, & P<0.05 vs WT (n = 3-5 animals per group 
for all measurements).
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ω1 induces fibrotic gene markers at least partly through type 2 immunity. Taken together, 
these results show that recombinant ω1 glycovariants improve whole-body metabolic 
homeostasis independent of their Th2 inducing capacity, while simultaneously inducing 
early markers of mild hepatic fibrosis.
DISCUSSION
Type 2 immunity is involved in the maintenance of metabolic homeostasis and its disruption 
during obesity promotes chronic low-grade inflammation, associated with insulin resistance 
(1). Since helminths induce type 2 immunity, the association between helminths and their 
potential effects on insulin sensitivity and glucose homeostasis has gained increasing 
attention (41), accompanied by the search for single helminth-derived molecules that are 
capable of driving the type 2 immune response (20). The glycoprotein omega-1, a T2 
ribonuclease which is secreted from S. mansoni eggs, has previously been identified as 
the major immunomodulatory component in SEA (23, 24) and was shown to condition 
dendritic cells to prime Th2 responses, as least partly through its glycan-mediated uptake 
and intracellular RNase activity (24). Here, we report that two plant-produced recombinant 
ω1 glycovariants induced a rapid and sustained reduction in body weight and improved 
HOMA-IR, whole-body insulin sensitivity and glucose tolerance in obese mice. Although 
both ω1 glycovariants induced a strong type 2 immune response in WAT, characterized by 
a significant increase in Th2 cells, eosinophils and AAMs, the beneficial effect on metabolic 
homeostasis was still present in Stat6-deficient obese mice, indicating that improvements 
of insulin sensitivity and glucose tolerance occurred independently of the Th2-inducing 
capacity of ω1. These findings indicate that helminth derived molecules may act through 
multiple distinct pathways that can improve metabolic homeostasis. Interestingly, a trend 
for a stronger effect on insulin sensitivity was observed with pLeX–ω1, whose glycans 
resemble the ones of native helminth ω1 the most, whereas the improvement of glucose 
tolerance was similar to pWT–ω1. 
A recent study from Hams et al. reported that acute treatment of HFD-fed obese 
mice with HEK-293-produced recombinant ω1 induced long-lasting weight loss, and 
improved glucose tolerance by a mechanism involving IL-33-mediated increase in WAT 
ILC2s and adipose beiging (25). However, in contrast to this finding, we only observed 
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L+PBS H+pWT-w1H+PBS H+pLeX-w1
100 mm 100 mm 100 mm
Figure 5. ω1 glycovariants do not affect hepatic steatosis, but increase fibrotic gene markers and 
liver damage. Mice were fed a LFD or a HFD and were treated with PBS or pWT/pLeX-ω1 as described 
in the legend of Figure 1. At sacrifice, a small piece of liver was immediately snap-frozen for qPCR 
and liver lipid content analyses, and another piece was used for H&E staining. From the remaining 
liver, CD45+ liver cells were isolated and analyzed by flow cytometry. The cell numbers per gram 
tissue and abundances of CD4 T cells (A) and T helper subsets (B), Kupffer cells (C), macrophage 
phenotypes (D-E) and Ly6Chi monocytes (G) were determined. mRNA expression of the indicated 
genes was analysed as described in the legend of figure 3 (F). H&E slides of the liver (H) were used 
for determining hepatic steatosis (I). Liver triglycerides were determined (J). mRNA expression of 
the indicated genes was analysed as described in the legend of Figure 3 (K). Sirius Red-stained 
sections were scored for fibrosis (L). Plasma alanine aminotransferase levels (M) were determined. 
WT and Stat6-/- mice were fed a LFD or a HFD and were treated as described in the legend of 
Figure 4. Frequencies of IL-5/IL-13-expressing CD4 T cells were determined (N). mRNA expression of 
the indicated genes was analysed as described in the legend of figure 3 (O). Data shown are a pool 
of at least two independent experiments, except for N-O. Results are expressed as means ± SEM. * 
P<0.05 vs HFD, $ P<0.05 vs pWT-ω1 (n 5=18 animals per group in A-M, and 3-5 animals per group 
in N-O).
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ILC2s after either one, or four weeks of treatment with plant-produced ω1 glycovariants. 
Moreover, we did not find any evidence of WAT beiging in both eWAT and iWAT from 
obese mice treated with ω1 glycovariants. Importantly, it should be noted that despite 
similar RNase activities when compared to native ω1 (27), the recombinant ω1 produced 
by HEK-293 cells and the glyco-engineered ones from tobacco plants harbor significantly 
different N-glycosylation patterns (23, 24). Finally, on top of differences in treatment 
regimen (2 injections in 4 days versus bi-weekly injection for 4 weeks in our study), it is 
worth mentioning that in Hams et al. the effects of HEK-produced ω1 were compared to 
the effects of ovalbumin (25), which is an immunomodulatory molecule by itself, differing 
significantly from our experimental condition where a neutral vehicle (PBS) was used 
as control. 
Both ω1 glycovariants were found to induce a type 2 immune response in WAT, 
characterized by a significant increase in Th2 cells, eosinophils and AAMs. In our study, 
as previously described for SEA (18), the ω1-induced increase in type 2 cytokines was 
shown to be clearly derived from CD4+ T cells, not ILC2s. Our data indicate that both 
pWT–ω1 and pLeX–ω1 require Th2 cells, rather than ILC2s to induce WAT eosinophilia and 
AAM polarization. It was previously shown that pLeX–ω1, compared to pWT-ω1, induced 
a stronger Th2 polarization in vivo using a footpad immunization model in mice (27). In 
our conditions, both glycovariants induced a similar increase in the percentage of Th2 
cells in metabolic tissue from obese mice, whereas pLeX–ω1 increased total CD4+ T cells 
to a greater extent in the liver and to a lesser extent in WAT when compared to pWT-ω1. 
Altogether, this suggests that the glycosylation pattern of ω1 might induce tissue-specific 
differences in total Th2 cells. 
In the liver, ω1 glycovariants increased IL-13-producing Th2 cells but, unlike SEA (18), 
promoted CD11c expression in Kupffer cells while not affecting the expression of Ym1, 
suggesting that macrophages are rather polarized towards a pro-inflammatory state. Of 
note, ω1 glycovariants also increased hepatic expression of fibrotic gene markers and 
circulating ALAT levels, both indicating increased liver damage. Interestingly, the pLeX–ω1-
induced increase in liver IL-13+ Th2 cells and hepatic IL-13 gene expression were markedly 
reduced in Stat6-deficient mice, which was accompanied by a decreased expression of 
fibrotic gene markers. Collectively, these findings confirmed previous studies in which 
IL-13 was shown to play a role in the development of liver fibrosis (39, 40).
As the type 2 immune response seems not to be significantly involved in the beneficial 
metabolic effects of ω1, the question of the underlying mechanism(s) remains. Interestingly, 
we found that treatment with both ω1 glycovariants significantly reduced food intake, with 
a trend for pLeX–ω1 being more potent than pWT–ω1. Furthermore, this anorexigenic 
effect of ω1, which was not observed previously when mice were chronically infected 
with S. mansoni or treated with SEA (18), was dose-dependent (already detectable at 
a concentration of 10 µg) and also present in Stat6-deficient mice. Altogether, these 
findings lead us to the hypothesis that the beneficial metabolic effects of ω1 might be 
mediated through a reduction in food intake, rather than an increase in type 2 immune 
cells. Of note, in the study from Hams et al. using HEK-produced ω1, the authors claimed 
that treatment with this recombinant molecule in obese mice did not significantly affect 
food intake, but unfortunately these crucial data were not shown (25).
Since both locomotor activity and lean body mass were not affected by ω1, we also 
conclude that the reduced food intake was not related to wasting or illness (as reviewed in 
(42)). In order to assess the contribution of reduced food intake to the metabolic benefits 
of recombinant ω1, paired-feeding could be used in future studies. In addition, in search 
for underlying mechanisms, it will be important to study the biodistribution of ω1 using 
labeled molecules, notably to investigate whether the molecules can be detected in brain 
areas known to be involved in the control of food intake, such as the hypothalamus (43). 
In line with this, it would be interesting to assess the effect of ω1 on the hypothalamic 
expression of anorexigenic (e.g. POMC, CART) and orexigenic (e.g. NPY, AgRP) peptides.
In conclusion, our work has revealed that the improvement of metabolic homeostasis 
in insulin-resistant obese mice by plant-produced recombinant ω1 glycovariants is 
independent of their Th2-inducing capacities. 
Our current hypotheses are that the beneficial metabolic effects of ω1 could be 
explained by brain-mediated food intake and/or immune-independent direct interaction 
of ω1 with metabolic cells. Further studies are undoubtedly required to unravel these 
underlying mechanisms. Of note, with regards to the therapeutic potential of ω1 as 
treatment for metabolic disorders, it is important to cautiously underline that recombinant 
ω1 induced early markers of mild hepatic fibrosis, by a mechanism partly mediated through 
ω1-induced type 2 immunity.
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Supplementary Figure S1. Gating strategies. Isolated cells were pre-gated on Aqua-CD45+ single cells 
(A). The gating strategy for analysis of ILCs, CD4 T cells (B), CD4 T helper subsets and intracellular 
cytokine expression (C) is shown. Here, the lineage channel includes antibodies against CD11b, 
CD11c, B220, GR-1, NK1.1 and CD3. Representative samples were chosen from eWAT samples; 
gating strategies for lymphocyte subsets were similar in liver samples. The gating strategy is shown 
for eosinophils, CD11c+Ym1- M1-like macrophages and CD11c-Ym1+ M2-like macrophages in eWAT, 
including Fluorescence Minus One (FMO) controls for CD11c and Ym1 (D). The gating strategy for 
liver eosinophils, neutrophils, Ly6Chi monocytes, CD11c+Ym1- Kupffer cells and CD11c-Ym1+ Kupffer 































































































































Supplementary Figure S2. ω1 glycovariants improve whole-body insulin sensitivity after one week 
of treatment, without affecting body composition. Mice were fed a LFD or a HFD for 12 weeks, after 
which they were treated i.p. with PBS or 50 µg pWT/pLeX-ω1 once every 2 days for 1 week. Body 
weight was monitored throughout the experimental period (A). Body composition (B-C) and weights 
of different fat pads and the liver (D) were measured after 1 week of treatment. Blood glucose and 
plasma insulin levels were determined and HOMA-IR was calculated as described in the legend of 
Figure 1 (E). An i.p. insulin tolerance test was performed as described in the legend of Figure 1 (F). 
Results are expressed as means ± SEM. * P<0.05 vs HFD (n = 4-9 animals per group in A-E).







































































































































Supplementary Figure S3. pLeX-ω1 improves whole-body insulin sensitivity and glucose tolerance in 
a dose-dependent manner. Mice were fed a LFD or a HFD and were treated i.p. with PBS or 10 μg, 
25 μg or 50 μg pLeX-ω1 every three days for four weeks. Body weight (A-B) and body composition (C) 
were determined after four weeks of treatment. Food intake was monitored throughout the treatment 
period (D). Blood glucose (E) and plasma insulin levels (F) were determined and HOMA-IR (G) was 
calculated as described in the legend of Figure 1. An i.p. glucose tolerance test (2 g/kg body weight; 
H-I) and i.p. insulin tolerance test (1U/kg lean body mass; J) were performed as described in the legend 
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Supplementary Figure S4. ω1 glycovariants increase WAT type 2 immune cells after one week of 
treatment. Mice were fed a LFD or a HFD and treated with PBS or pWT/pLeX-ω1 as described in 
the legend of Figure S2. At the end of the experiment, eWAT was collected, processed and analyzed as 
described in the legend of Figure 2. The numbers per gram tissue of CD4 T cells (A) and the frequencies 
of intracellular cytokine producing CD4 T cells (B) were determined. Numbers per gram tissue of ILCs 
were assessed (J), and frequencies of intracellular cytokine producing ILCs were determined (D). Cell 
numbers per gram tissue of eosinophils (E) and macrophages (F), and percentages of CD11c+Ym1- 
(M1-like; G) and CD11c-Ym1+ (M2-like; H) in macrophages were determined. The M2 over M1 
ratios were calculated (I). Results are expressed as means ± SEM. * P<0.05 vs HFD (n = 1-6 animals 
per group).
Supplementary Figure S5. pLeX-ω1 increases WAT type 2 immune cells in a dose-dependent manner. 
Mice were fed a LFD or a HFD and were treated with PBS or pLeX-ω1 as described in the legend of 
Figure S3. At the end of the experiment, eWAT was collected, processed and analysed as described 
in the legend of Figure 2. The numbers per gram tissue of CD4 T cells (E), and the frequencies of 
intracellular cytokine producing CD4 T cells (B-D) were determined. Numbers per gram tissue of 
eosinophils (E) and macrophages (F), and macrophages phenotypes (G-H) were assessed. Results are 
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Supplementary table S1. Primer sequences for qRT-PCR
Gene Accession number Forward primer Reverse primer
Acta2 NM_007392.3 AGCCATCTTTCATTGGGATGG CCCCTGACAGGACGTTGTTA
Ccl2 NM_011333.3 TCAGCCAGATGCAGTTAACGCCC GCTTCTTTGGGACACCTGCTGCT
Cidea NM_007702 CTCGGCTGTCTCAATGTCAA CCGCATAGACCAGGAACTGT
Col1a1 NM_007742.3 GAGAGGTGAACAAGGTCCCG AAACCTCTCTCGCCTCTTGC
Cox8b NM_007751.3 GACCCCGAGAATCATGCCAA CCTGCTCCACGGCGGAA
Il1b NM_008361 GACCCCAAAAGATGAAGGGCT ATGTGCTGCTGCGAGATTTG
Rplp0 NM_007475 TCTGGAGGGTGTCCGCAACG GCCAGGACGCGCTTGTACCC
Tgfb1 NM_011577 GCTGAACCAAGGAGACGGAA ATGTCATGGATGGTGCCCAG
Timp1 NM_001044384 TCGGACCTGGTCATAAGGGC GCTTTCCATGACTGGGGTGT
Tnfa NM_013693 GTCCCCAAAGGGATGAGAAG CACTTGGTGGTTTGCTACGA
Ucp1 NM_009463 TCAGGATTGGCCTCTACGAC TGCATTCTGACCTTCACGAC
Zfp423 NM_033327.2 TTCACAGTCTTCGTCCAGGC AGATTTTGTCCTCCTGCCCG
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Upon activation granulocytes upregulate several adhesion molecules (CD11b) and granule 
proteins (CD35, CD66b) and shed surface L-selectin (CD62L). These changes in expression, 
as assessed by flow cytometry, can be used as markers for activation. Whereas these markers 
are usually studied in fresh blood samples, a new method is required when samples are 
collected at a field site with no direct access to a flow cytometer. Therefore, we developed 
and tested a field-applicable method in which fixed leukocytes were cryopreserved. Using 
this method, the intensity of granulocyte activation markers was compared to samples 
that were either stained fresh, or fixed prior to staining but not cryopreserved. In addition, 
the response to an in vitro stimulation with fMLF was determined. While we observed 
differences in marker intensities when comparing fresh and fixed granulocytes, similar 
intensities were found between fixed cells that had been cryopreserved and fixed cells that 
did not undergo cryopreservation. Although fixation using FACS lysing solution might lead 
to membrane permeabilization, activation markers, and the responsiveness to fMLF or 
eotaxin could still be clearly measured. This method will, therefore, enable future studies 
of granulocyte activation in settings with limited resources and will allow simultaneous 
analysis of samples collected at different time points.
INTRODUCTION
Granulocytes form a class of innate effector cells and consist of eosinophils, neutrophils, 
and basophils, all characterized by the presence of lobulated nuclei and secretory 
granules in their cytoplasm. Upon inflammation, granulocytes are recruited from 
the circulation to the site of tissue injury or infection, where they become activated 
and exert their effector functions. To adhere to the endothelium, granulocytes 
express L-selectin (CD62L), and several selectin ligands which mediate “rolling” along 
the vessel endothelium (1, 2). This is followed by firm adhesion to and transmigration 
through endothelial cells, which is mainly mediated by the integrins Mac1 (CD11b/ 
CD18) and VLA4 (CD49d/CD29, only expressed by eosinophils and basophils) (1, 2). 
In addition to adhesion molecules, surface expression of proteins normally residing 
inside granule membranes can be used as markers for degranulation and, therefore, 
activation (3). Relevant are complement receptor 1 (CD35), mediating binding and 
phagocytosis of C3b coated particles and immune complexes, present in secretory 
vesicles, and CEACAM-8 (CD66b) which is present in specific granules (3).
Whereas neutrophils demonstrate a rapid upregulation of CD11b, CD35 and CD66b 
after in vitro activation with inflammatory agonists such as N-Formyl-Met-Leu-Phe (fMLF), 
the level of CD62L reduces as a result of stimulation-induced shedding (4, 5). Similarly, 
eosinophils respond to the chemokine eotaxin (amongst others) by upregulating CD11b 
and shedding their CD62L (6, 7). Therefore, quantification of these markers by flow 
cytometry can be used as read-out for the activation state and responsiveness of the cells 
for inflammatory mediators (4, 5, 8-14).
To study the expression of activation markers on granulocytes by flow cytometry, 
the use of lysed whole blood is preferred over cell isolation techniques as the latter could 
lead to nonspecific activation (15). In addition, purification procedures often require 
more time and a larger volume of blood compared to using whole blood. Therefore, 
total leukocytes are usually analysed by multicolour flow cytometry after staining whole 
blood with fluorescently-labelled antibodies followed by multiple gating (4, 5, 16). 
Whereas this method is suitable for laboratories with direct access to flow cytometers, 
circumstances are different when blood is collected at a field site with only basic laboratory 
infrastructure. Hence, a novel method is required in which samples can be collected in 
a setting with limited resources and stored for long time periods until analysis in a fully 
equipped laboratory. 
Fixation methods are often used to preserve cells and studies have successfully 
demonstrated the applicability of granulocyte fixation prior to staining (8, 10, 17). 
However, fixation can modify cell morphology as measured by forward scatter (FSC) 
and side scatter (SSC) of leukocytes (8, 17-19). Fixation may also affect granulocyte 
cell membrane permeability (18-20) and can affect antigen epitopes and, thereby, their 
interaction with the monoclonal antibodies (9). This requires careful evaluation of each 
antigen-antibody combination.
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As the cryopreservation of freshly isolated granulocytes has been proven difficult 
because of high susceptibility to damage during the cryopreservation method (21), 
cryopreservation of fixed lysed whole blood samples might be a suitable method for 
long-term storage. This would allow sample collection at the field site requiring only 
pipettes, a centrifuge and a -80°C freezer, followed by transport to a central laboratory 
for flow cytometric analysis. Moreover, long-term storage allows researchers to analyse 
samples collected at different time points simultaneously. 
Nemes et al. previously provided proof-of-principle that cryopreservation leads to 
accurate quantification of cell subsets (granulocytes, lymphocytes, monocytes, T cells 
and B cells) by flow cytometry in fixed whole blood samples (17). Our study tested 
the hypothesis that also granulocyte activation can be determined in such samples by 
comparing the expression of granulocyte activation markers on samples that were either 
fresh (no fixation), fixed prior to staining, or fixed and cryopreserved prior to staining. In 
addition, we set out experiments to measure the response of granulocytes to an in vitro 
stimulation with fMLF (neutrophils or basophils) or eotaxin (CCL11; eosinophils) in cells 
fixed and cryopreserved after activation. 
The applicability of cryopreservation of fixed cells was subsequently tested in 
a controlled laboratory model of acute inflammation (22) and in a field study in Flores, 
Indonesia (23). We now show that cryopreservation of fixed total leukocyte populations 
allows the determination of activated granulocytes, either activated by chemokines in vitro 
or by inflammation in vivo.
MATERIALS & METHODS
Sample preparation
Venous blood of three healthy volunteers was collected in sodium heparin vacutainers (BD 
Biosciences, Franklin Lakes, NJ, USA) and handled within 30 minutes. Different methods 
were compared, depicted in Figure 1, and for each method 2 polystyrene round-bottom 
tubes containing 200 μL of blood per donor were pre-incubated for 5 min in a 37°C 
waterbath, followed by a 5 min-stimulation at 37°C with fMLF (10−5 M; Sigma, Saint Louis, 
MO, USA) or left unstimulated. Subsequently, samples were subjected to the following 
treatments: (1) Erythrocyte lysis using lysing buffer consisting of 155 mM NH4Cl and 10 
mM Na2EDTA, with a pH of 7.0 and osmolarity of 298-305. Cells were transferred to ice 
and to each sample 900 μL lysing buffer was added. Cells were centrifuged at 1600 rpm 
for 5 min and washed with first 500 μL lysis buffer, followed by washing and resuspension 
in FACS buffer (PBS complemented with 0.5% BSA and 2 mM EDTA) and directly stained. 
(2) Erythrocyte lysis and leukocyte fixation using FACS lysing solution (BD Biosciences, 
#349202) for 15 min at room temperature. Following the recommended procedures, 
the FACS lysing solution (stock solution 10x) was diluted, and 4 mL of the diluted reagent 
was used for each whole blood sample. After lysis the cells were centrifuged, washed with 
RPMI 1640 containing 10% heat-inactivated foetal calf serum (FCS), centrifuged again and 
finally resuspended in FACS buffer and stored (<8 hrs) at 4°C until staining. (3) Erythrocyte 
lysis and leukocyte fixation using FACS lysing solution as described above (Treatment 2). 
Following lysis, cells were washed with 10% FCS/RPMI and resuspended in 10% FCS/10% 
dimethyl sulfoxide (DMSO)/RPMI. Cryovials containing the cell suspension were placed 
at -80°C. The cryopreserved fixed cells were thawed on the bench and subsequently 
transferred to 5 ml polystyrene round-bottom tubes containing 1 mL 10% FCS/RPMI. After 
centrifugation at 1600 RPM for 5 min, cells were resuspended in FACS buffer and stored 
(<2 hrs) at 4°C until staining. In the results section, Treatments 1, 2 and 3 will be referred 
to as “Fresh”, “Fixed” and “Fix & Freeze”, respectively. 
Cryopreservation of fixed leukocytes (Treatment 3), was applied in a clinical trial 
conducted in a rural area at Flores island in Indonesia to study the effect of soil-transmitted 
helminth infections on granulocyte activation. This SUGARSPIN trial was approved by 
the ethics committee of Faculty of Medicine, Universitas Indonesia (FKUI), filed by the ethics 
committee of Leiden University Medical Center (LUMC), and registered as a clinical trial 
(http://www.isrctn.com/ISRCTN75636394). The study protocol was published previously 
(23). Blood samples were collected after obtaining written consent and processed 
according to Treatment 3, with the only difference that cells were stored in liquid nitrogen 
after placement at -80°C for a minimum of 4 hours. In addition to the stimulation with fMLF 
described above, whole blood was stimulated for 5 min at 37°C with eotaxin (CCL11; 10−7 
M, R&D systems, Abingdon, UK) to study in vitro eosinophil activation.
Figure 1. Experiment overview.
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Figure 2. FSC/SSC properties of granulocytes. Numbers indicate different cell populations: (1) 
eosinophils, (2) neutrophils, (3) monocytes and (4) lymphocytes. After fixation, eosinophils change in 
FSC/SSC and monocytes and neutrophils show overlap in FSC/SSC properties. This overlap is further 
amplified after freeze-thawing the cells. Basophils overlap with lymphocytes in FSC/SSC properties.
Neutrophil subset identification after LPS challenge
To assess whether neutrophil activation can also be detected after using the method of 
fixation and cryopreservation following in vivo stimulation, cells from a large endotoxin 
trial (NCT02629874 at www.clinicaltrials.gov) were used. In short, healthy male volunteers 
were enrolled after screening and were prehydrated. U.S. Reference E. coli endotoxin (Lot 
Ec-5; Centre for Biologic Evaluation and Research, U.S. Food and Drug Administration, 
Bethesda, MD, USA) was used in this study. Endotoxin was reconstituted in 5 mL saline 
and injected as a single intravenous bolus (2 ng/kg) during 1 min at t = 0. The study 
protocol was approved by the Ethics Committee of the Radboud University Nijmegen 
Medical Centre and complies with the Declaration of Helsinki and Good Clinical Practice 
guidelines. Subjects gave written informed consent.
At t = 180 min, blood samples, anticoagulated with sodium heparin, were taken from 
the arterial catheter. The blood samples were processed according to Treatments 1 and 3 
described above. For Treatment 3, cells were first stored at -30°C for 8 days for operational 
reasons (no -80°C freezer at sampling site), before they were transferred to -80°C. 
Flow cytometric analysis
Irrespective of the method used, cells were counted by microscopy after erythrocyte lysis 
and 500.000 leukocytes were transferred to a 96-well V-bottom microplate and incubated 
for 30 min at 4°C with anti-CD35-FITC (E11, Biolegend, San Diego, USA), anti-CD66b-
PerCP/Cy5.5 (G10F5, Biolegend), anti-CD193-PE (5e, Biolegend), anti-CD16-PE/CF594 
(3G8, BD Biosciences), anti-CD69-PE/Cy5 (FN50, Biolegend), anti-CD3/CD19/CD20/
CD56-APC (UCHT1, HIB19, 2H7, 5.1H11, Biolegend), anti-CD11b-APC/eF780 (ICRF44, 
eBioscience Inc., San Diego, USA), anti-CD203c-BV421 (NP4D6, Biolegend), anti-CD14-
BV510 (M5E2, Biolegend) and anti-CD62L-BV605 (DREG-56, BD Biosciences). Cells 
collected after LPS challenge were stained with anti-CD16-Pacific Orange (3G8, Beckman 
Coulter) and CD62L-BV650 (DREG-56, Biolegend). Compensation beads (BD Biosciences) 
were stained with each antibody separately and run before acquisition to calculate 
the compensation matrix using BD Facs Diva flow cytometry software. 
As we aimed to compare three methods, all samples were measured on the same day 
and stained with the same antibody mix, with exception of the samples that were collected 
in the endotoxin clinical trial or as part of the SUGARSPIN study. Cells were measured on 
a LSR Fortessa flow cytometer (BD Biosciences), equipped with 405, 488, 561 and 640 
lasers. Data were analysed with FlowJo software (Treestar Inc., Ashland, OR, USA) and 
median fluorescence intensity (MFI) data are displayed. Representative gating schemes 
are shown in Supplementary Figure S1. Although neutrophils and eosinophils clearly 
differ in their FSC/SSC properties, we used the expression of CD193 (in fresh samples) or 
the autofluorescent signal (in fixed samples) to gate eosinophils. Neutrophils were gated 
based on their FSC/SSC properties and subsequently separated from monocytes based 
on their CD14-/CD11b+ expression. Basophils were gated based on their expression of 
CD193 and CD203c and lack of the lineage markers CD3, CD19, CD20 and CD56. 
Statistical analysis
Data analysis was performed using GraphPad Prism version 7 for Windows (Graphpad 
Software, San Diego, CA, USA) and this software was also used to make graphs. Paired 
t test was used to assess the effect of fMLF stimulation on the expression of activation 
markers in neutrophils and basophils. The effect of stimulation on markers expressed 
by neutrophils, eosinophils and basophils from samples collected in a field study was 
tested using Wilcoxon matched-pairs signed rank test. P values ≤ 0.05 were considered 
statistically significant.
RESULTS 
Fixation leads to changes in FSC/SSC profiles
After fixation, granulocytes displayed different forward scatter/ side scatter (FSC/SSC) 
profiles compared to fresh cells suggesting a change in morphology (Figure 2). Eosinophils 
showed a shift in FSC and became more autofluorescent after fixation (Supplementary 
Figure S2). No increase in autofluorescence was observed for neutrophils (data not shown). 
After fixation, neutrophils exhibited a lower SSC signal, resulting in an overlap between 
neutrophils and monocytes. The amount of overlap increased after freeze-thawing, and 
it was, therefore, important to add a monocyte marker (e.g. CD14) and/or a specific 
neutrophil marker (e.g. CD66b) to the panel to be able to discriminate between these 
cell types. Except for neutrophils, fixed leukocytes that had been cryopreserved displayed 
similar FSC-SSC properties compared to fixed cells that did not undergo cryopreservation. 




Cellular activation and responsiveness to fMLF can be measured by 
activation markers after fixation and cryopreservation
We observed changes in marker intensities when comparing fresh and fixed unstimulated 
neutrophils (Figure 3, Table 1). The measured intensities of CD11b, CD35 and CD66b 
were elevated after fixation when compared to fresh cells, whereas the detected intensity 
of CD62L on neutrophils was lower after fixation compared to fresh cells. These changes 
were consistent in all three donors. No major differences in the marker intensities were 
observed when fixed neutrophils that had been cryopreserved were compared to fixed 
cells that did not undergo cryopreservation (Figure 3), indicating that the observed 
differences with fresh cells are a consequence of fixation, and are not caused by the process 
of freeze-thawing. 
To assess whether it is possible to detect activation of neutrophils after fixation and 
cryopreservation, we measured the levels of activation markers in samples that were 
incubated with and without fMLF. Despite the changes in marker intensities that were 
described above, fMLF activation could still further increase the expression of measured 
activation markers in fixed and cryopreserved neutrophils (Figure 3, Table 1). The detected 
responsiveness of CD35 and CD11b to fMLF was similar in fresh and fixed neutrophils, 
irrespective of freezing. Regarding CD66b, we observed an increased expression after 
stimulation with fMLF in fresh neutrophils as well as fixed cells. However, in fixed cells, 
the increase in CD66b expression was rather weak compared to fresh cells, indicating that 
CD66b might not be suitable for studying functional capacity of neutrophils in terms of 
responding to a stimulus when this field applicable method is used. CD62L is shed from 
the membrane upon activation, and despite the overall lower intensity of CD62L in fixed 
neutrophils, we could still observe this response after activation with fMLF. 
Three neutrophil subsets can be identified based on CD16 and CD62L 
expression after fixation and cryopreservation
The experiments described above relied on the in vitro activation of leukocytes by fMLF. 
We next studied leukocyte subsets that have been described in fresh cells following 
Figure 3. Expression of CD11b, CD35, CD66b and CD62L on neutrophils and the response to 
fMLF. Median fluorescent intensity (MFI) of markers on neutrophils left unstimulated and stimulated 
with fMLF. Neutrophils were stained either fresh (Fresh), after fixation (Fixed) or after being fixed, 
cryopreserved and thawed (Fix & Freeze). Symbols (circle, triangle, square) represent three different 
donors. *indicates analysis with paired t test. *, P ≤ 0.05. **, P ≤ 0.01. ***, P ≤ 0.001. n.s., not significant.








Medium fMLF Medium fMLF Medium fMLF
CD11b 164 (20) 857 (124) 1175 (101) 1758 (222) 1525 (132) 2154 (186)
CD35 788 (92) 4054 (921) 1113 (160) 3729 (832) 1399 (99) 3981 (845)
CD66b 337 (25) 909 (113) 518 (62) 583 (18) 590 (74) 720 (17)
CD62L 5304 (753) 261 (49) 1216 (108) 169 (8) 1118 (41) 156 (8)
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in vivo stimulation by a systemic pro-inflammatory stimulus, LPS. Thus, since CD62L 
intensities were found to be decreased after fixation, we assessed whether we would still 
be able to identify the three different neutrophil subsets that were previously described 
on fresh cells (22). Although both CD16 and CD62L intensities were lower after fixation 
and cryopreservation, we were able to identify the three different neutrophil subsets 
(1- CD16brightCD62Lbright; 2- CD16dimCD62Lbright; 3- CD16brightCD62Ldim) based on expression 
of these two markers (Supplementary Figure S3).
Eosinophils and Basophils
The intensities of all eosinophil markers studied (CD193, CD66b, CD35, CD11b, CD62L 
and CD69) were similar between fixed eosinophils that had been cryopreserved and fixed 
cells that did not undergo cryopreservation (Figure 4). However, similar to the situation 
with neutrophils, differences were observed in the intensities of activation markers for 
eosinophils when comparing fresh and fixed cells. The measured intensities of CD35 
and CD66b were slightly higher after fixation, while the intensity of CD11b was strongly 
increased and CD62L detection was lower in fixed compared to fresh cells. 
Basophils also respond to fMLF (24) and the intensity of CD11b, CD35 and CD203c 
was increased after stimulation (Supplementary Figure S4, Table S1). Like the expression of 
these markers in unstimulated cells, the responsiveness to fMLF was similar between fresh, 
fixed and cryopreserved cells.
Field study application
The aim of this study was to set up a method to assess granulocyte activation and 
responsiveness in a field study with limited laboratory equipment. After testing 
the method to fix and cryopreserve leukocytes for flow cytometric analysis, this method 
was applied in a clinical trial in a rural area in Indonesia (23). Blood samples from 300 
subjects were processed according to the method described and stored in liquid nitrogen 
for up to two years until analysis. Figures 5 and 6 and Supplementary Figure S5 show 
representative samples collected during this study. Even after long-term storage we could 
measure the expression of activation markers on neutrophils (Figure 5A), eosinophils 
(Figure 6A) and basophils (Supplementary Figure S5A). Moreover, the response of 
neutrophils and basophils to fMLF evoked in samples in the field was clearly present (Figure 
5B, Supplementary Figure S5B, Table S2). To study the responsiveness of eosinophils, we 
stimulated whole blood with eotaxin and observed an increased intensity of CD35 and 
CD11b when compared to unstimulated cells (Figure 6B, Table S2). Although not compared 
to fresh cells, this shows that the activation effect in eosinophils can be measured after 


































































































































































































































Here, we show that the activation status of neutrophils, eosinophils, and basophils and 
their responsiveness to stimuli such as fMLF and eotaxin, can be studied in whole-blood 
samples that were lysed, fixed and cryopreserved. Previously, Nemes et al. showed that 
cryopreservation of fixed leukocytes provides for an accurate quantification of cell subsets 
based on the expression of lineage-specific markers (CD66b, CD14, CD3, CD19, CD16), 
as analysed by flow cytometry (17). However, they had not tested whether the method 
was also suitable for assessing the activation status of granulocytes. We show that 
cryopreservation of granulocytes allows detection of activation of granulocytes in vitro 
in response to fMLF and eotaxin, as well as activation in vivo during acute inflammation 
evoked by experimental endotoxemia in healthy volunteers. It will now be possible to 
measure differences in innate immune responses at field sites where no flow cytometers 
are available for direct analysis. 
Cryopreservation of fixed granulocytes induces some differences in cellular 
characteristics that preclude direct comparison with analysis of fresh cells. For instance, 
the differences detected in FSC/SSC profiles of granulocytes and marker intensities between 
cryopreserved and fresh cells were mainly caused by fixation. The increased intensity of 
CD11b, CD35 and CD66b in fixed neutrophils might be a consequence of fixation-induced 
membrane permeabilization, potentially leading to intracellular staining in the granules 
(19, 20). This is particularly relevant for markers normally residing in the granular 
CD11b – APC-eF780 CD35 – FITC CD66b – PercP-Cy5.5 CD62L – BV605A.
B.
Figure 5. Expression of CD11b, CD35, CD66b and CD62L on neutrophils collected in a field study. 
Samples were cryopreserved for 2 years in liquid nitrogen. (A) Histograms of a representative sample, 
filled lines display unstained neutrophils, the thin black lines unstimulated cells and the thick black 
lines fMLF-stimulated cells. (B) Median fluorescent intensity (MFI) of markers in neutrophils from 10 
representative donors left unstimulated and stimulated with fMLF. Means and standard deviations are 
shown in Supplementary Table S2. *indicates analysis with Wilcoxon matched-pairs signed rank test. 
**, P ≤ 0.01.
CD35 – FITC CD11b – APC-eF780 CD62L – BV605







Figure 6. Expression of CD35, CD11b, CD62L, CD66b, CD193 and CD69 on eosinophils collected 
in a field study. Samples were cryopreserved for 2 years in liquid nitrogen. (A) Histograms of 
a representative sample, filled lines represent unstained eosinophils, the thin black lines unstimulated 
cells and the thick black lines eotaxin-stimulated cells. (B) Median fluorescent intensity (MFI) of CD35 
and CD11b in eosinophils from 10 donors left unstimulated and stimulated with eotaxin. Means and 
standard deviations are shown in Supplementary Table S2. *indicates analysis with Wilcoxon matched-
pairs signed rank test. **, P ≤ 0.01.
compartment, which become expressed upon degranulation. Only 5% of the total cellular 
content of the CD11b-CD18 (Mac-1) complexes in unstimulated neutrophils is expressed 
on the plasma membrane, whereas 95% colocalized with specific granules and secretory 
vesicles (25). Therefore, the increased intensity of CD11b in fixed versus fresh neutrophils 
might reflect some staining of the intracellular pool of CD11b molecules. Importantly, 
despite the putative membrane permeability caused by fixation, we could still observe 
a significant effect of fMLF in neutrophils (in particular for CD35, CD11b and CD62L) and 
basophils (in particular for CD203c, CD35 and CD11b), and of eotaxin in eosinophils (in 
particular for CD35 and CD11b). This activation effect was also clearly present in samples 
collected in the field which had been cryopreserved for up to two years. 
Hamblin et al. observed no intracellular leukocyte staining of p8,14 (expressed 
in all circulating monocytes and neutrophils) nor DNA staining after fixation with 0.4% 
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formaldehyde (8). This suggests that different fixation methods might have different effects 
in terms of cell permeabilization. However, the use of FACS lysing solution is a quick and 
easy method and, therefore, suitable to be used in the field. 
We also observed that eosinophils became more autofluorescent after fixation and 
it is, therefore, difficult to determine in eosinophils whether the differences in marker 
intensity between fresh and fixed cells are a result of cell membrane permeabilization, 
affected antigen epitopes, or increased autofluorescence. The effect of autofluorescence 
on the intensity of a certain marker depended on the fluorescent channel being used, 
as we observed no shift in the channel used to detect APC/eF780. CD193 (chemokine 
receptor CCR3 / eotaxin receptor) is a well-known marker for eosinophils and we observed 
a lower detection of CD193 in fixed compared to fresh eosinophils. Combined with an 
increased autofluorescent signal in the PE-channel, we recommend not to use CD193 
as single eosinophil marker when analysing fixed, cryopreserved granulocytes. CD193 
functioned well as a basophil marker, irrespective of fixation (26, 27). For similar reasons, 
we advise to use a CD62L antibody with a different fluorophore than BV605, or to increase 
the amount of antibody when staining fixed eosinophils to be able to detect CD62L.
In summary, these results demonstrate that fixation and cryopreservation of lysed 
whole blood samples can be applied at field sites with limited laboratory infrastructure. We 
showed that the activation status of granulocytes and responsiveness to fMLF or eotaxin 
could be measured after cryopreservation, allowing to measure changes in the innate 
immune response in patients. This will enable future studies of granulocyte activation in 
settings with limited resources and allows the parallel analysis of samples collected at 
different time points and at different sites.
REFERENCES
1. Rosenberg HF, Dyer KD, Foster PS. 
Eosinophils: changing perspectives 
in health and disease. Nature reviews 
Immunology 2013; 13(1): 9-22.
2. Kolaczkowska E, Kubes P. Neutrophil 
recruitment and function in health 
and inflammation. Nature reviews 
Immunology 2013; 13(3): 159-75.
3. Cowland JB, Borregaard N. Granulopoiesis 
and granules of human neutrophils. 
Immunol Rev 2016; 273(1): 11-28.
4. Mann BS, Chung KF. Blood neutrophil 
activation markers in severe asthma: lack of 
inhibition by prednisolone therapy. Respir 
Res 2006; 7: 59.
5. Berends C, Hoekstra MO, Dijkhuizen B, 
de Monchy JG, Gerritsen J, Kauffman HF. 
Expression of CD35 (CR1) and CD11b (CR3) 
on circulating neutrophils and eosinophils 
from allergic asthmatic children. Clinical 
and experimental allergy: journal of 
the British Society for Allergy and Clinical 
Immunology 1993; 23(11): 926-33.
6. Santamaria LF, Palacios JM, Beleta J. Inhibition 
of eotaxin-mediated human eosinophil 
activation and migration by the selective 
cyclic nucleotide phosphodiesterase type 
4 inhibitor rolipram. British journal of 
pharmacology 1997; 121(6): 1150-4.
7. Tenscher K, Metzner B, Schopf E, Norgauer 
J, Czech W. Recombinant human eotaxin 
induces oxygen radical production, Ca(2+)-
mobilization, actin reorganization, and 
CD11b upregulation in human eosinophils 
via a pertussis toxin-sensitive heterotrimeric 
guanine nucleotide-binding protein. 
Blood 1996; 88(8): 3195-9.
8. Hamblin A, Taylor M, Bernhagen J, et al. 
A method of preparing blood leucocytes for 
flow cytometry which prevents upregulation of 
leucocyte integrins. Journal of immunological 
methods 1992; 146(2): 219-28.
9. Finn A, Rebuck N. Measurement of adhesion 
molecule expression on neutrophils 
and fixation. Journal of immunological 
methods 1994; 171(2): 267-70.
10. Torsteinsdottir I, Arvidson NG, Hallgren R, 
Hakansson L. Enhanced expression of integrins 
and CD66b on peripheral blood neutrophils 
and eosinophils in patients with rheumatoid 
arthritis, and the effect of glucocorticoids. 
Scand J Immunol 1999; 50(4): 433-9.
11. Mawhorter SD, Stephany DA, Ottesen EA, 
Nutman TB. Identification of surface molecules 
associated with physiologic activation of 
eosinophils. Application of whole-blood flow 
cytometry to eosinophils. Journal of immunology 
(Baltimore, Md: 1950) 1996; 156(12): 4851-8.
12. Chiba T, Kamada Y, Saito N, et al. RANTES 
and eotaxin enhance CD11b and CD18 
expression on eosinophils from allergic 
patients with eosinophilia in the application of 
whole Blood flow cytometry analysis. Int Arch 
Allergy Immunol 2005; 137 Suppl 1: 12-6.
13. Yoon J, Terada A, Kita H. CD66b regulates 
adhesion and activation of human eosinophils. 
Journal of immunology (Baltimore, 
Md: 1950) 2007; 179(12): 8454-62.
14. Zhao L, Xu S, Fjaertoft G, Pauksen K, Hakansson 
L, Venge P. An enzyme-linked immunosorbent 
assay for human carcinoembryonic 
antigen-related cell adhesion molecule 
8, a biological marker of granulocyte 
activities in vivo. Journal of immunological 
methods 2004; 293(1-2): 207-14.
15. Kuijpers TW, Tool AT, van der Schoot CE, et 
al. Membrane surface antigen expression 
on neutrophils: a reappraisal of the use of 
surface markers for neutrophil activation. 
Blood 1991; 78(4): 1105-11.
16. Fujiwara RT, Cancado GG, Freitas PA, et al. 
Necator americanus infection: a possible 
cause of altered dendritic cell differentiation 
and eosinophil profile in chronically infected 
individuals. PLoS neglected tropical 
diseases 2009; 3(3): e399.
17. Nemes E, Kagina BM, Smit E, et al. 
Differential leukocyte counting and 
immunophenotyping in cryopreserved 
ex vivo whole blood. Cytometry Part A : 
the journal of the International Society for 
Analytical Cytology 2015; 87(2): 157-65.
18. Carulli G, Sbrana S, Azzara A, et al. 
Detection of eosinophils in whole 
blood samples by flow cytometry. 
Cytometry 1998; 34(6): 272-9.
19. Tiirikainen MI. Evaluation of red blood 
cell lysing solutions for the detection of 
intracellular antigens by flow cytometry. 
Cytometry 1995; 20(4): 341-8.



















































































20. Vuorte J, Jansson SE, Repo H. Evaluation of 
red blood cell lysing solutions in the study 
of neutrophil oxidative burst by the DCFH 
assay. Cytometry 2001; 43(4): 290-6.
21. Vian AM, Higgins AZ. Membrane 
permeability of the human granulocyte 
to water, dimethyl sulfoxide, glycerol, 
propylene glycol and ethylene glycol. 
Cryobiology 2014; 68(1): 35-42.
22. Pillay J, Kamp VM, van Hoffen E, et al. 
A subset of neutrophils in human systemic 
inflammation inhibits T cell responses 
through Mac-1. The Journal of clinical 
investigation 2012; 122(1): 327-36.
23. Tahapary DL, de Ruiter K, Martin I, et al. 
Helminth infections and type 2 diabetes: 
a cluster-randomized placebo controlled 
SUGARSPIN trial in Nangapanda, 
Flores, Indonesia. BMC infectious 
diseases 2015; 15: 133.
24. Chirumbolo S, Vella A, Ortolani R, et al. 
Differential response of human basophil 
activation markers: a multi-parameter 
flow cytometry approach. Clin Mol 
Allergy 2008; 6: 12.
25. Sengelov H, Kjeldsen L, Diamond MS, 
Springer TA, Borregaard N. Subcellular 
localization and dynamics of Mac-1 (alpha m 
beta 2) in human neutrophils. The Journal of 
clinical investigation 1993; 92(3): 1467-76.
26. Hausmann OV, Gentinetta T, Fux M, Ducrest S, 
Pichler WJ, Dahinden CA. Robust expression 
of CCR3 as a single basophil selection marker 
in flow cytometry. Allergy 2011; 66(1): 85-91.
27. Uguccioni M, Mackay CR, Ochensberger 
B, et al. High expression of the chemokine 
receptor CCR3 in human blood basophils. 
Role in activation by eotaxin, MCP-4, and 
other chemokines. The Journal of clinical 
investigation 1997; 100(5): 1137-43.
SUPPLEMENTAL DATA
Supplementary Figure S1. Gating strategies. The gating strategy for the analysis of eosinophils, 
neutrophils and basophils in a representative fresh sample (upper panel) and fixed-cryopreserved 
sample (lower panel) is shown. 





Supplementary Figure S2. Increased autofluorescence of eosinophils after fixation. The filled 
lines represent fresh, non-fixed, unstained eosinophils, while the thin black lines display fixed 
unstained cells that did not undergo cryopreservation and the thick black lines fixed, unstained cells 
after cryopreservation. 
Supplementary Figure S3. Expression of CD203c, CD11b and CD35 on basophils and the response 
to fMLF. (A) Median fluorescent intensity (MFI) of markers on basophils left unstimulated and 
stimulated with fMLF. (B) The response of basophils to fMLF expressed as the difference in MFI 
between stimulated and unstimulated cells. The symbols (circle, triangle, square) represent three 
different donors. Means and standard deviations are shown in Supplementary Table S1. Data analysed 
with paired t test. n.s., not significant.
CD203c – BV421 CD11b – APC-eF780 CD35 – FITCA.
B.
Supplementary Figure S4. CD16/CD62L expression of neutrophils that were activated in vivo 
in response to intravenous LPS infusion. Two extra neutrophil subsets (CD16dimCD62Lhi and 
CD16hiCD62Ldim) can be identified in both (A) fresh and (B) fixed and cryopreserved cells. 
Supplementary Figure S5. Expression of CD203c, CD11b and CD35 on basophils collected in a field 
study. Samples were cryopreserved for 2 years in liquid nitrogen. (A) Histograms of a representative 
sample, filled lines display a fluorescence-minus-one (FMO) sample, the thin black line unstimulated 
cells and the thick black line fMLF-stimulated cells. (B) Median fluorescent intensity (MFI) of markers in 
basophils from 10 donors left unstimulated and stimulated with fMLF. Means and standard deviations 
are shown in Supplementary Table S2. *indicates analysis with Wilcoxon matched-pairs signed rank test. 
**, P ≤ 0.01.
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Medium fMLF Medium fMLF Medium fMLF
CD203c 682 (260) 3172 (3844) 1397 (417) 4661 (4840) 1288 (401) 3542 (3007)
CD11b 234 (69) 368 (261) 191 (21) 332 (226) 219 (15) 353 (207)
CD35 582 (148) 1361 (1122) 886 (157) 1618 (938) 888 (157) 1538 (779)
Supplementary table S2. Expression of activation markers on neutrophils, eosinophils and basophils 
from 10 representative donors collected in a field study presented as mean MFI and standard deviation.
Neutrophils Medium fMLF
CD11b 1237 (151) 1527 (181)
CD35 1895 (728) 3203 (735)
CD66b 543 (59) 713 (164)
CD62L 641 (278) 105 (23)
Eosinophils Medium Eotaxin
CD35 3044 (596) 3933 (714)
CD11b 1147 (438) 2079 (550)
Basophils Medium fMLF
CD203c 1374 (615) 4587 (1779)
CD11b 133 (20) 249 (80)
CD35 880 (275) 1663 (718)
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Eosinophils are a prominent cell type in the host response to helminths, and some 
evidence suggests that neutrophils might also play a role. However, little is known about 
the activation status of these granulocytes during helminth infection. 
Methods
We analysed the expression of eosinophil and neutrophil activation markers in peripheral 
blood by flow cytometry, and measured serum levels of eosinophil granule proteins in 
300 subjects residing in an area endemic for soil-transmitted helminths (STH). The data 
generated are on samples before and after 1 year of 3-monthly albendazole treatment. 
Results
Anthelmintic treatment significantly reduced the prevalence of STH. While eosinophil 
numbers were significantly higher in STH-infected subjects compared to those uninfected 
and significantly decreased following albendazole treatment, there was no effect exerted 
by the helminths on either eosinophil nor neutrophil activation. Although at baseline, 
eosinophil granule protein levels were not different between STH-infected and uninfected 
subjects, treatment significantly reduced the levels of eosinophil-derived neurotoxin (EDN) 
in those infected at baseline. 
Conclusions
These results show that besides decreasing eosinophil numbers, anthelmintic treatment 
does not significantly change the activation status of eosinophils, nor of neutrophils, and 




Eosinophilia is a well-known hallmark of helminth infections. While these bone marrow-
derived, innate cells reside primarily in the tissues where they can survive up to two weeks 
(1), elevated frequencies are found in peripheral blood during helminth infections and, 
to a lesser extent, in allergic diseases. Although in vitro, eosinophils have been shown to 
be able to kill helminths (2-5), their role during helminth infections remains uncertain, as 
in vivo depletion of eosinophils has shown inconclusive results regarding their protective 
efficacy (6), and helminths such as Trichinella larvae, appear to benefit from the presence of 
eosinophils (7, 8). Furthermore, eosinophils are increasingly being recognized as cells that 
contribute to tissue, metabolic and immune homeostasis (9). Adipose tissue eosinophils 
for example, play a crucial role in maintaining insulin sensitivity through the secretion of 
the cytokines IL-4 and IL-13 (10). 
Whereas increased eosinophil concentrations are characteristic of helminth infections, 
it is the activation status of these cells that drives the eosinophil mediated effects (11). 
Eosinophils can exist in different states of activation, and this is reflected by the expression 
of certain surface markers and by the increased serum levels of eosinophil-specific granule 
proteins. Upon recruitment to inflammatory sites, eosinophils alter the expression of 
a number of surface molecules that are involved in tethering, rolling along and adhesion to 
endothelial cells, followed by trans-endothelial migration into the tissue (12). The presence 
of these surface molecules (e.g. CD11b, CD35, CD69, CD66b and CD62L) on peripheral 
blood eosinophils is a useful indicator of cellular activation, during both helminth 
infections (13-15) and allergic diseases (16-19). Moreover, eosinophils respond to eotaxin, 
a chemokine responsible for eosinophil recruitment into tissues, by upregulating CD11b 
and shedding CD62L (20, 21).
Upon eosinophil degranulation, cytotoxic proteins including major basic protein (MBP), 
eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN) and eosinophil 
peroxidase (EPO) are released from secondary granules, and increased serum levels of 
these granule proteins are also considered to be a measure of eosinophil activation (19).
While neutrophils are known primarily for their potent anti-bacterial properties through 
the secretion of their granule proteins such as myeloperoxidase (MPO), they have also 
been shown to kill helminth larvae (22-24), and levels of MPO were significantly elevated 
in subjects infected with Strongyloides stercoralis (25) indicating that neutrophils can also 
become activated during helminth infections. Similar to eosinophils, neutrophil activation 
is associated with the upregulation of several surface molecules including CD11b, CD35, 
CD66b and the shedding of CD62L (16, 18). Although the expression of these markers and 
their upregulation or shedding in response to N-Formyl-Met-Leu-Phe (fMLF) have been 
used as a very sensitive measure of neutrophil (pre-)activation in patients with allergic 
asthma (16-18), it has never been studied in the context of helminth infections. 
In this study, we assessed the effect of helminth infections on the activation status and 
responsiveness of both eosinophils and neutrophils. Although previous work has shown 
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that helminth infections are associated with increased eosinophil activation by assessing 
either activation markers (13-15) or eosinophil granule proteins (11, 25-28), these studies 
often had a cross-sectional design, a relatively small sample size, and did not assess 
eosinophil responsiveness. To this end, we measured the expression of eosinophil and 
neutrophil activation markers by flow cytometry,  both ex vivo and after in vitro stimulation, 
in subjects infected with soil-transmitted helminths (STH), before and after 1 year of 
anthelmintic treatment. In addition, serum levels of eosinophil granule proteins were 
assessed. This study is part of a large cluster-randomized, placebo-controlled trial (29) 




This report describes a nested study within the SugarSPIN trial (29), a household-based 
cluster-randomized double-blind trial that was conducted in Nangapanda, Ende district 
of Flores Island (East Nusa Tenggara), Indonesia. After randomisation, all study subjects 
received either a single tablet of albendazole (400 mg) or matching placebo (tablets from 
PT Indopharma Pharmaceutical, Bandung, Indonesia) for three consecutive days under 
direct supervision from the research team members. This treatment regimen was given 
every three months for a total of four rounds (maximum of 12 tablets in total), between 
May 2014 and February 2015. 
Although the study was aimed at subjects aged 16 and above, all subjects in the study 
area, except children below 2 years of age and pregnant women, were included in 
the trial to avoid cross-contamination between household members. Subjects aged 16 
and above underwent clinical and laboratory examination, excluding subjects with active 
treatment for diabetes mellitus and serious concomitant diseases. Written informed 
consent was obtained from participants prior to the study. The study was approved by 
the ethics committee of the Faculty of Medicine, Universitas Indonesia (FKUI) (ref: 549/
H2·F1/ETIK/2013), and filed by the ethics committee of Leiden University Medical Center 
(LUMC), the Netherlands. The trial is registered as a clinical trial (Ref: ISRCTN75636394).
Study population
The randomization for the total study was based on 752 households comprising 
3698 individuals, resulting in 1825 (377 houses) and 1741 (375 houses) subjects in 
the placebo and albendazole group, respectively (Supplementary Figure S1). An additional 
randomization was performed on the 2406 subjects aged 16 and above, in order to study 
immune mechanisms in more detail (29). For this subgroup, we aimed to select one 
subject per household and stratified by age group (16-36 years, 36-56 years, and >56 
years) to ensure that sufficient numbers of all groups were represented. Randomization 
was based on households. This resulted in a total of 300 subjects who were included for 
immunological studies (152 subjects on placebo and 148 subjects in albendazole group) 
and randomly selected, paired samples from 195 subjects were subsequently used for flow 
cytometric analysis. 
We also collected venous blood of 9 healthy volunteers which had not been exposed 
to helminth infections, hereafter referred to as “Europeans”. We used the whole blood 
samples for flow cytometric analysis to assess granulocyte phenotype and response in 
naïve subjects.
Parasitological examination
Fresh stool samples were frozen at -20°C in the field centre and subsequently at -80°C 
at the Department of Parasitology of FKUI. Stool DNA isolation and real-time PCR were 
performed pairwise (baseline and follow-up). DNA isolation from stool was performed as 
described elsewhere (30, 31). Multiplex real-time polymerase chain reaction (PCR) was 
performed to simultaneously detect the presence of hookworm (Ancylostoma duodenale, 
Necator americanus), Ascaris lumbricoides, Trichuris trichiura, and Strongyloides stercoralis, 
using a method described previously (30). Stool samples were considered positive by PCR 
when cycle threshold (Ct) values were <50. Since the prevalence of S. stercoralis at baseline 
appeared to be very low (1.4% (4/284)), this species was not included in the analysis.
Sample collection
Blood samples were collected and processed as previously described (29, 32). Briefly, from 
each subject 3 polystyrene tubes containing 200 μL of heparinised venous blood were 
pre-incubated for 5 minutes in a 37°C waterbath, followed by a 5 minute-stimulation at 
37°C with fMLF (10−5 M; Sigma, Saint Louis, MO, USA) or eotaxin (10−7 M; R&D systems, 
Abingdon, UK) or left unstimulated. While both Indonesian and European blood samples 
were stimulated with fMLF, stimulation with eotaxin was only applied to Indonesian 
samples. Subsequently, 4 mL of FACS lysing solution (BD Biosciences) was added and 
after an incubation period of 15 minutes at room temperature, cells were washed with 
RPMI 1640 containing 10% heat-inactivated foetal calf serum (FCS) and resuspended in 
RPMI 1640 containing 10% FCS and 10% dimethyl sulfoxyde (DMSO). Cryovials containing 
the cell suspension were placed at -80°C for a minimum of 4 hours, followed by storage in 
liquid nitrogen until analysis. 
Flow cytometry of granulocyte surface markers
While flow cytometric analysis of the samples was randomly divided over multiple 
measurement days, all samples belonging to one individual were thawed, stained 
and measured pairwise (baseline and follow-up) on the same day. After thawing, cells 
were washed in RPMI 1640 containing 10% FCS and resuspended in FACS buffer (PBS 
supplemented with 0.5% BSA and 2 mM EDTA). Cells were counted using microscopy and 
500.000 white blood cells were stained for 30 minutes at 4°C with anti-CD35-FITC (E11, 
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Biolegend), anti-CD66b-PerCP/Cy5.5 (G10F5, Biolegend), anti-CD193-PE (5e, Biolegend), 
anti-CD16-PE/CF594 (3G8, BD Biosciences), anti-CD69-PE/Cy5 (FN50, Biolegend), 
anti-CD274-PE/Cy7 (MIH1, eBioscience), anti-CD3/CD19/CD20/CD56-APC (UCHT1, 
HIB19, 2H7, 5.1H11, Biolegend), anti-CD11b-APC/eF780 (ICRF44, eBioscience), anti-
CD203c-BV421 (NP4D6, Biolegend), anti-CD14-BV510 (M5E2, Biolegend), anti-CD62L-
BV605 (DREG-56, BD Biosciences). Antibody dilutions can be found in Supplementary 
Table S1. For each antibody, a fluorescence-minus-one (FMO) control sample was included 
using pooled cells from different subjects. Cells were acquired on a LSR Fortessa flow 
cytometer (BD Biosciences) and before each measurement a performance run was 
conducted with cytometer setup and tracking (CS&T) beads (BD Biosciences). Data was 
analysed in FlowJo software (version 9.9.3) and median fluorescence intensity (MFI) data 
are displayed. Representative gating schemes to select eosinophil and neutrophils are 
shown in Supplementary Figure S2. As all cells of each sample were acquired, the absolute 
number of eosinophils and neutrophils which was analysed, would differ per sample.
After gating all leukocyte populations (eosinophils, neutrophils, basophils, monocytes, 
lymphocytes), percentages of eosinophils and neutrophils were calculated relative 
to the total amount of white blood cells. The absolute eosinophil count (AEC) reflects 
the number of eosinophils in 200 µl blood, and was calculated using the proportion of 
eosinophils and the white blood cell count after thawing. 
As described previously (32), the detection of CD62L on eosinophils was impaired as 
a result of fixation and this marker was therefore not included in the analysis as activation 
marker for eosinophils. 
Serum eosinophil granule proteins
The serum concentrations of eosinophil granule proteins, MBP, ECP, EDN and EPO were 
measured in a suspension array assay in multiplex as previously described (33). As the levels 
of EPO were below the limit of detection of 6 ng/ml in every sample, this protein was 
excluded from analysis. Eosinophil granule proteins were measured in the total subgroup 
selected for immunological studies (300 and 258 subjects at baseline and follow up, 
respectively). In 5/558 samples, one of the proteins could not be detected while in 1/558 
samples, neither MBP, ECP, nor EDN could be detected. 
Statistical analysis
For continuous variables, normally distributed data were presented as mean and standard 
deviation, while non-normally distributed data (eosinophil count, total IgE, eosinophil 
granule proteins and eosinophil activation markers) were presented as geometric mean 
and 95% confidence interval, and log-transformed for analyses. Categorical data such as 
infection prevalence were expressed as proportions. Comparisons between STH-infected 
and uninfected subjects at baseline were performed with Student’s t test. Comparisons 
between Indonesian STH-infected, Indonesian uninfected and European subjects were 
performed with ANOVA followed by Tukey’s multiple comparisons test. ANOVA followed 
by a Dunnett’s multiple comparison test was used to test granulocyte counts after 
stratifying subjects by helminth species. To determine the relationship between serum 
levels of eosinophil granular proteins and eosinophil counts Spearman’s rank correlation 
was used. Paired t tests were performed to assess the responsiveness of granulocytes to 
eotaxin or fMLF. P values < .05 were considered statistically significant.
The effect of anthelmintic treatment on eosinophil counts, eosinophil granule proteins 
and eosinophil activation markers was assessed using an intention-to-treat approach, 
applying mixed models to account for the correlation within households. Two random 
effects were used: to model clustering within households a random household specific 
intercept was used and to model correlation within subjects random subject-specific 
intercept was used. Parameter estimates for treatment effect and 95% CIs were reported. 
The reported p values were obtained using a likelihood ratio test comparing the model 
with and without the treatment effect. For the binary outcome (helminth infection status), 
a logistic model was used with random household effects and random subject effects. All 
models were fitted using the lme4 package (R software). 
RESULTS
Study population
At baseline, 300 subjects were included for immunological studies (152 subjects 
and 148 subjects in the placebo and the albendazole group respectively) 
(Supplementary Figure S1). The loss to follow up was 14% which was mainly due to 
movement out of the village. Baseline characteristics of the study participants are shown in 
Table 1, while details of a subset of the study population (n=195), used to study granulocyte 
activation markers by flow cytometry can be found in Supplementary Table S1. 
At baseline 59.2% (168/284) of the individuals were infected with one or more helminth 
species, with hookworm infection being the most prevalent. In all subjects treated with 
albendazole in the SugarSPIN trial, the prevalence of helminth infection was 55.4% before, 
and 11.3% after treatment (30). Similar to this result, we observed that albendazole 
treatment reduced the percentage of subjects with any helminth (55.9% (80/143) to 9.2% 
(11/120) in the albendazole arm vs 62.4% (88/141) to 51.2% (62/121) in the placebo arm, 
P < .0001). The highest reduction was seen for hookworm, followed by A. lumbricoides 
and T. trichiura infection (Supplementary Figure S3).
Granulocyte counts in peripheral blood
At baseline, the frequency of eosinophils in whole blood was significantly higher in 
infected subjects compared to non-infected subjects (Geomean (95% CI), STH+ 7.0 
(6.3-7.8)% vs STH- 5.5 (4.7-6.5)%, P = .01) (Figure 1A). Irrespective of coinfection with 
other helminths, subjects infected with hookworm showed the highest eosinophil counts 
(7.9 (6.9-8.9)%) (Figure 1A). As observed in the whole SugarSPIN trial (34), anthelmintic 
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treatment effectively reduced eosinophil counts, especially in those infected with 
helminths at baseline (Estimated treatment effect (95% CI), -0.187 (-0.258 – -0.117), 
P = .01) (Figure 1C). Neutrophil counts did not differ between uninfected and infected 
subjects at baseline (P = 0.59, Figure 1B). Interestingly, albendazole treatment significantly 
increased the frequency of neutrophils in peripheral blood in those who were infected 
with helminths at baseline (0.041 (0.017 – 0.066), P < .01)  (Figure 1D). While Europeans 
exhibited significantly lower eosinophil frequencies (Geomean (95% CI), 1.9 (0.9-3.7)%) 
compared to Indonesians, irrespective of current helminth infections, similar frequencies 
of neutrophils were observed (53 (45-62)%). 
Eosinophil activation status and responsiveness
At baseline, the intensity of the eosinophil activation markers CD11b, CD35, CD66b and 
CD69 was similar in STH-infected and uninfected subjects (Table 2). Albendazole treatment 
did not influence the expression of these markers (Table 3). Neither at community level, 
nor when analysing subjects with helminth infection as baseline. The comparison with 
Europeans revealed a lower intensity of CD35 in Indonesian subjects, both STH-infected 
and uninfected, while other markers did not differ (Table 2).
Whole blood stimulated with eotaxin or fMLF was used to assess the responsiveness 
of eosinophils. The intensity of CD11b, CD35, CD66b and CD69 on eotaxin- or fMLF-
stimulated eosinophils did not differ between uninfected subjects and those infected with 
helminths at baseline (Supplementary Figure S4 A-B). Moreover, albendazole treatment did 
not affect the responsiveness (data not shown). Interestingly, not all individuals responded 

































































































Figure 1. Granulocyte counts. Percentage of eosinophils (A) and neutrophils (B) relative to 
the total number of white blood cells (WBC). Counts at baseline are shown displaying geomeans 
and corresponding 95% confidence intervals (STH- n=73, STH+ n=118, Al+ n=42, Hw+ n=81, Tt+ 
n=61). The effect of anthelmintic treatment eosinophil (C) and neutrophil (D) counts is displayed with 
the corresponding 95% confidence intervals (n=195). Differences between STH- and STH+ subjects 
were tested with Student’s t test. Differences between STH-, Al+, Hw+ and Tt+ subjects were tested 
with ANOVA followed by a Dunnett’s multiple comparison test. Treatment effect was assessed using 
mixed models (see Methods). *P <.05; **P <.01; n.s. not significant; STH Soil-transmitted helminths; 
Al A. lumbricoides; Hw Hookworm; Tt T. trichuria. 
Table 2. Expression of granulocyte activation markers at baseline.
STH- (n=73) STH+ (n=118) EU (n=9)
Eosinophils
CD11b 1444 (1337-1559) 1376 (1297-1459) 1700 (1551-1864)
CD35 3269 (3144-3435) 3254 (3150-3360) 3915 (3688-4155)a,b
CD66b 2100 (2031-2172) 2055 (2004-2108) 2046 (1825-2295)
CD69 783 (735-834) 772 (737-809) 677 (632-725)
Neutrophils
CD11b 1151 (1107-1196) 1172 (1141-1203) 1387 (1238-1554)a,b
CD35 1571 (1457-1695) 1618 (1519-1722) 1413 (1101-1816)
CD66b 581 (553-609) 592 (568-617) 590 (532-654)
CD62L 748 (676-827) 788 (726-856) 1358 (1262-1462)a,b
Geomean of MFI and corresponding 95% confidence intervals are shown. a P <.05 analysed using ANOVA Tukey 
statistical test for comparison with Indonesian STH- subjects. b P <.05 analysed using ANOVA Tukey statistical 
test for comparison with Indonesian STH+ subjects. STH soil-transmitted helminths.
Table 1. Baseline characteristics of the study population.
n Placebo n Albendazole
Age (mean in years, SD) 151 46.7 (13.4) 148 46.2 (16.2)
Sex (female, n, %) 151 100 (66.2) 148 86 (58.1)
BMI (kg/m2) (mean, SD) 149 23.1 (4.2) 147 22.5 (4.2)
Total IgE (IU/mL) (GM, 95% CI) 150 663 (506-870) 148 672 (514-878)
Eosinophil count* (GM, 95% CI) 148 5.5 (4.9-6.2) 146 6.1 (5.5-6.8)
MBP (ng/mL) (GM, 95% CI) 150 978 (859-1154) 147 969 (830-1132)
ECP (ng/mL) (GM, 95% CI) 150 908 (756-1124) 147 935 (786-1111)
EDN (ng/mL) (GM, 95% CI) 149 346 (295-408) 147 380 (326-442)
Helminth infection by PCR (n,%) 141 88 (62.4) 143 80 (55.9)
A. lumbricoides 141 36 (25.5) 143 22 (15.4)
Hookworm 141 62 (44.0) 143 53 (37.1)
T. trichuris 141 50 (35.5) 143 36 (25.2)
*Determined by using a Giemsa-stained peripheral thin blood smear. Abbreviations: BMI body mass index; ECP 
eosinophil cationic protein; EDN eosinophil-derived neurotoxin; GM geometric mean; IgE immunoglobulin; MBP 
major basic protein; PCR polymerase chain reaction; SD standard deviation.
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was an increase in the MFI of the activation markers whereas in the other half the MFI of 
markers decreased after stimulation (Supplementary Figure S4 C-D). Of note, in those 
who had a low intensity of markers before stimulation, the expression of the markers 
went up whereas the opposite was seen in subjects who had a high marker expression 
(Supplementary Figure S4 C-D). However, this observation could not be associated with 
the infection status, since in both infected and uninfected subjects the same was seen. In 
Europeans, most subjects responded to fMLF by upregulating the activation markers, also 
reflected in a stronger responsiveness (Supplementary Figures S4 B).
Neutrophil activation status and responsiveness
We found no difference in the expression levels of neutrophil activation markers (CD11b, 
CD35, CD66b, CD62L) between STH-infected and uninfected subjects at baseline 
(Table 2), and treatment did not alter the intensity of these markers (Table 3). When compared 
to Europeans, levels of both CD11b and CD62L were lower in Indonesians, irrespective of 
their current infection status (Table 2). Although neutrophils strongly responded to fMLF 
by upregulating CD11b, CD35 and CD66b, while shedding CD62L, the responsiveness 
was similar in all subjects, irrespective of their helminth infection status (Supplementary 
Table 3. The effect of anthelmintic treatment on granulocyte activation markers.
All (n=195) STH- (n=73) STH+ (n=118)
Eosinophils Estimated treatment effect (95% CI), p value

















































Treatment effect was assessed using mixed models (see Methods). Estimated treatment effects are displayed 
with the corresponding 95% confidence intervals. P values were obtained using a likelihood ratio test comparing 
the model with and without the treatment effect. STH soil-transmitted helminths.
Figure S5). Albendazole treatment did not affect neutrophil responsiveness (data not 
shown). When neutrophils in Europeans were considered, the responsiveness was more 
marked compared to Indonesians (Supplementary Figure S5). 
Eosinophil granule proteins
Serum levels of MBP, ECP and EDN were similar in STH-infected and uninfected 
subjects at baseline (Geomean, (95% CI), MBP, STH+ 979 (864-1156) ng/ml vs STH- 910 
(766-1063) ng/ml, P = .52; ECP, STH+ 892 (748-1077) ng/ml vs STH- 920 (764-1129) 
ng/ml, P = .82; EDN, STH+ 362 (313-423) ng/ml vs STH- 353 (297-419) ng/ml, P = .83) 
(Figure 2A). No relation was found between protein concentrations and different 
helminth species or the total number of helminth species a subject was infected with 
(data not shown). Levels of EDN correlated with absolute eosinophil counts (AEC) 
at baseline (r=0.54, P < .01), however, the correlation coefficient for MBP, although 
statistically significant, was weak (MBP: r = 0.27, P < .01) and when considering ECP no 
correlation could be found with eosinophil counts (ECP: r = 0.03, P = .69) (Supplementary 
Figure S6). Albendazole treatment decreased the level of MBP (Estimated treatment effect 







































































Figure 2. Eosinophil granule proteins. Major basic protein (MBP), eosinophil cationic protein (ECP) 
and eosinophil derived neurotoxin (EDN) concentrations in serum at baseline (A) and the effect of 
albendazole treatment (B) are shown. Lines represent geomeans and corresponding 95% confidence 
intervals (STH- n=116, STH+ n=168 (A)). The effect of anthelmintic treatment is displayed with 
the corresponding 95% confidence intervals (n=299 (B)). Differences between STH- and STH+ subjects 
were tested with Student’s t test. Treatment effect was assessed using mixed models (see Methods). 
n.s. not significant; STH Soil-transmitted helminths.
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whereas the level of ECP did not change (0.006 (-0.078-0.090), P = .93) at community 
level (Figure 2B). When analysing those infected with helminths at baseline, EDN levels 
significantly decreased after treatment (-0.093 (-0.172 – -0.013), P = .02). 
DISCUSSION
Eosinophil numbers are associated with helminth infections. We hypothesized that not only 
eosinophil numbers, but also their activation status would be affected by the presence of 
helminths. As a measure of activation, a range of activation markers in peripheral blood 
eosinophils and neutrophils were assessed, as well as the responsiveness to stimulation. 
In addition, circulating levels of eosinophil granule proteins were measured as a marker 
for the activation status of eosinophils, not only in blood but also in tissues. This study 
was nested within a cluster-randomized, double-blind placebo-controlled trial, conducted 
in a rural area in Indonesia (29). To our knowledge, this is the first placebo-controlled trial 
studying the effect of helminth infections on granulocyte activation and derives strength 
from its design and large sample size. 
Although the number of eosinophils was higher in STH-infected compared to uninfected 
subjects and decreased significantly after albendazole treatment, the intensities of 
eosinophil, as well as neutrophil, activation markers were not affected by helminths and 
did not change upon anthelmintic treatment. This is in contrast to what has been reported 
(11, 13-15, 25-28). Previously, Mawhorter et al. showed an elevated percentage of CD69, 
CD66 and CD81 positive eosinophils in 18 subjects recruited in the USA, infected with one 
or more species of seven helminths, and found CD66 to be decreased in the five subjects 
that were followed after short term anthelmintic treatment (13). In a study conducted 
in Brazil, the observation that the frequency of CD23+ eosinophils was increased while 
that of CD62L+ cells was decreased in subjects infected with Schistosoma mansoni, 
led to the conclusion that eosinophils were chronically activated during infection (15). 
However, this conflicted with a lower frequency of CD69+ eosinophils, indicating little 
early activation of eosinophils (15). In another study in Brazil, Fujiwara et al. demonstrated 
a highly activated state of eosinophils in subjects infected with hookworms compared to 
uninfected individuals (14). None of these studies, in contrast to ours, included uninfected 
subjects from the endemic regions. Moreover, they included a relatively small number 
of study subjects (varying from 23 to 35 individuals), and perhaps more importantly, 
the antibody staining was directly performed on fresh blood. As we were limited by 
the infrastructure at the field study site with no direct access to a flow cytometer, we 
developed a method to analyse granulocyte activation markers in cryopreserved, fixed 
whole blood (32). As previously described, it was observed that marker intensities varied 
when comparing fresh and fixed granulocytes, most likely due to intracellular staining 
and increased eosinophil autofluorescence as a consequence of fixation (32). However, 
we showed that the responsiveness to stimuli could still be clearly measured after 
fixation. Nevertheless, it is possible that the use of fresh cells allows smaller differences 
to be detected. 
By taking along European subjects, we could compare the results with naïve eosinophils 
and neutrophils from individuals with lower exposure to microorganisms and helminths. 
The eosinophils from Indonesians had a lower expression of the activation marker CD35 
and a lower responsiveness to fMLF. With respect to neutrophils, there was an interesting 
observation that both CD62L and CD11b showed a lower expression in Indonesians. While 
lower CD11b on neutrophils from Indonesians would indicate a lower activation status of 
these cells, the lower expression of CD62L, which is shed by activated neutrophils, would 
suggest a higher activation status of neutrophils in Indonesians, contradicting the CD11b 
data. However, the loss of CD62L has also been associated with aged neutrophils (35) 
and therefore, it is possible that in Indonesia, the higher exposure of the granulocytes to 
microbes or inflammation, results in more aged granulocytes with lower responsiveness. 
Indeed, this is supported by the lower activation of neutrophils from Indonesian subjects 
by fMLF compared to the response of neutrophils from Europeans. However, future studies 
are needed to clarify this further. 
Whereas the expression of activation markers was assessed in circulating eosinophils, 
mature eosinophils are predominantly tissue dwelling cells and serum levels of eosinophil 
granule proteins are thought to be an indirect measure of degranulation in the tissues. 
MBP, being stored in the core of secondary granules is the most abundant protein and 
its release is toxic to helminths (1). EDN and ECP, also known as RNase 2 and RNase 3 
respectively, both have ribonuclease activity and can be found in the granule matrix (1). 
Whereas ECP is cytotoxic to helminth larvae, EDN seems to be less efficient in killing 
helminths (2). In contrast to our hypothesis, we observed no differences in the levels of 
eosinophil granule proteins between helminth infected and uninfected subjects. It should 
be noted that the study area was highly endemic for STH infections (36) and perhaps 
exposure to an environment contaminated with parasite eggs or infective larvae can lead 
to altered eosinophil homeostasis and maturity/activation, thereby masking the potential 
difference between currently infected and uninfected subjects. 
Elevated eosinophil cationic protein levels have previously been described in subjects 
infected with filaria (Onchocerca volvulus (26), Loa Loa (37), Wuchereria bancrofti (26)), 
soil-transmitted helminths (A. lumbricoides (27), hookworm (27), and S. stercoralis (25)) 
and S. mansoni (26, 28). Whereas most studies had a cross-sectional design, two reports 
described a significant decline in granular protein levels in subjects infected with S. 
mansoni or S. stercoralis, respectively, after anthelmintic treatment, indicating a decrease 
in eosinophil degranulation (25, 28). In our study, albendazole treatment significantly 
decreased EDN levels in subjects that were infected at baseline, whereas the levels of 
MBP and ECP did not change. Out of the three proteins, EDN also showed the strongest 
correlation with the number of eosinophils at baseline and therefore its decrease is likely 
to reflect the decrease in eosinophil numbers after treatment.
The aim of this study was to investigate the effect of soil-transmitted helminths on 
granulocyte activation. Based on our results, we can conclude that helminths affect 
eosinophil numbers in the circulation, but the activation status and responsiveness of 
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these cells is similar between infected and uninfected subjects, and was not influenced 
by anthelmintic treatment. The same applies to neutrophils. However, this study should 
be repeated in an endemic setting with access to a flow cytometer that would allow 
the analysis of fresh granulocytes to assess activation of these cells, as fixing cells might 
not allow subtle differences to be detected between helminth infected and uninfected or 
before and after treatment. 
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Supplementary Figure S2. FlowJo gating strategy of eosinophils and neutrophils. Eosinophils were 
selected from single cells and subsequently gated on autofluorescence (CD14-BV510/SSC-H plot). 
Neutrophils were selected from single cells, then distinguished from monocytes based on their 






























































Supplementary Figure S3. The effect of albendazole treatment on the prevalence of soil-transmitted 
helminths. Percentage of helminth-infected subjects at baseline and following treatment, in placebo 
(n=141) and albendazole (n=143) treatment arms, as detected by PCR (A). Statistical analysis by 
a logistic model with random household effects and random subject effects; ***P <.001. Fold change 
in infection prevalence stratified by helminth species (B). 
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Supplementary Figure S4. Eosinophil responsiveness to eotaxin and fMLF. Median fluorescent 
intensity (MFI) of CD11b, CD35, CD66b and CD69 of eosinophils left unstimulated (-) and after 
stimulation with eotaxin (A, C) or fMLF (B, D). Indonesian subjects were either stratified by helminth 
infection (A,B; STH- (n=73) vs STH+ (n=118)) or by responsiveness (C,D; ∆MFI <0 vs ∆MFI >0). 
Europeans were not included in D, as most responded to fMLF. Geomeans and corresponding 95% 
confidence intervals are shown. Differences between before and after stimulation were tested with 
paired t tests. Differences between ∆MFI <0 and ∆MFI >0 before stimulation were tested by unpaired 
t tests. *P <.05; **P <.01; n.s. not significant; STH Soil-transmitted helminths.
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Supplementary Figure S5. Neutrophil responsiveness. Median fluorescent intensity (MFI) of CD11b, 
CD35, CD66b and CD62L of neutrophils left unstimulated (-) and after stimulation with fMLF. 
Indonesian subjects were stratified by helminth infection (STH- (n=73) vs STH+ (n=118)). Geomeans 
and corresponding 95% confidence intervals are shown. Differences between before and after 
stimulation were tested with paired t tests. **P <.01.

































Supplementary Figure S6. Association between eosinophil granule proteins and eosinophil counts. 
Major basic protein (MBP), eosinophil cationic protein (ECP) and eosinophil derived neurotoxin (EDN) 
concentrations in serum at baseline and their association with absolute eosinophil counts (AEC). 
Spearman’s rank correlation was used for statistical analysis (n=195). 
Supplementary table S1. Antibody panel used for flow cytometry
Fluorochrome Specificity Clone Vendor Cat.no. Dilution
Stock conc. 
(µg/mL)
FITC CD35 E11 Biolegend 333404 300x 200
PerCP-Cy5.5 CD66b G10F5 Biolegend 305107 100x 50
PE CD193 5e8 Biolegend 310705 100x 100
PE-CF594 CD16 3G8 BD Biosciences 562320 4000x 100
PE-Cy5 CD69 FN50 Biolegend 310907 50x 20
PE-Cy7 CD274 MIH1 eBioscience 25-5983-41 80x 50




Biolegend 363601 150x 5, 6.25, 
1.5, 17.5
APC-eF780 CD11b ICRF44 eBioscience 47-0118-41 100x 50
BV421 CD203c NP4D6 Biolegend 324611 100x 25
BV510 CD14 M5E2 Biolegend 301841 100x 150
BV605 CD62L DREG-56 BD Biosciences 562720 100x 50
Supplementary table S2. Baseline characteristics of a subset of the study population, used to study 
granulocyte activation markers by flow cytometry.
n Placebo n Albendazole
Age (mean in years, SD) 94 48.6 (12.4) 101 47.4 (15.6)
Sex (female, n, %) 94 64 (68.1) 101 58 (57.4)
BMI (kg/m2) (mean, SD) 93 23.3 (4.2) 100 22.5 (4.4)
Total IgE (IU/mL) (GM, 95% CI) 94 547 (376-794) 101 572 (410-797)
Eosinophil count (GM, 95% CI) 94 6.3 (5.6-7.1) 101 6.5 (5.6-7.5)
MBP (ng/mL) (GM, 95% CI) 93 816 (691-1010) 101 966 (814-1146)
ECP (ng/mL) (GM, 95% CI) 93 758 (610-981) 101 836 (698-1000)
EDN (ng/mL) (GM, 95% CI) 92 403 (238-352) 101 376 (316-448)
Eosinophil activation markers









































Helminth infection by PCR (n,%) 91 63 (69.2) 100 55 (55.0)
 A. lumbricoides 91 26 (28.6) 100 16 (16.0)
 Hookworm 91 44 (48.4) 100 37 (37.0)
 T. trichuris 91 34 (37.4) 100 27 (27.0)
Abbreviations: BMI body mass index; ECP eosinophil cationic protein; EDN eosinophil-derived neurotoxin; 
GM geometric mean; IgE immunoglobulin; MBP major basic protein; PCR polymerase chain reaction; 
SD standard deviation.
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Helminth parasites induce a strong Th2 response, characterized by high levels of IgE 
and elevated signature cytokines such as IL-5. As many global deworming programs are 
underway, there is concern that this might lead to emergence of Th1-mediated pathologies 
when the counterbalancing helminth-induced Th2 response is absent. Therefore, we 
assessed the effect of deworming on Th2-mediated responses in a household-clustered 
randomized controlled trial in Indonesia. Total plasma IgE and whole-blood IL-5 responses 
to mitogen phytohaemagglutinin (PHA) were measured in 1494 and 682 subjects, 
respectively, at baseline, 9 and 21 months after three-monthly single-dose treatment 
with albendazole or placebo. Anthelmintic treatment did not result in complete removal 
of helminth infections in the community. However, treatment significantly decreased 
IgE levels in albendazole- compared to placebo-treated subjects. IL-5 responses to 
PHA were not significantly affected by anthelmintic treatment and tended to increase 
in albendazole-treated subjects, indicating that intensive treatment of helminth parasites 
has different outcomes on B-cell (IgE levels) and T-cell (IL-5) responses. The data shows 
that 2 years of deworming can have differential effects on responses typified as Th2-
mediated, which needs to be taken into account when examining the impact of helminths 
on noncommunicable diseases. 
INTRODUCTION
Amongst helminth parasites, soil-transmitted helminths (STHs) which reside in the gut, 
are most prevalent. More than 1.5 billion people are infected with STHs worldwide, and 
infections are widely distributed in tropical and subtropical countries (1). Important STHs 
include Ascaris lumbricoides, Trichiuris trichiura and hookworm (Ancylostoma duodenale 
and Necator americanus).
Helminth parasites are the most potent natural stimuli for T helper 2 (Th2) responses, 
characterized by Th2 cytokines (IL-4, IL-5 and IL-13), eosinophilia and high levels of IgE 
antibodies. Whereas IL-5 regulates eosinophilia, IL-4 and IL-13 promote IgE production by 
inducing B-cell switching to IgE-producing cells. 
Th2 responses do not solely protect against helminth infections but also play an 
important role in the development of various inflammatory diseases, where an imbalance 
between Th1/Th2 cell responses and their regulation can lead to pathogenesis. Studies 
in animal models and in humans have indicated that helminths might play a protective 
role in the development of allergies, autoimmunities and inflammatory bowel disease (2). 
Moreover, recent in vivo studies showed that helminth infections might protect against 
insulin resistance as helminth-induced Th2 responses were associated with improved 
glucose metabolism and insulin signalling in mice (3-6). This has raised concern regarding 
the implementation of deworming programs, which might lead to emergence of Th1-
mediated pathologies. The immunological consequences of deworming should therefore 
be examined in detail, given that Th2 responses consist of multiple arms. 
To this end, we analysed the immunological data obtained from a household-based 
cluster-randomized double-blind placebo-controlled trial of three-monthly single-dose 
albendazole treatment in an area where STHs are highly endemic (7). This study describes 
the effect of anthelmintic treatment on two different components of the Th2 response, 
namely total IgE levels and total IL-5 production in response to a polyclonal stimulation 
(phytohemagglutinin, PHA). 
MATERIALS AND METHODS 
Study design 
This report describes a nested study within the ImmunoSPIN trial (8, 9). The trial was 
conducted in 2 villages, Nangapanda and Anaranda, in Ende district, Flores Island, 
Indonesia. In 2008, the double-blind placebo-controlled trial of 2 year duration was initiated 
by randomizing all households to receive either a single dose of 400 mg albendazole or 
a matching placebo every 3 months over a 2-year study period (tablets from PT Indofarma 
Pharmaceutical, Bandung, Indonesia). Treatment allocation was based on household to 
minimize the risk of cross-contamination and therefore reinfection of treated individuals. 
Treatment was provided to all household members older than 2 years of age, except for 
pregnant women. Drug intake was observed by field workers. The study was approved by 
the Ethical Committee of the Medical Faculty, University of Indonesia, Jakarta (ref: 194/
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PT02.FK/Etik/2006) and has been filed by the ethics committee of the Leiden University 
Medical Center, The Netherlands. The trial was registered as clinical trial (ISRCTN83830814). 
Informed consent or parental consent was obtained from all participants.
Study population
The randomization for the total study was based on 954 households comprising of 4004 
individuals in the 2 villages, resulting in 2022 (481 houses) and 1982 (473 houses) subjects 
in the placebo and albendazole group, respectively, as described before (7). The current 
study included 1762 (363 houses) and 1731 (362 houses) subjects in the placebo 
and albendazole group in the village of Nangapanda, respectively (Supplementary 
Figure S1). At baseline, blood samples from 2349 subjects were collected to analyse 
total IgE levels and after inclusion of subjects with at least one follow-up blood sample, 
1494 subjects were included at baseline, corresponding to 753 placebo- and 741 
albendazole-treated individuals.
To study immunological responses, 250 households were randomly selected and 
individuals older than 4 years of age were invited for morning venous blood sampling and 
assessment of anthropometric parameters. This resulted in the inclusion of 882 individuals, 
of which 858 provided sufficient blood samples for whole-blood cultures. After inclusion 
of subjects with at least baseline and one follow-up blood sample, we ended up with 
682 subjects at baseline, corresponding to 374 placebo- and 308 albendazole-treated 
individuals (Supplementary Figure S1). As this is a nested immunology study, 86% (584 of 
682) of the subjects were also part of the group of 1494 subjects included for the analysis 
of IgE levels.
Parasitological examination
Yearly stool samples were collected in order to examine the effect of treatment on helminth 
prevalence. T. trichiura was detected by microscopy after formol-ether concentration and 
18S-based multiplex real-time PCR was used for the specific amplification and detection 
of hookworm (A. duodenale, N. americanus), A. lumbricoides, and S. stercoralis DNA, as 
described previously (9). PCR output was expressed as the cycle threshold (Ct) reflecting 
the load of parasite specific DNA in the sample tested. Parasite specific DNA loads of A. 
duodenale, N.americanus and A.lumbricoides were categorized as low load (Ct≥30) and 
high load (Ct<30), irrespective of infection with T. trichiura of which only microscopy data 
were available. A subject was defined to have a heavy infection when a high DNA load 
(Ct<30) was measured for either hookworm or A. lumbricoides, whereas a light infection 
refers to subjects with low DNA loads (Ct≥30) for both of these helminth species, including 
subjects that are helminth negative.
Plasma IgE 
The levels of total IgE were measured by ELISA in Jakarta as described previously (9). 
The results are expressed in International Units (IU/ml). 
Whole blood culture and IL-5 measurements
Whole blood was stimulated in vitro as described before (9, 10). Cultures were stimulated 
for 72h to detect adaptive responses to phytohaemagglutinin (PHA, 2 μg/ml, Wellcome 
Diagnostics, Darford, UK) and unstimulated control wells were included. Due to budget 
restrictions, we could only measure one Th2 cytokine and opted for IL-5. Supernatants were 
stored at -20°C until IL-5 was quantified using Luminex cytokine kits (Biosource, Camarillo, 
USA) on a Liquichip 200® Workstation (Qiagen, Venlo, The Netherlands) equipped with 
Liquichip analyzer software (Qiagen, Venlo, The Netherlands). Cytokine levels that fell 
below the assay’s detectable range were replaced by half of the detection limit provided 
by the manufacturer. 
Statistical analysis 
The total IgE and cytokine data were log-transformed to obtain a normally distributed 
variable. Cross-sectional comparisons between groups at baseline were tested with 
Student’s t test. To assess treatment effects, generalized linear mixed models were used 
with addition of three random effects, namely a random household-specific intercept to 
model clustering within households and a random subject-specific intercept and slope 
to model correlation within subjects, as previously described (10). Parameter estimates 
for treatment effects at 9 and 21 months and 95% confidence intervals are reported, as 
well as interaction P values when a subgroup analysis was performed. The reported P 
values are obtained using likelihood ratio tests by comparing the model with and without 
the treatment effect. All models were fitted using the lme4 package (11). The analysis 




Baseline characteristics of the study participants are shown in Table 1. At baseline, 84.8% 
of the individuals were infected with one or more helminth species, with hookworm 
infections being the most prevalent (73.1% of total). At baseline, total IgE levels and IL-5 
production in response to PHA were similar in both treatment arms. The consort diagram 
of the study is shown in Supplementary Figure S1. Subjects were included in the analysis 
when data from baseline and at least one of the two follow-up time points were available. 
Effect of albendazole treatment on helminth prevalence
Similar to the major study (7), subset analysis in this study revealed that intensive treatment 
with albendazole resulted in a reduction in STHs both after 9 (percentage infected: 49.9% 
for albendazole vs. 80.5% for placebo) and after 21 months of treatment (39.9% for 
albendazole vs. 75.4% for placebo; Figure 1A). Albendazole had the largest effect on 
hookworm (from 74.4% at baseline to 29.0% at 9 months and 20.7% at 21 months of 
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treatment) compared to placebo (from 71.8% to 66.7% to 62.1% respectively). This was 
followed by A. lumbricoides (albendazole from 33.3%, to 14.5% and 10.1%; placebo from 
35.1% to 33.6% and 32.1%), while the effect on T. Trichiura was much less pronounced 
(albendazole from 27.7%, to 22.0% and 18.2%; placebo from 25.8%, to 30.0% and 25.9%).
Baseline IgE levels
Baseline analysis of total IgE in subjects with light and heavy infections, as defined in 
Materials and Methods (section Parasitological examination), revealed that higher infection 
intensity was associated with significantly elevated IgE levels (light infection: 809 (695-940) 
IU/ml (GM, 95 CI), heavy infection: 1544 (1376-1732) IU/ml, P<.001) (Table S1). Polyclonal 
IgE levels were significantly lower in adults (1185 (1086-1294) IU/ml) compared to children 
≤ 19 years (1766 (1561-1999) IU/ml) (P<.001), whereas no significant difference was found 
between males (1307 (1189-1437) IU/ml) and females (1434 (1283-1603) IU/ml) (P=.219). 
Effect of albendazole treatment on plasma IgE levels
Figure 1B presents the estimated effect of treatment on total IgE levels after 9 and 21 
months. Total IgE levels were significantly lower after 9 and 21 months in the albendazole-
treated group (estimates (95% CI) at 9 months -0.071 (-0.112 to -0.030), at 21 months 
-0.060 (-0.099 to -0.020); overall P value: Ptime<.001). When infection was defined as 
light or heavy based on parasite-specific DNA loads of hookworm and A. lumbricoides 
at baseline, the estimated treatment effect on IgE levels was significant in subjects with 
a heavy infection at baseline (at 9 months -0.074 (-0.142 to -0.005), at 21 months -0.083 
(-0.146 to -0.019); Ptime=.051). In subjects with light infections, we observed no significant 
Table 1. Baseline characteristics of the study population
N Placebo N Albendazole
Age (mean in years, SD) 753 32.2 (18.7) 741 32.4 (19.0)
Sex (female, n, % of total) 753 459 (61.0) 741 445 (60.0)
BMI > 19 years old (mean, SD) 490 22.5 (4.0) 486 21.9 (3.7)
Z score of BMI ≤ 19 years old (mean, SD) 254 -1.17 (1.17) 235 -1.27 (1.18)
Parasite infection (n, %)
















A. lumbricoides1 439 154 (35.1) 438 146 (33.3)
T. trichiura2 558 144 (25.8) 541 150 (20.2)
Total IgE (IU/ml [GM, 95 CI]) 753 1372 (1239-1519) 741 1340 (1210-1485)
Interleukin-5 production in response to PHA 
(pg/ml [median, IQR])
374 511 (287-777) 308 490 (291-808)


















































p-value (overall) = 0.146











































































Figure 1. Effect of deworming on the prevalence of helminth infections, total IgE levels and whole 
blood IL-5 production in response to PHA. A) Percentage of helminth infected subjects in placebo 
and albendazole treated arms. The estimated effect of albendazole treatment on serum total IgE 
levels (B) and IL-5 response to PHA in supernatant of 72h-stimulated whole blood cultures (C), is 
displayed for the 9 and the 21 month time points, with corresponding 95% confidence intervals. 
The estimates of the treatment effect were obtained by general linear mixed models and overall 
p-values over time are indicated.
treatment effect on IgE (at 9 months -0.039 (-0.126 to 0.047), at 21 months -0.001 (-0.08 
to 0.079); Ptime=.664; P value for interaction=.252), nor in subjects who were uninfected 
at baseline (at 9 months -0.134 (-0.280 to 0.012), at 21 months -0.040 (-0.078 to 0.158); 
overall P value: Ptime= .140). 
Similar effects of treatment on IgE levels were observed in children (at 9 months 
-0.069 (-0.134 to 0.004), at 21 months -0.071 (-0.134 to 0.009); Ptime=.003) and adults (at 
9 months -0.070 (-0.120 to -0.021), at 21 months -0.053 (-0.099 to -0.007); Ptime=.006; P 
value for interaction=.876). Albendazole treatment reduced total IgE to a similar extent in 
both males (at 9 months -0.038 (-0.102 to 0.025), at 21 months -0.067 (-0.125 to -0.009); 
Ptime=.059) and females (at 9 months -0.093 (-0.143 to -0.042), at 21 months -0.055 (-0.103 
to -0.007); Ptime=.001; P value for interaction=.349).
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Baseline IL-5 production in response to PHA
At baseline, we detected no significant difference in IL-5 levels to PHA between subjects 
with light (474 (242-775) pg/ml (median, IQR)) and heavy infections (490 (283-801) pg/
ml) (P=.364) (Table S1). IL-5 responses were significantly lower in adults (472 (258-728) 
pg/ml) compared to children (534 (319-841) pg/ml) (P=.04). When considering gender, 
significantly higher levels of IL-5 were observed in males (588 (347-884) pg/ml) compared 
to females (460 (259-698) pg/ml); P<.001).
Effect of albendazole treatment on whole blood IL-5 responses to PHA
There was no significant treatment effect on IL-5 production in response to PHA at 9 
months (estimates (95% CI), 0.037 (-0.052 to 0.127)). However, we observed significantly 
elevated levels of IL-5 to PHA at 21 months (0.107 (0.000 to 0.214)). When both time 
points were taken into account, the overall P value over time fell short of statistical 
significance (Ptime=.146). IL-5 measured in unstimulated blood revealed no treatment-
related differences (data not shown). 
Additionally, we observed no effect of treatment on IL-5, nor differences in 
the treatment effect between subgroups when subjects with light and heavy infections 
(P value for interaction=.850) or children and adults (P value for interaction=.998) were 
analysed separately. In males, treatment did not show a significant effect on the IL-5 
response (at 9 months -0.027 (-0.163 to 0.108), at 21 months 0.041 (-0.135 to 0.218); 
Ptime=.780), whereas a trend towards an increase in IL-5 response was observed in females 
(at 9 months 0.086 (-0.031 to 0.203), at 21 months 0.164 (0.018 to 0.311); Ptime=.192; 
P value for interaction=.316). 
DISCUSSION
This is the first time that the effects of long-term placebo-controlled anthelmintic treatment 
on different components of a helminth-induced Th2 response have been analysed in a whole 
community. We show a significant decline in plasma IgE levels in albendazole-treated 
subjects over a period of 21 months compared to placebo-treated subjects. However, 
whereas both IgE and IL-5 are important products of the helminth-induced Th2 response, 
IL-5 production by peripheral blood cells in response to PHA was not significantly affected 
by anthelmintic treatment and rather tended to increase.
It is well known that helminth parasites are potent inducers of IgE production (12-15). So 
far, only a few longitudinal studies have been performed to study the effect of anthelmintic 
treatment on polyclonal IgE levels (16-18). In line with our findings, Cooper et al. (14) 
showed that 1 year of anthelmintic treatment was associated with a significant reduction 
in total IgE levels in children, suggesting that current STH infections are important 
determinants of IgE levels. Whereas previous studies only included children below 12 
years of age (14, 16), in the current randomized trial, we studied the general population 
across all ages to show decreases in IgE levels in the whole community irrespective of age.
Overall, the treatment effect on IgE was seen at 9 months, and this effect remained 
at 21 months and IgE levels did not further decrease. The major effect seen on IgE 
after 9 months probably reflects the large decrease in prevalence of hookworm and A. 
lumbricoides which was 2.5- and 2.3-fold compared to baseline, respectively, whereas 
after 21 months, the prevalence of both species decreased 1.4-fold compared to 9 months 
post-treatment. The lack of further decrease in IgE at 21 months may be due to continued 
exposure to incoming parasites in a contaminated environment, which would stimulate 
long-lived IgE plasma cells contributing to sustained IgE antibody production (14, 19). 
Given the observed treatment effect on IgE, it would appear that deworming decreases 
Th2-mediated responses. However, we found no significant effect of treatment on IL-5 in 
response to PHA and even a trend towards increase at 21 months post-treatment. As 
described elsewhere in more detail (10), analysis of uninfected subjects showed that 
treatment had no effect on IL-5 production, ruling out a direct effect of albenzole on immune 
responses. It has been reported before that IL-5 responses may be suppressed during 
helminth infections and treatment results in enhanced helminth-specific and unrelated 
antigen responses (10, 20-22). A study conducted in Kenya showed that in schoolchildren 
infected with Schistosoma mansoni, type 2 cytokine responses including IL-4, IL-5, IL-9 
and IL-13, were significantly increased upon stimulation with egg antigen 1 and 2 years 
post treatment (23). Another study in Gabon showed that specifically IL-5, but neither 
IL-4 nor IL-13, was downregulated during an active S. haematobium infection as only IL-5 
responses to worm antigens were increased in subjects who remained free from infection 
2 years after helminth clearance, compared to subjects who became reinfected (22). This 
enhanced cytokine response can be due to either removal of the immunosuppressive 
effects of active infection or immunological boosting by antigens released from dying 
parasites (23). Although it is possible that treatment boosts the antigen-specific responses, 
often also responses to unrelated antigens such as PHA are enhanced by anthelmintic 
treatment. The latter cannot be explained by helminth antigens boosting specific T-cell 
responses, unless it is due to cross-reactive antigen responses that are enhanced in these 
unrelated antigens (10, 21). 
As anthelmintic treatment appears to have opposite effects on type 2 cytokine 
production and total IgE, and IL-4 and IL-13 promote IgE production, this raises 
the question whether there are IL-4/IL-13 independent pathways of IgE regulation. T-cell-
independent IgE+ B-cell maturation in tissues has been described, suggesting that IgE 
class switching does not fully depend on Th2 cytokine levels (24). Perhaps IgE memory 
B cells and/or long-lived IgE plasma cells can maintain the production of IgE via Th2 
cytokine-independent pathways, concurrent to Th2 cells becoming hyporesponsive and 
producing less Th2 cytokines. However, as there is very little data from human studies on 
IgE memory B cells and the pathways by which IgE is regulated, this remains a speculation. 
T follicular helper (Tfh) cells, a subset of CD4+ T cells that migrates to B-cell follicles 
and induces antibody production by B cells (25), have been described as the dominant 
source of IL-4 in vivo during infection with Heligmosomoides polygyrus (26). In humans, 
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the frequencies of total and activated peripheral memory Tfh cells were found to be 
significantly increased during Schistosoma japonicum infection (27). Although it is currently 
unknown what happens to Tfh cell numbers after helminth clearance, decreasing numbers 
could possibly explain the observed decline in total IgE after treatment, as this would lead 
to less IL-4 production in B-cell follicles, hence less IgE secretion.
Based on our findings, we could conclude that 2 years of anthelmintic treatment 
might have differential effects on Th2 responses. IgE responses are elevated in helminth-
infected subjects and decline after intensive deworming, whereas IL-5 production by 
peripheral blood cells seems suppressed in infected subjects and might be reversed after 
deworming. Both phenomena have separately been reported by others, and here we report 
the occurrence of both within one community. These differential effects on responses 
typified as Th2-mediated need to be taken into account when examining the effects of 
helminths on noncommunicable diseases. The concern that upon deworming, inflammatory 
diseases such as allergies could increase, might be justified if we look at Th2 cytokines, 
but not if one considers IgE. However, it is also known that IgE responses during helminth 
infection are dominated by antibodies that have poor biological activity (28) and therefore 
a decrease in IgE that is not functional might still be in line with a relative increase in IgE 
that can trigger mast cell degranulation.
It would be interesting to complement these findings with data on eosinophilia and 
other Th2 cytokine responses like IL-4 and IL-13, in order to further investigate helminth’s 
immunomodulatory effects on Th2 responses. 
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SUPPLEMENTAL DATA
Supplementary Figure S1. Consort diagram. The current study is nested within the ImmunoSPIN 
trial [8, 9], with a total of 3493 individuals living in the village of Nangapanda. Allocation of placebo 
and albendazole resulted in 363 and 362 households including 1762 and 1731 subjects, respectively. 
Subjects were included in the analysis when IgE and/or cytokine data from baseline and at least one 
of the two follow-up time points were available. While the upper diagram shows the profile with 
total IgE as outcome, the lower diagram displays the diagram of 250 households that were randomly 
selected to study immunological responses (IL-5). Availability of parasitological data is indicated 
at the different time points for treatment arms, numbers reflecting the follow-up of subjects with 






















IgE data N=597 















Microscopy data N=342  
Lost to follow-up n=119
Back in study n=156
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Back in study n=178
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No baseline IgE data n=562
No IgE follow-up data n=447
No baseline IgE data n=582
No IgE follow-up data n=408
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No baseline IL-5 data n=46












[GM, 95 CI] P value N
IL-5 response to PHA 
(pg/ml) [median, IQR] P value
Light infection 337 809 (695-940) <0.001 150 474 (242-775) 0.364
Heavy infection 540 1544 (1376-1731) 226 490 (283-801)
Children (≤19 yr) 504 1766 (1561-1999) <0.001 289 534 (319-841) 0.040
Adult (>19yr) 990 1185 (1086-1294) 393 472 (258-728)
Male 590 1307 (1189-1437) 0.219 286 588 (347-884) <0.001
Female 904 1434 (1283-1603) 396 460 (259-698)
Parasite specific DNA loads of A. duodenale, N.americanus and A.lumbricoides were categorized as low load 
(Ct≥30) and high load (Ct<30), irrespective of infection with T. trichiura of which only microscopy data were 
available. A subject was defined to have a heavy infection when a high DNA load was measured for either one of 
the helminth species. A light infection refers to subjects with low DNA loads (Ct≥30) for both of these helminth 
species, including subjects that are helminth negative. Data were tested by Student’s t-test.
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Numerous studies have shown that helminths can have a profound role in shaping 
immune responses to vaccines, allergens or autoantigens, by inducing strong type 2 and 
regulatory responses, however, the degree of heterogeneity of such cells has not been 
studied before. Mass cytometry, which provides a method that allows in depth profiling of 
immune responses, was used to profile type 2 and regulatory immune cells in Europeans 
not exposed to helminth infections, and in Indonesians who were infected with soil-
transmitted helminths (STH), before and 1 year after deworming. The use of Hierarchical 
Stochastic Neighbor Embedding (HSNE) in Cytosplore allowed the identification of very 
distinct immune signatures in Europeans and Indonesians, showing expanded frequencies 
of Th2 cells, in particular CD161+ cells, and regulatory T cells, but only those expressing 
CTLA4 and co-expressing CD38, HLA-DR, ICOS or CD161, in STH-infected Indonesians. 
It was also possible to analyse ILC2s,  which are difficult to study in peripheral blood, 
and to show that these cells are expanded in STH-infected Indonesians. The expansion 
of type 2 cells was confirmed functionally through analysis of type 2-cytokine producing 
cells, whereas IL-10 production alone could not capture the difference seen in regulatory 
T cells observed through phenotypic characterization.  However, CD11c+  B cells were 
the main IL-10 producers among B cells in Indonesians, a subset which was almost absent 
in Europeans. In addition to ILC2s and CD4+ T cells, CD8+ T cells as well as γδ T cells 
were found to be producers of type 2 cytokines in STH-infected Indonesians. A number of 
these expanded responses were shown to be driven by current helminth infection as they 
decreased following treatment and clearance of infection. These results provide us with 
a detailed insight into the types of cells that participate in strong type 2 and regulatory 
networks, and show that treatment of helminths affects specific groups of cells in these 
immune networks.
INTRODUCTION
Parasitic helminths represent one of the most prevalent infections affecting nearly one-third 
of the population worldwide (1), and are known as the strongest natural inducers of type 
2 immune responses (2). These are characterized by CD4+ T helper 2 (Th2) cells secreting 
the hallmark cytokines interleukin (IL)-4, IL-5 and IL-13, systemic and localized eosinophilia, 
expansion of basophils and mast cells, goblet cell hyperplasia and the production of IgE 
(3). There is evidence for a role of type 2 immune responses in controlling the number of 
parasites through direct killing or expulsion, and in inducing tissue repair, necessary to 
protect against damage caused by tissue-migrating helminths (4). In addition, an innate 
source of type 2 cytokines, termed group 2 innate lymphoid cells (ILC2s) described in both 
mice (5-7) and humans (8) are also part of the “type 2 immune system”. Whereas murine 
ILC2s have been shown to contribute to anti-helminth immunity (5-7), information about 
their role in human helminth infections is lacking, and it has been challenging to study 
these cells considering their low frequency in peripheral blood (9). 
Studies have shown that helminths can have a profound role in shaping immune 
responses to vaccines, allergens or autoantigens, and besides polarizing the immune 
system towards a strong type 2 immune response, their modulatory effects can be 
attributed to the induction of a strong regulatory network (2). Regulatory T cells (Tregs), 
expressing FOXP3, are an important component of such a network, and mediate their 
effects through cytokine-mediated suppression (e.g. IL-10 and TGF-β) and the expression 
of suppressory molecules such as cytotoxic T lymphocyte antigen 4 (CTLA4) (10). Several 
studies in animal models and humans show that helminth infections are associated with 
increased Treg frequencies and/or functional capacity (11-14). Although longitudinal 
studies assessing the effect of deworming on Tregs are rare, we recently found that not 
Treg frequencies, but the expression of CTLA4 on CD4+ T cells significantly declined in 
anthelmintic-treated individuals (15). 
To fully understand the diverse immune modulatory processes mediated by helminths 
and identify specific cells that might be important, we performed unbiased immune 
profiling of Indonesians residing in a rural area of Indonesia, who were infected with soil-
transmitted helminths (STH), and 1 year after 3-monthly anthelmintic treatment, were free 
of these infections. Mass cytometry (Cytometry by time-of-flight; CyTOF) was applied, 
which allows high-resolution dissection of the cellular composition of the immune system 
by the simultaneous measurement of 37 cellular markers at the single-cell level. 
A well-established technique for mass cytometry data analysis is t-distributed 
Stochastic Neighbour Embedding (t-SNE) (16), an algorithm that allows visualization of all 
concurrent marker expression profiles of cells on a two-dimensional plot in an unbiased 
fashion. However, t-SNE does not scale well to large amounts of data. Recently introduced 
techniques, such as Uniform Manifold Approximation and Projection (UMAP) (17) and 
Hierarchical Stochastic Neighbor Embedding (HSNE) (18) promise to overcome this 
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and cluster the data. This allowed efficient visualization of our dataset containing 20 
million cells without the need for downsampling of the data, while preserving single-cell 
resolution. These methods were applied to study the effect of helminths on the immune cell 
phenotype ex vivo, in addition to determination of functional effects in terms of cytokine 
production. Moreover, immune profiles were compared to those of healthy Europeans who 
had not been exposed to helminths.
MATERIALS AND METHODS
Study population 
Samples in this study were part of the SugarSPIN trial, a household-based cluster-
randomized double-blind trial that was conducted in three villages in Nangapanda, Ende 
district of Flores island (East Nusa Tenggara), Indonesia (20). The trial was approved by 
the ethics committee of Faculty of Medicine, Universitas Indonesia (FKUI) (ref: 549/H2·F1/
ETIK/2013), and filed by the ethics committee of Leiden University Medical Center (LUMC). 
The trial is registered as a clinical trial (Ref: ISRCTN75636394). Written informed consent 
was obtained from participants prior to the study. 
All subjects selected for the current study were infected with soil-transmitted helminths 
at baseline (Table 1), and cleared their infection after 1 year of albendazole treatment. 
The treatment consisted of a single tablet of albendazole (400 mg; PT Indopharma 
Pharmaceutical, Bandung, Indonesia) for three consecutive days, and this regimen was 
given every three months for a total of four rounds (maximum of 12 tablets in total), 
between May 2014 and February 2015. Before the start of drug administration and 6 
weeks after the last round of drug administration, blood and stool samples were collected 
as previously described (20).
With regards to the European samples, we collected venous blood of 10 healthy 
volunteers who had not been exposed to helminths for PBMC isolation. Except for sex 
and age (Table 1), no additional data were collected. 
Parasitology
Aliquots of fresh stool samples were frozen at -20°C in the field study centre and 
subsequently at -80°C at the Department of Parasitology of FKUI and LUMC for DNA 
extraction. Stool DNA isolation and real-time PCR were performed pairwise (baseline 
and follow-up). DNA isolation from stool was performed as described elsewhere (21). 
Multiplex real-time polymerase chain reaction (PCR) was performed to simultaneously 
detect the presence of hookworm (Ancylostoma duodenale, Necator americanus), Ascaris 
lumbricoides, Trichuris trichiura, and Strongyloides stercoralis, using a method described 
previously (21). Stool samples were considered positive by PCR when cycle threshold (Ct) 
values were <50. 
Eosinophil count and total IgE
A Giemsa-stained peripheral thin blood smear was read to assess the differential 
white blood cell count, resulting in a relative percentage of basophils, eosinophils, 
neutrophils, lymphocytes and monocytes. Total IgE was measured in serum as described 
previously (22).
PBMC cryopreservation
After diluting heparinised venous blood 2x with HBSS, PBMCs were isolated using Ficoll 
density gradient centrifugation within 12 hours after blood collection. The HBSS contained 
100 U/mL penicillin G sodium and 100 µg/mL streptomycin. After washing twice with 
HBSS, the PBMCs were cryopreserved in RPMI 1640 containing 20% of heat-inactivated 
foetal calf serum (FCS; Bodinco, Alkmaar, the Netherlands) and 10% dimethyl sulfoxyde 
(DMSO). The RPMI medium contained 1 mM pyruvate, 2 mM L-glutamine, penicillin G 
and streptomycin. Cryovials containing the cell suspension were transferred to a Nalgene 
Mr Frosty Freezing Container (Thermo Scientific, Waltham, MA, USA) which was placed 
at a -80°C freezer for a minimum of 4 hours. Subsequently, vials were stored in liquid 
nitrogen until analysis. The cryopreserved PBMCs collected in the field were shipped in 
a liquid nitrogen dry vapour shipper from Jakarta, Indonesia, to Leiden, the Netherlands, 
for analysis. 
Mass cytometry antibody staining 
Two antibody panels were designed to 1) phenotype immune cells ex vivo and 2) assess 
cytokine production after 6 hours of stimulation with phorbol 12-myristate 13-acetate 
(PMA) and ionomycin. Details on antibodies used are listed in Supplementary table S1 and 
S2. Antibody-metal conjugates were either purchased or conjugated using a total of 100 
μg of purified antibody combined with the MaxPar X8 Antibody Labelling Kit (Fluidigm, 
South San Francisco, CA, USA) according to manufacturer’s protocol V7. The conjugated 
antibody was stored in 200 µL Antibody Stabilizer PBS (Candor Bioscience, GmbH, 
Wangen, Germany) at 4°C. All antibodies were titrated on study samples. 
Table 1. Characteristics of the study population.
Characteristic Europeans (n=10) Indonesians (n=10)
Age, years (median, min, max) 32.0 (26-55) 35.9 (18-56)
Sex, female, n 5 5
Eosinophil count, %, (GM, min, max) na 13.7 (9-28)
Total IgE, IU/mL, (GM, min, max) na 823 (124-7753)








GM, geometric mean; na, not applicable
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On the day of the staining, cryopreserved PBMCs were thawed with 50% FCS/
RPMI medium at 37°C and washed twice with 10% FCS/RPMI medium. Next, 3x106 
cells per sample, used for phenotyping (Panel 1), were temporarily stored on ice while 
another 3x106 cells per sample were transferred to 5 ml round-bottom Falcon tubes (BD 
Biosciences, Bedford, MA, USA) for 6 hours of incubation in 10% FCS/RPMI with 100 ng/
mL PMA (Sigma; cat.P8139) and 1 µg/mL ionomycin (Sigma; cat. I0634). After 2 hours 
of incubation at 37°C, 10 µg/mL brefeldin A (Sigma; cat. B7651) was added after which 
the cells were incubated for 4 more hours. Subsequently, the cells were washed with PBS 
and resuspended in MaxPar staining buffer (Fluidigm) before continuing with the antibody 
staining (Panel 2).
For phenotyping (Panel 1), the staining was based on MaxPar Nuclear Antigen Staining 
Protocol V2 (Fluidigm). First, cells were washed with MaxPar staining buffer and centrifuged 
for 5 minutes at 300g in 5 mL eppendorf tubes. Then, the cells were incubated with 1 
mL 500x diluted 500 µM Cell-ID Intercalator-103Rh (Fluidigm) in staining buffer at room 
temperature for 15 minutes to identify dead cells. After washing with staining buffer, cells 
were incubated with 5 µL Human TruStain FcX Fc-receptor blocking solution (BioLegend, 
San Diego, CA, USA) and 40 µL staining buffer at room temperature for 10 minutes. Then, 
50 µL of freshly prepared surface antibody cocktail was added and incubated at room 
temperature for another 45 minutes. Subsequently, cells were washed 2x with staining 
buffer and fixed and permeabilized using the eBioscience FOXP3/Transcription factor 
staining buffer set (eBioscience, cat. 00-5523-00). After cells were incubated with 1 mL of 
the freshly prepared Fix/Perm working solution (prepared according to the manufacturer’s 
instructions) for 45 minutes, cells were washed 2x with 1x Permeabilization buffer at 800g 
for 5 minutes. Next, 50 µL of the intranuclear antibody cocktail was added to 50 µL of 
cells resuspended in 1x Permeabilization buffer and incubated for 30 minutes at room 
temperature. Following the incubation, cells were washed once with 1x Permeabilization 
buffer and twice with staining buffer, before being stained with 1 mL 1000x diluted 125 µM 
Cell-ID Intercalator-Ir (Fluidigm) in MaxPar Fix and Perm buffer (Fluidigm) at 4°C overnight 
to stain all cells. After 3 washes with staining buffer and centrifugation at 800 g, cells were 
stored as a pellet at 4°C and measured within 2 days.
To assess the cytokine production of PBMCs (Panel 2), the staining was based on 
MaxPar Cytoplasmic/Secreted Antigen Staining Protocol V3. While the surface staining 
was performed exactly as described above, cells were afterwards fixed by incubating them 
with 1 mL of freshly prepared 1x MaxPar Fix I buffer (Fluidigm) for 20 minutes at room 
temperature. Next, cells were washed 3x with MaxPar Perm-S buffer (Fluidigm) and 50 µL 
of cytokine antibody cocktail was added to 50 µL of cell suspension and incubated for 40 
minutes at room temperature. Then, cells were washed 3x with staining buffer and stained 
with Cell-ID Intercalator-Ir as described above. 
Mass cytometry data acquisition
Measurement of samples was randomised per subject to avoid bias, but samples belonging 
to the same subject were stained and measured together. Samples were measured 
with a HeliosTM mass cytometer (Fluidigm), which was automatically tuned according to 
Fluidigm’s recommendations. Before measuring, cells were counted, washed with Milli-Q 
water, passed over a cell strainer, and brought to a concentration of 1.0x106 cells/mL 
with 10% EQ Four Element Calibration Beads (Fluidigm) in Milli-Q water. Mass cytometry 
data were acquired and analysed on-the-fly, using dual-count mode and noise-reduction 
on. Next to channels to detect antibodies, channels for intercalators (103Rh, 191Ir, 
193Ir), calibration beads (140Ce, 151Eu, 153Eu, 165Ho, and 175Lu) and background/
contamination (133Cs, 138Ba, 206Pb) were acquired. After data acquisition, the mass 
bead signal was used to normalize the short-term signal fluctuations with the reference EQ 
passport P13H2302 during the course of each experiment. When applicable, normalized 
FCS files were concatenated using Helios software, without removing beads. 
Mass cytometry data analysis
FlowJo V10 for Mac (FlowJo LLC, Ashland, OR, USA) was used to gate out beads and 
we discriminated live, single CD45+ immune cells with DNA stain and event length. 
The selected cells were exported as FCS files and analysed using novel HSNE (18), as 
implemented in Cytosplore (19, 23). HSNE constructs a hierarchy of non-linear similarities 
that can be interactively explored with a stepwise increase in detail up to the single-cell 
level (19). Briefly, the data exploration starts with the visualization of the embedding at 
the highest level, the overview level, where the layout of the landmarks (representative 
cells) indicates similarity in the high-dimensional space. The landmark size reflects its 
area of influence (AoI), containing cells that are well-represented by the landmark, and 
the similarity of two landmarks is defined as the overlap of their respective AoIs. Colouring 
of the landmarks is used to represent marker expressions. At the overview level, a group 
of landmarks (also referred to as cluster) can be selected, by manual gating based on 
visual cues such as marker expression, or by performing unsupervised Gaussian mean 
shift (GMS) clustering (23, 24) of the landmarks based on the density representation of 
the embedding. Next, we can zoom into this selection by means of a more detailed 
embedding and visualize all selected landmarks in a next level. While this process can be 
repeated until the data level is reached where each dot represents a single cell, this is not 
imperative and we often clustered at an intermediate level without reaching the data level. 
The number of hierarchical levels depended on the input-data size.
Before HSNE was applied, data were transformed using a hyperbolic arcsin with 
a cofactor of 5. Furthermore, within Cytosplore, an extra channel called ‘SampleTag’ was 
added to the FCS files to be able to identify from which sample an event originated 
after HSNE. 
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Clusters produced in Cytosplore were analysed using R software (R x64 version 3.5.1; 
R Foundation for Statistical Computing, Vienna, Austria, http://www.r-project.org/) and 
RStudio (Rstudio, Inc., Boston, MA, USA, www.rstudio.com). The package ‘cytofast’ was 
used to produce heatmaps, scatterplots showing subset abundance and histograms 
showing the median signal intensity distribution of markers (25).
Statistical Analysis
Statistical analyses were performed using R software. To compare subpopulation and 
cluster abundance between Europeans and Indonesians pre-treatment unpaired t tests 
were used. Paired t tests were applied to compare pre- and post-treatment samples of 
Indonesians. Total IgE levels and eosinophil counts were log-transformed for analysis 
and paired t tests were used in GraphPad Prism (GraphPad Software, San Diego, CA, 
USA). Spearman’s correlation was used to assess the relationship between the frequency 
of Tc2 cells and type 2 cytokine-producing CD8+ T cells. P values <.05 were considered 
statistically significant. 
RESULTS 
Distinct immune signatures between Europeans and Indonesians
Study population characteristics are shown in Table 1. To analyse the cellular composition 
of the immune system at high-resolution, we developed a 37-metal isotope-tagged 
monoclonal antibody panel (Table S1) which allowed the identification of the six major 
immune lineages (CD4+, CD8+, γδ T cells, B cells, myeloid cells and innate lymphoid 
cells (ILCs; CD3-CD7+)), and major subpopulations and detailed cell clusters within. 
Importantly, by using the t-SNE-based HSNE (19), we could explore the full mass 
cytometry dataset containing 20.3 million live CD45+ cells at the single-cell level without 
the need for downsampling. At the overview level, landmarks (representative cells) 
depict the global composition of the entire immune system and distinguished the major 
immune lineages, which were annotated based on lineage marker expression overlays 
(Fig. 1A-B). Quantification of cell frequencies revealed a significantly higher frequency 
of B cells in Indonesians (P = .03), but no other differences were found between 
Europeans and Indonesians at the lineage level (Fig. 1C, Fig. S1). Next, CD4+ T cell 
landmarks, representing 6.3 million cells, were selected at the overview level (Fig. 1B) and 
a new higher resolution embedding was generated at the second level of the hierarchy 
(Fig. 1D), revealing subpopulations within the CD4+ T cell lineage (Fig. 1D). Stratification 
by origin of the samples revealed a strikingly different distribution of the CD4+ T cells 
between European and Indonesian individuals, visualized by cell density plots (Fig. 1E). 
Different cellular distributions were also observed within other lineages (CD8+, γδ T cells, 
B cells, myeloid cells and ILCs) (Fig. 1E), suggesting distinct immune signatures between 
Europeans and Indonesians in both the innate and adaptive immune compartment.
















































Figure 1. Distinct immune signatures between Europeans and Indonesians. A. First HSNE level 
embedding of 20.3 million cells. Colour represents arsin5-transformed marker expression as indicated. 
Size of the landmarks represents AoI. B. The major immune lineages, annotated on the basis of lineage 
marker expression. C. Comparison of lineage proportions relative to total cells between Europeans 
(EU) and Indonesians (ID). Differences between EU and ID were tested with Student’s t test. *P <.05. 
D. Second HSNE level embedding of the CD4+ landmarks selected from the overview level of total 
PBMCs, as indicated by the red encirclement. Both landmarks (left panel) and the density features of 
the CD4+ T cells (right panel) are shown. Density is indicated by colour. E. Density plots per lineage, 
stratified by sample origin, and therefore illustrating the differences between EU and ID.
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A CD161+ subpopulation of Th2 cells is expanded in Indonesians and 
decreases after anthelmintic treatment 
Within the CD4+ T cells, a distinct population of Th2 cells was found that expressed GATA3, 
CD25, CD127, CD45RO and chemoattractant receptor-homologous molecule expressed 
on Th2 (CRTH2), the latter being the most reliable marker to identify human Th2 cells (26) 
(Fig. 2A). The frequency of total Th2 cells was significantly higher in Indonesians compared 
to Europeans (P = .003) and importantly, deworming resulted in a significant decrease 
(P = .008) (Fig. 2B). This is in line with the observation that the proportion of circulating 
eosinophils as well as serum levels of total IgE, both markers of the type 2 response, 
significantly decreased in the STH-infected Indonesian individuals after treatment (Fig. S2).
Further analysis of Th2 cells revealed 22 phenotypically distinct clusters using the GMS 
clustering (Fig. 2C) and generated a heatmap showing the distinct marker expression 
profiles for each cluster (Fig. 2G). Th2 cells were found to be heterogeneous and based on 
the expression of the lectin-like receptor CD161 and CD27, the latter which is lost on highly 
differentiated memory CD4+ T cells (27, 28), three subpopulations could be identified 
(CD161+CD27-, CD161-CD27- and CD161-CD27+ Th2 cells; Fig. 2C-D). Visualization of Th2 
cells by density plots (Fig. 2E) showed that the proportion of CD161+ Th2 cells was expanded 
in Indonesians compared to Europeans, although the difference fell short of statistical 
significance, but a significant decrease was observed after anthelmintic treatment (P = .01) 
(Fig. 2F). Deeper analysis at the cluster level revealed three clusters within the CD161+ 
Th2 population that significantly declined upon deworming, characterized as CD161+CD7-
KLRG1-, CD161+CD7-KLRG1+ and CD161+CD7+KLRG1- (Fig. 2G). In contrast, after one year 
of treatment we observed a significant increase of three CD7+ Th2 clusters that only weakly 
expressed GATA3 and CRTH2 (Fig. 2G).
Although Indonesian blood samples contained more Th2 cells, the proportion of 
poorly differentiated CD27+ Th2 cells was significantly higher in Europeans (P = .019) 
(Fig. 2F) and this difference was in particular seen in the CCR7- cluster within the CD27+ 
Th2 cell subpopulation (Fig. 2G). This finding indicates the relatively low presence of highly 
differentiated memory effector Th2 cells in the immune system of Europeans. 
Overall frequency of ILC2s is expanded in Indonesians but does not 
decrease after anthelmintic treatment.
When 2.8 million ILCs (CD3-CD7+), which include NK cells and helper-like ILCs, 
were analysed at a more detailed level, the embedding of a CD25+CD127+CD161+ 
subpopulation revealed 2 distinct clusters that were phenotyped as ILC2s and ILC3s, 
based on the expression of CRTH2 and c-Kit, respectively (Fig. 3A). It was found that other 
markers such as GATA3, KLRG1, CD45RA and CCR6 could also be expressed by ILC2s 
and/or ILC3s (Fig. 3A). Consistent with previous work (29), we observed that while GATA3, 
the Th2 master transcription factor, was highly expressed in CRTH2+ ILC2s, it was also 
expressed in CRTH2- ILCs and can therefore not exclusively be used to define ILC2 cells. 
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Figure 2. A CD161+ subpopulation of Th2 cells is expanded in Indonesians and decreases after 
anthelmintic treatment. A. Fourth HSNE level embedding of the CRTH2+ landmarks (Th2 cells) 
selected from the second HSNE level embedding of 6.3 million CD4+ T cells, as indicated by 
the black encirclement. Colour represents arsin5-transformed marker expression as indicated. Size 
of the landmarks represents AoI. B. Frequency of Th2 cells relative to CD4+ T cells. Differences 
between Europeans (EU) and Indonesians pre-treatment (ID Pre) were tested with Student’s t test, 
while differences between ID Pre and ID Post were assessed using paired t tests. **P <.01. C. Cluster 
partitions of Th2 cells using density-based GMS clustering. The black encirclement indicates three 
subpopulations, whose frequencies are shown in f. D. Marker expression of CD27 and CD161 on Th2 
cells. E. Density features of Th2 cells illustrating the different distribution of cells between EU, ID Pre 
and ID Post. F. Frequency of three Th2 subpopulations (CD161+CD27-, CD161-CD27-, CD161-CD27+) 
relative to total Th2 cells. *P <.05. G. A heatmap summary of median expression values (same colour 
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In contrast to ILC3s, the proportion of ILC2s was significantly higher in Indonesians 
compared to Europeans (P = .003), and did not change after anthelmintic treatment 
(Fig. 3B). Further characterization of ILC2s resulted in 8 phenotypically distinct clusters 
that were mainly distinguished by the expression of KLRG1, CD45RA and CCR6 (Fig. 3C). 
Except for a higher frequency of KLRG1+CCR6- ILC2s (cluster 2) present in STH-infected 
Indonesians and a lower frequency of KLRG1+CCR6+ ILC2s (cluster 5) compared to 
Europeans, no significant differences at the cluster level were observed (Fig. 3D). 
Not Treg frequency, but their expression of CTLA4 is induced by helminth 
infections
Regulatory T cells (Tregs) were characterized as FOXP3+CD25highCD127low cells and 
appeared as a clearly distinct subpopulation within CD4+ T cells (Fig. 4A). The frequency 
of Tregs, when assessed as a whole, did not differ between Europeans and Indonesians, 
nor changed after deworming (Fig. 4B). However, the immune profile of Indonesians 
consisted of significantly more effector Tregs expressing CD45RO (P = .036) (Fig. 4C), 
whereas in Europeans, a clear population of Tregs was positioned in the naïve, CD45RA+, 
compartment (Fig. 4A,D). In line with previous studies describing Tregs as phenotypically 
and functionally heterogeneous (10), we found several subpopulations within the effector 
Treg compartment expressing CTLA4, HLA-DR, CD38 and/or ICOS (Fig. 4E). A significant 
proportion of the effector Tregs expressed CTLA4, a marker that is associated with 
the suppressive function of Tregs (30). In concordance with this, the proportion of CTLA4+ 
Tregs was significantly higher in Indonesians compared to Europeans (P = .007) and 
decreased after treatment (P = .052) (Fig. 4F).
Next, we identified 27 phenotypically distinct clusters within Tregs (Fig. 4G-H). 
Analysis at the cluster level revealed that the frequencies of 6 out of 27 clusters were 
significantly higher in Indonesians compared to Europeans, which could be distinguished 
by the expression of only CTLA4+, or co-expressing CD38 and/or HLA-DR and/or ICOS 
(Fig. 4H). One of these clusters (cluster 7) expressing CTLA4, HLA-DR, CD38 and ICOS 
decreased significantly upon deworming, suggesting that this population of effector Tregs 
is particularly important in the immune response induced by STH. 
Of note, among the CTLA4+ Tregs, we identified a cluster expressing CD161 (cluster 
25; Fig. 4H), characterizing a subpopulation that was previously described as the major 
source of Treg-derived proinflammatory cytokines with the ability to produce IL-17 under 
inflammatory conditions (31, 32). The proportion of CD161+ Tregs was significantly higher 
in Indonesians compared to Europeans (P = .001) but did not change after deworming 
(Fig. 4I). 
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Figure 3. Overall frequency of ILC2s is expanded in Indonesians but does not decrease 
after anthelmintic treatment. A. The right panel shows the third HSNE level embedding of 
the CD25+CD161+CD127+ landmarks selected from the second HSNE embedding of 2.8 million ILCs 
(CD3-CD7-), as indicated by the black encirclement. Next to a distinct cluster of CRTH2+ ILC2s, a cluster 
of cKit+ ILC3s was found. Colour represents arsin5-transformed marker expression as indicated. Size 
of the landmarks represents AoI. B. Frequency of ILC2s relative to total CD45+ cells. Differences 
between Europeans (EU) and Indonesians pre-treatment (ID Pre) were tested with Student’s t test, 
while differences between ID Pre and ID Post were assessed using paired t tests. **P <.01. C. Data 
level embedding of ILC2s. The upper left panel shows the cluster partitions using GMS clustering, 
whereas the other panels show the expression of KRLG1, CCR6 and CD45RA. D. A heatmap summary 
of median expression values (same colour coding as for the embeddings) of cell markers expressed 
by ILC2 cell clusters identified in c. and hierarchical clustering thereof. To compare cluster abundance 
between EU and ID Pre Student’s t test was used, while paired t test was used to compare ID Pre and 
ID Post. Coloured symbols below the clusters indicate statistical significance.
Type 2 cytokine-producing cells in Indonesians (ILC2s, CD4+, CD8+ and γδ 
T cells) and their alteration after deworming
Following the phenotypic characterization of the cells, the cytokine-producing capacity 
of the cells was analysed to assess functional type 2 immune cells. PBMCs from identical 
donors as described above, were stimulated with PMA/ionomycin for 6h and subsequently 
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stained with a 37-metal isotope-tagged monoclonal antibody panel which included 
the following cytokine antibodies: IFNγ, TNFα, IL-2, IL-17, IL-10 and IL-4/IL-5/IL-13 
(simultaneously assessed and hereafter referred to as ‘type 2 cytokines’). 
Type 2 cytokine-producing CD45+ cells were analysed in Cytosplore and clustering on 
surface markers clearly revealed four distinct type 2 cytokine-producing subpopulations 
(Fig. 5A-D, Fig. S3). Th2 cells and ILC2s have been described as the main producers of 
type 2-cytokines, and this was confirmed by the finding that the median signal intensity 
(MSI) of type 2 cytokines was highest in CD4+ T cells and ILC2s (Fig. 5E). However, we 
also identified a cluster of γδ T cells and multiple CD8+ T cell clusters producing type 2 
cytokines, although the MSI of IL-4/5/13 was lower compared to CD4+ T and ILC2 cells 
(Fig. 5E). Interestingly, whereas ILC2s did not produce IFNγ, a CD25- proportion of CD4+ 
and CD8+ T cells, and all γδ T cells co-expressed IFNγ (Fig. 5E-F). 
Density plots of type 2 cytokine-producing cells revealed striking differences between 
Europeans and STH-infected Indonesians (Fig. 5C). While Indonesians not only exhibited 
a significantly higher frequency of type 2 cytokine-producing cells (Fig. 5G), the number of 
cellular sources for these cytokines also appeared to be expanded (Fig. 5C-D,H). In both 
populations it were mainly CD4+ T cells that produced type 2 cytokines, however, the ILC2 
and γδ T cell subpopulations that were found in Indonesians, were much less pronounced 
in Europeans. Importantly, the proportion of type 2 cytokine-producing cells significantly 
declined after deworming (P < .001) (Fig. 5G) and this can be attributed to a significant 
decrease in type 2 cytokine-producing CD4+ T (P < .001) and ILC2s (P  = .004) (Fig. 5H). 
When cells were phenotyped ex vivo, we identified a GATA3+ cluster (2.1% of CD8+ 
T cells) within a subpopulation of CD45RO+CCR7-CD161-CD56- CD8+ T cells (Fig. 6A-B), 
a subset previously defined as type 2 cytotoxic T cells (Tc2) cells (33, 34). In addition, Tc2 
cells expressed CRTH2, CD25, CD127 and CD7 (Fig. 6B). Although Tc2 frequencies did 
not change after deworming, its proportion correlated strongly with the type 2 cytokine-
producing CD8+ T cells (r=0.87, P < .001; Fig. 6C), suggesting that Tc2 cells are the source 
of Th2 cytokines within the CD8 lineage. However, it should be noted that the frequency 
of Tc2 cells ranged widely from 0.09-16.8% of CD8+ T cells among individuals, and 56% 
of the cells within the Tc2 subpopulation were from one individual (including both before 
and after treatment samples). 
IL10-producing B and CD4+ T cells revealed by mass cytometry
Similar to what was described above, we sought cells that produced the suppressory 
cytokine IL-10. The IL-10-producing CD45+ cells were analysed in Cytosplore 
Figure 4. Not Treg frequency, but their expression of CTLA4 is induced by helminths. A. Fourth HSNE 
level embedding of the FOXP3+ landmarks (Tregs) selected from the second HSNE embedding of 6.3 
million CD4+ T cells, as indicated by the black encirclement. Colour represents arsin5-transformed 
marker expression as indicated. Size of the landmarks represents AoI. B. Frequency of Tregs relative to 
CD4+ T cells. Differences between Europeans (EU) and Indonesians pre-treatment (ID Pre) were tested 
with Student’s t test, while differences between ID Pre and ID Post were assessed using paired t tests. 
C. Frequency of CD45RO+ effector Tregs relative to total Tregs. *P <.05. D. Density features of Tregs 
illustrating the different distribution of cells between EU, ID Pre and ID Post. E. Marker expression 
of CTLA4, ICOS, CD38, HLA-DR and CD161 by Tregs. F. Frequency of CTLA4+ Tregs relative to total 
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of median expression values (same colour coding as for the embeddings) of cell markers expressed 
by FOXP3+ Treg clusters identified in g. and hierarchical clustering thereof. To compare cluster 
abundance between EU and ID Pre Student’s t test was used, while paired t test was used to compare 
ID Pre and ID Post. Coloured symbols below the clusters indicate statistical significance. I. Frequency 
of CD161+ Tregs relative to total Tregs. *P <.05.





































































































































Figure 5. Type 2 cytokine-producing cells in Indonesians (ILC2s, CD4+, CD8+ and γδ T cells) and 
their alteration after deworming. A. IL-4/5/13+ cells were manually gated using Flowjo. Data from 
one representative individual is shown. B. First HSNE level embedding of total IL-4/5/13+ cells, 
clustered on surface markers. Colour represents arsin5-transformed marker expression as indicated. 
Size of the landmarks represents AoI. C. Density features of IL-4/5/13+ cells illustrating the different 
distribution of cells between Europeans (EU), Indonesians pre- (ID Pre) and post-treatment (ID Post). 
D. The major immune cell subpopulations producing type 2 cytokines, annotated on the basis of 
lineage marker expression (See Fig. S3). E. Histogram showing the median signal intensity (MSI) 
distribution of IL-4/5/13 and IFNγ for the subpopulations identified in d. F. Marker expression 
of CD25 and IFNγ by IL-4/5/13+ cells. G. Frequency of total IL-4/5/13-producing cells relative 
to total CD45+ cells. Differences between EU and ID Pre were tested with Student’s t test, while 
differences between ID Pre and ID Post were assessed using paired t tests. **P <.01. H. Frequency 
of IL-4/5/13-producing clusters identified in d. relative to total CD4+ T, ILC2, γδ T or CD8+ T cells. 
*P <.05; **P <.01.
(Fig. 7A-B) and clustering on surface markers revealed a major cluster of CD4+ T cells, and 
minor clusters of CD8+ T cells, CD4-CD8- T cells and B cells (Fig. 7C-D, Fig. S4). Similar 
frequencies of total IL-10-producing cells (relative to CD45+ cells) were observed among 
Europeans and Indonesians, and these did not change after anthelmintic treatment (data 
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Figure 6. Tc2 cells are the source of type 2 cytokines produced by CD8+ T cells. A. CCR7-CD161-
CD56- landmarks were selected from the second level HSNE embedding of CD8+ T cells, as indicated 
by the black encirclement. B. From the next level embedding, GATA3+ landmarks were selected and 
their marker expression is shown at the fourth level embedding. Colour represents arsin5-transformed 
marker expression as indicated. Size of the landmarks represents AoI. C. Correlation of GATA3+ CD8+ T 
(Tc2) cells identified in b. and IL-4/5/13-producing CD8+ T cells identified in Fig. 5D. Colours indicate 
paired samples (pre and post treatment) from Indonesian individuals. Spearman’s rank correlation was 
used for statistical analysis.
not shown). Also regarding the IL-10+ subpopulations (CD4+, CD8+, CD4-CD8- T and B 
cells), no significant differences were found (data not shown).
Interestingly, a distinct population of IL-10+ B cells (0.5% of total B cells) was identified 
and further analysis showed that it consisted of three clusters, namely CD11c+CD38-, 
CD11c-CD38+ and CD11c-CD38- cells (Fig. 7E). Whereas the composition of IL-10+ B cells 
did not change after deworming, IL-10+ B cells from Indonesians clearly contained more 
CD11c+CD38- cells compared to Europeans, who had relatively more CD11c-CD38+ IL-10+ 
B cells (Fig. 7F). These results indicate a different phenotype of IL-10+ B cells in the two 
populations, which is in line with the finding that the immune system of Indonesians 
contained significantly more CD11c+ B cells as assessed by phenotypic markers compared 
to Europeans (data not shown). 
When IL-10-producing CD4+ T cells were clustered on cytokines, four clusters were 
identified which all expressed type 2 cytokines but varied in terms of co-expression of 
other cytokines (IFNγ, TNFα, and/or IL-2) (Fig. 7G-H). When considering all CD4+ T cells 
producing IL-10 and type 2 cytokines, irrespective of other cytokines, their frequency was 
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significantly higher in Indonesians compared to Europeans (P < .001; data not shown). 
However, only the cluster that was negative for IFNγ, TNFα, and IL-2 (cluster 1) decreased 
significantly after deworming (P = .041; Fig. 7I). 
DISCUSSION
There are large population differences in immune responses that, although in part can be 
explained by genetic factors, seem to be largely driven by environmental exposures (35). 
One such exposure is to helminths, that are ubiquitous in many parts of the world. These 
parasites induce strong type 2 and regulatory responses and can shape vaccine efficacy or 
influence the development of inflammatory diseases. By understanding these responses 
in depth it will be possible to devise interventions that could help vaccine responses or 
curtail inflammation that damages tissues and organs. To this end, mass cytometry was 
applied to analyse type 2 and regulatory immune cells of healthy Europeans, as well as 
of STH-infected Indonesians before and one year after deworming, thereby starting to 
understand the differences in the immune response of populations living in different 
geographical areas.
Here, we have identified and shown the enhanced presence of Th2 and ILC2 cells, both 
sources of the type 2 cytokines IL-4, IL-5 and IL-13, in STH-infected Indonesians compared 
to Europeans. When considering the cells by their phenotype, Th2 cell frequencies 
significantly decreased after deworming, but the frequencies of ILC2s remained 
unchanged. However, the frequency of ILC2s producing type 2 cytokines declined after 
anthelmintic treatment, indicating decreased functional ILC2 activity. There is very little 
known about the role of ILC2s in human helminth infections. Although the identification of 
CRTH2 as a marker of human ILC2s (8) has been a great advantage, only two studies have 
analysed ILC2s in the context of human helminth infections (36, 37). In a cross-sectional 
study, Boyd et al. found a higher frequency of c-Kit+ ILCs (reported as Lin-CD45+CD127+) 
in filarial-infected adults (36), however, c-Kit+ ILCs have been described to contain both 
ILC2s and ILC3s (38), and here we did not detect c-Kit+ ILC2s. Another study showed that 
the proportions of ILC2s (reported as Lin-CD45+CD127+CRTH2+CD161+), when expressed 
as percentage of Lin-CD45+CD127+ cells, were significantly lower in Schistosoma 
haematobium-infected African children (6-9 years) when compared to age and sex matched 
uninfected individuals and increased 6 weeks after clearing the infection (37). In our study, 
when based on phenotypic characterization, there was a tendency for ILC2 frequencies 
to be higher (although not statistically significant) after deworming. However, decreased 
functional ILC2 activity in terms of cytokine production was observed and as this study did 
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Figure 7. IL-10-producing B and CD4+ T cells revealed by mass cytometry. A. IL-10+ cells were 
manually gated using Flowjo. Data from one representative individual is shown. B. First HSNE level 
embedding of total IL-10+ cells, clustered on surface markers. Colour represents arsin5-transformed 
marker expression as indicated. Size of the landmarks represents AoI. C. Density features of IL-10+ cells 
illustrating the different distribution of cells between Europeans (EU), Indonesians pre- (ID Pre) and 
post-treatment (ID Post). D. The major immune cell subsets producing IL-10, annotated on the basis 
of lineage marker expression (See Fig. S4). E. Data level embedding of IL-10+ B cells and the cluster 
partitions using GMS clustering (lower right panel). F. Relative composition of IL-10+ B cells, comparing 
EU and ID Pre. Below, density features of IL-10+ B cells are shown illustrating the different distribution 
of cells between EU and ID Pre. G. First level HSNE embedding of IL-10+CD4+ landmarks selected in 
d. and clustered on cytokines. Four IL-4/5/13+ clusters were identified as indicated in the right panel 
showing the cluster partitions. H. Histograms showing the median signal intensity (MSI) distribution 
of cytokines for the four clusters identified in g. I. Frequency of cluster 1, co-expressing IL-4/5/13 and 
IL-10 (identified in g), relative to total IL-10-producing CD4+ T cells. Differences between EU and ID 
Pre were tested with Student’s t test, while differences between ID Pre and ID Post were assessed 
using paired t tests. *P <.05; **P <.01.
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not analyse the cytokine production by the cells, it is difficult to compare it with our data. 
As suggested by the authors (37), the reduction observed in infected individuals might be 
a consequence of ILC2s migrating and accumulating at the site of infection, or a decline in 
the generation or maintenance of the cells. 
Unlike ILC3s, only one (functional) subset of ILC2s has been characterized in healthy 
humans (38). We identified 8 ILC2 clusters based on the heterogeneous expression of 
KLRG1, CD45RA and CCR6, but the significance of these is currently unknown and requires 
further investigation. Interestingly, we identified CD45RA+c-Kit+ ILC3s that did not express 
CCR6, a marker previously described to be expressed by ILC3s (29, 38), and hypothesize 
that this subpopulation might consist of the recently described ILC precursors (ILCPs), as 
these cells lack CCR6 expression and are CD45RA+ (39). 
There is increasing evidence that Th2 cells can be heterogeneous. For example, 
a minority subpopulation of Th2 cells termed pathogenic effector Th2 (peTh2) cells, found 
in patients with allergic eosinophilic inflammatory diseases, have been described that have 
enhanced effector function (27, 40). PeTh2 cells are characterized as CD161+hPGDS+CD27- 
Th2 cells, expressing IL-5 in addition to IL-4 and IL-13 and respond to innate stimuli including 
IL-25, IL-33 and TSLP indicating that they have innate-like properties (27). Although 
chronic antigen exposure is thought to drive peTh2 differentiation from conventional Th2 
cells, it is unknown whether peTh2 cells are induced by or play a role in human helminth 
infections (27). Anarudha et al. previously identified IL-5-IL-4+IL-13+ and IL-5+IL-4+IL-13+ 
human CD4+ T cell subpopulations in the context of filariasis, but the expression of CD161 
was not assessed (41). Here, we describe the enhanced presence of a peTh2-like CD27-
CD161+ subset of Th2 cells in STH-infected individuals which significantly decreased 
after deworming. However, whether these cells are identical to peTh2 cells needs to be 
investigated in future studies. 
Unlike Th2 cells, Tregs have been described as a heterogeneous population and 
previous work showed that HLA-DR (42), ICOS (43) and CD38 (44) are differentially 
expressed within the FOXP3+ Treg population, marking cells with distinct capacities and 
modes of suppression. While Tregs expressing HLA-DR or CD38 were shown to be highly 
suppressive compared to their negative counterparts (42, 44), the expression of ICOS seems 
to define a Treg subset that has the capacity to produce large amounts of IL-10, in contrast 
to ICOS- Tregs producing mainly TGF-β (43). By using mass cytometry, we could not only 
confirm the presence of these distinct Treg phenotypes in our study population, but also 
visualize the marker distribution which revealed that all HLA-DR+, ICOS+ and CD38+ cells 
were found within the CTLA4+ Treg subset. Similar to CD25 and GITR, CTLA4 is a T cell 
activation marker (10) and has been shown to correlate with FOXP3 expression in human 
CD4+ T cells (45). Experimental models showed that CTLA4 is crucial for the suppressive 
function of Tregs through the modulation of APCs (30) and its interaction with CD80 and 
CD86 on conventional T cells (46). 
Although Treg frequencies were not expanded in helminth infected individuals and 
no treatment-related change was seen, consistent with previous work in children from 
the same study area (14, 15), the proportion of CTLA4+ Tregs was significantly higher in 
helminth infected individuals and declined after treatment which is in line with previous 
reports (15, 47). Analysis at the cluster level revealed that the CTLA4+ clusters in particular, 
often co-expressing ICOS and/or HLA-DR and/or CD38, were expanded in Indonesians 
compared to Europeans, indicating that helminths induce a particular Treg phenotype 
which could be represented by cells with increased regulatory capacity.
Besides Th2 cells and ILC2s being a source of type 2 cytokines, we identified Tc2 cells 
(type 2 cytokine-secreting CD8+ T cells (33)) and a cluster of γδ T cells, which were capable 
of producing type 2 cytokines. Although Tc2 cells have recently been found to be enriched 
in patients with eosinophilic asthma (34), this subset has rarely been investigated, and 
therefore the current study is one of the first to characterize these cells in the context of 
human helminth infections.
Like Tc2 cells, not much is known about type 2 cytokine-producing γδ T cells, although 
their existence has been described before (48-52). Inagaki et al. showed a protective role 
of γδ T cells against infection with N. brasiliensis in mice, which was associated with 
the production of type 2 cytokines, in particular IL-13 (49). However, to our knowledge, 
the presence of type 2 cytokine-producing γδ T cells in human helminth infection has 
not been reported before. Here, we identified type 2 cytokine-producing γδ T cells, and 
showed that these cells were present in helminth-infected individuals, indicating their 
possible participation in the development of Th2 responses. However, further studies are 
required to investigate the function of Tc2 and type 2 cytokine-producing γδ T cells. 
IL-10 producing B cells, known as regulatory B cells (Bregs), represent a relatively rare 
cell type within the human immune system that can suppress inflammatory responses (53). 
Although the frequency of IL-10 producing B cells was similar in Europeans and Indonesians 
and deworming did not affect their frequency, the phenotype of these cells was strikingly 
different with relatively more CD11c+CD38-, and less CD11c-CD38+ IL-10+ B cells present 
in Indonesians. CD11c+ B cells are increasingly recognized as a distinct population of 
memory B cells, and have been shown to expand in settings of chronic infections such 
as HIV, malaria and TB as well as in several autoimmune diseases (54, 55). In line with 
this, we found a significantly expanded population of CD11c+Tbet+ B cells in helminth-
infected Indonesians compared to Europeans, of which a small fraction appeared capable 
of producing IL-10. Whereas CD38 has previously been reported as a marker for human 
Bregs (53), the expression of CD11c has not yet been associated with Bregs and further 
studies investigating the suppressive properties of CD11c+IL-10+ B cells will be needed. 
Our study has a number of limitations. The small number of study subjects, 
the lack of placebo-treated individuals and the possibility that other infections are affected 
by deworming. 
The work described here provided a detailed insight into the types of cells that 
participate in the strong type 2 and regulatory response induced by helminths. We 
demonstrate the advantage of using mass cytometry combined with HSNE, which allowed 
the identification of rare cell populations, such as ILC2s, Tc2 cells and Bregs, and provided 
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an opportunity to analyse the heterogeneity within Th2 cells and Tregs. Therefore this study 
forms the basis for the analysis of the identified cell subpopulations by flow cytometry in 
larger studies, not only in helminth infections, but also in other disease settings, as well as 
for their further functional characterization. 
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Supplementary Figure S1. Lineage frequencies. Scatterplots comparing lineage frequencies of 
Europeans (EU) and Indonesians (ID). Median is shown. Differences between EU and ID Pre were 
























A. Eosinophils B. Total IgE
Supplementary Figure S2. Eosinophil counts and total IgE levels. A. Eosinophil counts expressed as 
percentage of white blood cells (WBC) and B. Serum levels of total IgE of Indonesians pre- and post-










































Supplementary Figure S3. Type 2-cytokine producing cells. A. First level embedding of IL-4/5/13+ 
cells clustered on surface markers and cluster partitions of IL-4/5/13+ cells using GMS clustering 
(lower right panel). The expression of CD4 was reduced as a consequence of the stimulation. Colour 
represents arsin5-transformed marker expression as indicated. Size of the landmarks represents 
AoI. B. Second level embedding of the CD3-CD7+ landmarks selected from the first level in a, as 
indicated by the black encirclement, allowed the identification of ILC2s. C. A heatmap summary of 
median expression values of cell markers expressed by IL-4/5/13+ cells identified in a. and hierarchical 
clustering thereof.
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Supplementary Figure S4. IL-10 producing cells. A. First level embedding of IL-10+ cells clustered 
on surface markers. The expression of CD4 was reduced as a consequence of the stimulation. Colour 
represents arsin5-transformed marker expression as indicated. Size of the landmarks represents AoI. 
B. Cluster partitions of IL-10+ cells using GMS clustering. C. A heatmap summary of median expression 
values of cell markers expressed by IL-10+ cells identified in b. and hierarchical clustering thereof.
Supplementary table S1. Antibody panel 1 (Phenotyping).
Label Specificity Clone Vendor Catalogue number Dilution
89Y CD45 HI30 Fluidigma 3089003B 200x
113CD CD45RA HI100 eBioscienceb 83-0458-42 50x
141Pr CD196 (CCR6) G034E3 Fluidigm 3141003A 100x
142Nd CD19 HIB19 Fluidigm 3142001B 200x
143Nd CD117 (c-Kit) 104D2 Fluidigm 3143001B 100x
145Nd CD4 RPA-T4 Fluidigm 3145001B 100x
146Nd CD8a RPA-T8 Fluidigm 3146001B 200x
147Sm CD183 (CXCR3) G025H7 BioLegendc 353733 100x
148Nd CD14 M5E2 BioLegend 301843 100x
149Sm CD25 (IL-2Ra) 2A3 Fluidigm 3149010B 100x
150Nd CD185 (CXCR5) J252D4 BioLegend 356902 100x
151Eu CD123 6H6 Fluidigm 3151001B 100x
152Sm TCRγδ 11F2 Fluidigm 3152008B 50x
153Eu CD7 CD7-6B7 Fluidigm 3153014B 100x
154Sm CD163 GHI/61 Fluidigm 3154007B 100x
155Gd CD278 (ICOS) C398.4A BioLegend 313502 50x
156Gd CD294 (CRTH2) BM16 BioLegend 350102 50x
158Gd CD122 (IL-2Rb) TU27 BioLegend 339015 100x
159Tb CD197 (CCR7) G043H7 Fluidigm 3159003A 100x
160Gd FOXP3 PCH101 eBioscience 14-4776-82 50x
161Dy KLRG1 (MAFA) REA261 Miltenyid Special order 100x
162Dy CD11c Bu15 Fluidigm 3162005B 200x
163Dy CD152 (CTLA-4) BNI3 BioLegend 369602 100x
164Dy CD161 HP-3G10 Fluidigm 3164009B 100x
165Ho CD127 (IL-7Rα) AO19D5 Fluidigm 3165008B 200x
166Er Tbet 4B10 BioLegend 644825 50x
167Er CD27 O323 Fluidigm 3167002B 200x
168Er HLA-DR L243 BioLegend 307651 200x
169Tm GATA3 REA174 Miltenyi 130-108-061 50x
170Er CD3 UCHT1 Fluidigm 3170001B 100x
171Yb CD28 CD28.2 BioLegend 302937 200x
172Yb CD38 HIT2 Fluidigm 3172007B 200x
173Yb CD45RO UCHL1 BioLegend 304239 100x
174Yb CD335 (NKp46) 92E BioLegend 331902 100x
175Lu CD279 (PD-1) EH 12.2H7 Fluidigm 3175008B 100x
176Yb CD56 NCAM16.2 Fluidigm 3176008B 100x
209BI CD16 3G8 Fluidigm 3209002B 400x
aFluidigm, South San Francisco, CA, USA. beBioscience, San Diego, CA, USA. cBiolegend, San Diego, CA, USA. 
dMiltenyi Biotech, Bergisch Gladbach, Germany. CCR, C-C chemokine receptor. CD, cluster of differentiation. 
CRTH2, prostaglandin D2 receptor 2. CXCR, CXC chemokine receptor. FOXP3, forkhead box P3. HLA-DR, human 
leukocyte antigen-D-related. IL-2R, interleukin-2 receptor. IL-7Rα, interleukin-7 receptor α. KLRG1, killer cell lectin-
like receptor subfamily G member 1. MAFA, mast cell function-associated antigen. PD-1, programmed cell death 




Supplementary table S2. Antibody panel 2 (Cytokine production).
Label Specificity Clone Vendor Catalogue number Dilution
89Y CD45 HI30 Fluidigma 3089003B 200x
113CD CD45RA HI100 Ebioscienceb 83-0458-42 50x
141Pr CD196 (CCR6) G034E3 Fluidigm 3141003A 100x
142Nd CD19 HIB19 Fluidigm 3142001B 200x
143Nd CD117 (c-Kit) 104D2 Fluidigm 3143001B 100x
144Nd IL-2 MQ117H12 BioLegendc 500339 400x
145Nd CD4 RPA-T4 Fluidigm 3145001B 100x
146Nd CD8a RPA-T8 Fluidigm 3146001B 200x
147Sm CD183 (CXCR3) G025H7 BioLegend 353733 100x
148Nd CD14 M5E2 BioLegend 301843 100x
149Sm CD25 (IL-2Ra) 2A3 Fluidigm 3149010B 100x
150Nd CD185 (CXCR5) J252D4 BioLegend 356902 100x
151Eu CD123 6H6 Fluidigm 3151001B 100x
152Sm TCRγδ 11F2 Fluidigm 3152008B 50x
153Eu CD7 CD7-6B7 Fluidigm 3153014B 100x
154Sm CD163 GHI/61 Fluidigm 3154007B 100x
155Gd IFNγ B27 BioLegend 506521 400x
156Gd CD294 (CRTH2) BM16 BioLegend 350102 50x
158Gd CD122 (IL-2Rb) TU27 BioLegend 339015 100x
159Tb CD197 (CCR7) G043H7 Fluidigm 3159003A 100x
160Gd TNFα MAb11 BioLegend 502941 400x
161Dy KLRG1 (MAFA) REA261 Miltenyid Special order 100x
162Dy CD11c Bu15 Fluidigm 3162005B 200x
163Dy IL-17 BL168 BioLegend 512331 400x
164Dy CD161 HP-3G10 Fluidigm 3164009B 100x
165Ho CD127 (IL-7Ra) AO19D5 Fluidigm 3165008B 200x
166Er IL-10 JES39D7 Fluidigm 3166008B 400x
167Er CD27 O323 Fluidigm 3167002B 200x
168Er HLA-DR L243 BioLegend 307651 200x
169Tm IL-4 MP4-25D2 Fluidigm 3169016B 400x
169Tm IL-5 TRFK5 BioLegend 500829 400x
169Tm IL-13 JES105A2 BioLegend 504309 400x
170Er CD3 UCHT1 Fluidigm 3170001B 100x
171Yb CD28 CD28.2 BioLegend 302937 200x
172Yb CD38 HIT2 Fluidigm 3172007B 200x
173Yb CD45RO UCHL1 BioLegend 304239 100x
175Lu CD279 (PD-1) EH 12.2H7 Fluidigm 3175008B 100x
176Yb CD56 NCAM16.2 Fluidigm 3176008B 100x
aFluidigm, South San Francisco, CA, USA. beBioscience, San Diego, CA, USA. cBiolegend, San Diego, CA, USA. 
dMiltenyi Biotech, Bergisch Gladbach, Germany. CCR, C-C chemokine receptor. CD, cluster of differentiation. 
CRTH2, prostaglandin D2 receptor 2. CXCR, CXC chemokine receptor. HLA-DR, human leukocyte antigen-
D-related. IL-2R, interleukin-2 receptor. IL-7Rα, interleukin-7 receptor α. KLRG1, killer cell lectin-like receptor 
subfamily G member 1. MAFA, mast cell function-associated antigen. PD-1, programmed cell death protein. TCR, 
T-cell receptor. Markers in grey were stained intracellular, while all other markers were stained on the cell surface.
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WHAT WAS ALREADY KNOWN ABOUT HELMINTHS, THEIR 
IMMUNOMODULATORY EFFECTS AND THE ASSOCIATION 
WITH TYPE 2 DIABETES?
Helminth parasites are the strongest natural inducers of type 2 immunity, and landmark 
studies have shown that conditions which induce type 2 immune responses improve 
metabolic disorders (1-6). Furthermore, in several epidemiological studies an inverse 
association between helminth infections and the prevalence of type 2 diabetes (T2D) or 
metabolic syndrome was found (7-11). However, the cross-sectional design of these studies 
have prevented conclusions on the causal relationship between helminth infections and 
T2D in humans. 
Although the mechanisms underlying the potential association between helminth 
infections and T2D are still largely unknown, experimental infections with helminths or 
helminth-derived molecules in high fat diet-induced obese mice have indicated that 
changes in the immune cell composition, in particular in white adipose tissue, contribute 
to the insulin-sensitizing effects. While obese adipose tissue is characterized by pro-
inflammatory type 1 cytokines, a type 2 cytokine environment is present in metabolic 
tissues under homeostatic, insulin sensitive conditions. Group 2 innate lymphoid cells 
(ILC2s) and CD4+ T helper 2 (Th2) cells produce the type 2 cytokines interleukin (IL)-4, IL-5 
and IL-13 in healthy adipose tissue and sustain a white adipose tissue (WAT) eosinophil 
and alternatively macrophage (AAM) axis that is largely driven by eosinophil-produced IL-4 
(1, 12). Of note, whereas a recent study showed an association between soil-transmitted 
helminth (STH) infections and insulin sensitivity in humans, no indication for differences in 
systemic inflammation between subjects with and without STH infections was found (11). 
The induction of a strong regulatory network involving regulatory T cells (Tregs) is 
another important hallmark of helminth infections which might explain the possible 
beneficial effects of helminth infections. Although filarial antigen-mediated improvement 
in glucose tolerance in obese mice was shown to occur independently of Tregs (5), 
the establishment of a regulatory network may contribute to the control of overt immune 
responses, restricting the chronic low-grade inflammation in adipose tissue that is key to 
the development of insulin resistance (13). Wammes et al. recently found that not Treg 
frequencies, but the expression of CTLA4, a molecule expressed by Tregs and involved 
in putting the brake on immune activation, significantly declined in anthelmintic-treated 
individuals, indicating that helminths have a modulatory effect on Tregs resulting in 
increased regulatory capacity (14). 
In addition to modulation of the host immune response, helminth infections might 
confer protection against the development of T2D through caloric restriction, induced 
by changes in digestion and decreased absorption of nutrients (15, 16). It was previously 
shown that helminth infections were associated with a lower body mass index (BMI) 
and waist hip ratio (WHR). However, after adjustment for BMI, the negative association 
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between STH infections and HOMA-IR persisted, indicating that this association cannot be 
explained by effects of STH infections on BMI alone (11). 
Taken together, previous work has identified the interplay between helminths, 
inflammation and metabolic homeostasis as an exciting new area that needs 
further dissection. 
HOW DID OUR STUDIES ADVANCE THE FIELD?
Helminths and metabolic homeostasis
To investigate the causal relationship between helminth infections and the development 
of T2D, we assessed the effect of anthelmintic treatment on changes in insulin resistance 
(IR), in an area endemic for STH on Flores Island, Indonesia. To this end, a double-blind, 
household-cluster-randomized, placebo-controlled trial was conducted which is described 
in chapter 2. During one year, study participants (≥ 16 years of age) received four rounds 
of albendazole or matching placebo with three-month intervals, for three consecutive 
days. In chapter 3 we describe the trial outcomes, showing that intensive anthelmintic 
treatment significantly reduced STH prevalence, as well as infection intensity. Moreover, 
type 2 immune responses, assessed by eosinophil counts and total IgE levels in peripheral 
blood, were significantly reduced in albendazole-treated subjects. Although treatment did 
not lead to an increase of whole-body IR, assessed by homeostatic model assessment of IR 
(HOMA-IR), at the community level, a significant increase in HOMA-IR was observed among 
helminth-infected subjects. The latter was accompanied by a significant increase in BMI, 
and pathway analysis showed that adjustment for BMI and eosinophil count attenuated 
the treatment effect on HOMA-IR among helminth-infected subjects. Altogether, this is 
the first cluster-randomized trial in humans demonstrating the causal relationship between 
helminth infections and whole-body IR in an area endemic for STH. However, it should be 
noted that the anthelmintic treatment-induced increase in IR might have a relatively small 
contribution to the multi-factorial pathogenesis of IR, and the assessment of other more 
established factors such as diet and physical activity will be needed to investigate this. 
Experimental infections with helminths in obese mice have enabled us to investigate 
the potential mechanisms by which helminths can influence metabolic outcomes. Moreover, 
the identification of single, active helminth-derived molecules has gained increasing 
attention, as administration of these molecules eliminates the potential helminth-induced 
pathological condition, and excludes the possibility that the beneficial effects of helminth 
infections on metabolic homeostasis are simply a result of parasitism. Chapter 4 builds 
on previous work showing that chronic treatment with a mixture of Schistosoma mansoni 
soluble egg antigens (SEA) improved whole-body metabolic homeostasis in high-fat diet 
(HFD)-induced obese mice (4). In this chapter, we investigated the effects of two plant-
produced glycosylation variants of omega-1 (ω1), a glycoprotein present in SEA which was 
previously identified as the major immunomodulatory component in SEA (17, 18), on whole-
body metabolic homeostasis. Both recombinant ω1 glycovariants decreased fat mass and 
improved whole-body metabolic homeostasis in obese mice, an effect associated with 
increased adipose tissue Th2 cells, eosinophils and AAM. The use of mice deficient for 
STAT6, a transcription factor which is essential for IL-4/IL-13 receptor-mediated signaling, 
allowed us to assess whether type 2 immunity induced by either SEA or ω1 is required for 
its metabolic effects. Remarkably, although the metabolic effects of SEA were abolished 
(data not shown), those of ω1 were still observed, despite the abrogation of the Th2-
mediated immune response in these Stat6-deficient mice. In addition, ω1 was found to 
inhibit food intake in both WT and Stat6-deficient mice, suggesting that the improvement 
of metabolic homeostasis in insulin-resistant obese mice by plant-produced recombinant 
ω1 glycovariants is independent of their Th2-inducing capacities, and may be explained 
by brain-mediated inhibition of food intake and/or immune-independent direct interaction 
of ω1 with metabolic cells. Further studies are required to investigate the anorexigenic 
effect of ω1, which might be a specific property of this molecule since it was not described 
previously when mice were chronically infected with S. mansoni or treated with SEA (4). 
Thus, although the schistosome egg antigen mixture improves metabolic homeostasis 
through type 2 immune responses, the single molecule ω1, which is capable of inducing 
strong type 2 responses, improves metabolic homeostasis, but not through its effect on 
type 2 immune responses.
In summary, our work on helminth infections and metabolic disorders, in both human 
and mice, has provided valuable insights into the effects of helminths and their molecules 
on metabolic homeostasis (Figure 1). The clinical trial revealed that in helminth-infected 
subjects, anthelmintic treatment significantly increases IR, highlighting the need for 
education and prevention strategies for noncommunicable diseases such as T2D, to go 
hand in hand with infectious disease control measures such as mass drug administration 
programs. Furthermore, repetitive injections of ω1 in a pathogen-free setting were found 
to have a beneficial effect on metabolic homeostasis in obese mice. However, as this effect 
appeared independent of the Th2-inducing capacity of ω1, it questions the role of type 2 
immune cells in this particular experimental model. 
Immune modulation by helminths
In the subsequent chapters, we further characterized the immunomodulatory effects 
of helminths as these might be associated with improved metabolic homeostasis. 
Eosinophilia is a well-known hallmark of helminths, and considering the presumed role 
of WAT eosinophils in maintaining whole-body metabolic homeostasis, we assessed 
the effect of STH infections on the activation status and responsiveness of eosinophils. In 
addition, neutrophil activation was analyzed as, despite a recent study showing enhanced 
neutrophil activation in subjects infected with helminths (19), little is known about the role 
of neutrophils during helminth infections. Chapter 5 describes a field-applicable method 
that was developed to monitor changes in the expression of certain granulocyte surface 
molecules by flow cytometry, in order to assess granulocyte activation. As we were limited 
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by the resources at the field study site with no direct access to a flow cytometer, we set 
up a method to analyze granulocyte activation markers in whole-blood samples that were 
lysed, fixed and cryopreserved. Although marker intensities varied when comparing fresh 
and fixed granulocytes, most likely due to intracellular staining and increased eosinophil 
autofluorescence as a consequence of fixation, it was shown that the responsiveness to 
stimuli could still be clearly measured after fixation.
We applied this method in our clinical trial (chapter 2) and collected samples for flow 
cytometric analysis from a subset of 300 subjects, before and after one year of albendazole 
treatment. Chapter 6 describes that, although anthelmintic treatment effectively reduced 
the prevalence of helminth infections and circulating eosinophil numbers (similar to 
the results described in Chapter 3), helminths did not affect the activation status, nor 
responsiveness of eosinophils and neutrophils as assessed by the expression of activation 
markers (CD11b, CD35, CD69, CD66b and CD62L). Serum levels of eosinophil granule 
proteins represent another measure of eosinophil activation, as these cytotoxic proteins 
are released upon eosinophil degranulation. Whereas the levels of major basic protein 
(MBP), eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN) were 
not different between helminth-infected and uninfected subjects at baseline, treatment 
significantly reduced the levels of EDN in those infected at baseline. In contrast to previous 
studies (19-26), the findings in this chapter indicate that STH infections do not induce 
increased eosinophil activation, although they do increase eosinophil numbers. However, 
it should be noted that this applies to eosinophils circulating in the peripheral blood, and 
it might be different at the site of infection or in the case of tissue-residing eosinophils. 
This study is the first placebo-controlled trial studying the effect of helminth infections 
on granulocyte activation and derives strength from its large sample size. Nevertheless, 
future studies, preferentially analyzing fresh instead of fixed eosinophils, are needed to 
investigate this further.
Besides eosinophilia, the type 2 response induced by helminths is also characterized 
by high levels of IgE and elevated signature cytokines such as IL-5. In chapter 7 we 
assessed the effect of anthelmintic treatment on these two different components - total 
plasma IgE levels and IL-5 responses to mitogen PHA - of the Th2-mediated response, by 
analyzing immunological data obtained from a previously conducted randomized placebo-
controlled trial of three-monthly single-dose albendazole treatment in an area highly 
endemic for STH (27). Remarkably, we showed that two years of anthelmintic treatment 
might have differential effects on different arms of Th2-mediated responses. Whereas IgE 
levels significantly declined in albendazole-treated subjects, IL-5 production by peripheral 
blood cells in response to PHA was not significantly affected by the treatment and rather 
tended to increase. The latter could be described as reversed T-cell hyporesponsiveness, 
a phenomenon which has been associated with chronic helminth infections and is thought 
to be mediated by Tregs (28). However, in Chapter 8 (see below), we observed a significant 
reduction in PMA+ionomycin stimulated cells producing IL-4/IL-5/IL-13 after albendazole 
treatment, which supports the decrease seen in total IgE, yet it contrasts with the increased 
IL-5 production in PHA-stimulated whole blood. A combination of higher responsiveness 
to PHA, a different composition of cells in whole blood producing IL-5, and the stimuli 
used could account for this anomaly. This raises the question whether different types of 
Th2 cells are involved in various arms of the type 2 response. 
As the sample collection during our field study progressed, so did the technology 
to study immune cells, and in chapter 8 we used a recently developed platform termed 
mass cytometry (cytometry by time-of-flight; CyTOF) to get a better understanding of 
immune modulation by helminths and to identify specific cells that might be important 
in this process. Mass cytometry is an advanced form of flow cytometry that allows single-
cell analysis of more than 40 different cellular markers, without the need for spectral 
compensation (29). Together with advances in computational analysis approaches such as 
Hierarchical Stochastic Neighbor Embedding (HSNE) (30), implemented in Cytosplore (31, 
32), mass cytometry has emerged as a powerful tool to dissect the cellular composition of 























Figure 1. Summary of findings demonstrating the causal relationship between helminths or 
the helminth-derived molecule ω1 and whole-body metabolic homeostasis. This figure summarizes 
the results described in chapter 3 & 4. A) Intensive anthelmintic treatment in an STH-endemic 
area significantly reduced both STH infection prevalence and intensity, as well as its related type 2 
immune responses (eosinophil counts and total IgE levels), while BMI increased. Deworming did not 
lead to an increase of whole-body IR at the community level, but it increased IR among those with 
a microscopy-detected STH infection. B) Treatment of obese mice with plant-produced recombinant 
ω1 glycovariants decreased fat mass and improved whole-body metabolic homeostasis, independent 
of its Th2-inducing capacity (indicated by the arrows with dashed lines), and may be explained by 
brain-mediated inhibition of food intake (indicated by the arrow with uninterrupted lines). BMI, body 
mass index; AAM, alternatively activated macrophages; WAT, white adipose tissue. 
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We performed unbiased immune profiling of Indonesians who were infected with STH, 
before and 1 year after 3-monthly anthelmintic treatment, as well as of healthy European 
volunteers who had not been exposed to helminths. Expanded populations of total Th2 
cells and ILC2s, but not Tregs, were found in STH-infected Indonesians compared to 
Europeans. After deworming, the frequency of Th2 cells significantly decreased and this 
was marked by a decrease in CD161+ Th2 cells, a subpopulation which might be identical to 
previously described pathogenic effector Th2 cells (33). Interestingly, whereas anthelmintic 
treatment did not affect the frequency of ILC2s, the proportion of ILC2s producing type 
2 cytokines declined after treatment, indicating decreased functional activity. Whereas 
ILC2s represent the innate source of type 2 cytokines, little is known about their role in 
human helminth infections and this is partly due to their low frequencies in peripheral 
blood. Here, we demonstrated a helminth-induced expansion of ILC2s in blood and future 
studies are needed to investigate their relative contribution to the different effector arms 
of the type 2 immune response.
Although the frequency of total Tregs was similar in Europeans and Indonesians, the use 
of mass cytometry allowed us to investigate the heterogeneity within Tregs. A significantly 
expanded population of CTLA4+ Tregs was identified in STH-infected Indonesians 
compared to Europeans, which decreased after deworming. CTLA4 is a molecule which is 
crucial for the suppressive function of Tregs (34) and interestingly, further analysis showed 
that this CTLA4+ subpopulation contained clusters expressing HLA-DR, CD38 and/or 
ICOS, all markers which have been associated with distinct Treg capacities and modes of 
suppression (35-37). Taken together, this indicates that helminths induce a particular Treg 
phenotype which could be represented by cells with increased regulatory capacity. 
The use of mass cytometry also enabled us to identify rare cell populations such as 
type-2 cytokine producing CD8+ T cells (termed Tc2 cells) and γδ T cells, subsets which 
were expanded in STH-infected Indonesians but did not change after treatment. Moreover, 
IL-10 producing B cells (regulatory B cells; Bregs) were identified and CD11c+ B cells were 
shown to be the main IL-10 producers among B cells in Indonesians, a subset which is 
almost absent in Europeans. 
Collectively, these results provide us with a detailed insight into the specific cell 
populations that participate in the type 2 and regulatory networks, and show that treatment 
of helminths affects specific cell subsets in these networks. In addition, we demonstrated 
that the combined use of mass cytometry and HSNE allowed us to identify rare cell 
populations in blood, such as ILC2s, Tc2 cells and Bregs.
In summary, the data presented in chapter 6, 7 and 8 have shed light on 
the immunomodulatory effects of helminths involving different components of the immune 
response. Whereas chapter 6 focused on eosinophil activation, chapter 7 studied 
the effects of anthelmintic treatment on IgE levels and the production of IL-5 in response 
to PHA, followed by a detailed characterization of circulating Th2 cells, ILC2s and Tregs 
before and after deworming in chapter 8. Regarding the beneficial effects of helminth 
infections on metabolic homeostasis, our work showed that CD161+ Th2 cells, CTLA4+ 
Tregs and ILC2s are of particular interest and enhancement of these populations might 
reduce systemic inflammation, and hence should be further analyzed. Whereas the relative 
contribution of each cell type to the beneficial effects of helminth infections in humans 
remains unknown, the helminth-induced regulatory network involving Tregs is thought 
to play a key role. However, experimental studies describing the effects of helminth-
derived molecules on Tregs residing in WAT have shown inconclusive results. Previous 
work showed that treatment with ω1 (6), as well as with filarial antigens (5), resulted in 
increased Treg abundance in WAT of obese mice, while we demonstrated no change 
in WAT Treg frequencies following repetitive injections with ω1 (chapter 4). Moreover, 
a single footpad injection of ω1 increased both the percentage of total Tregs and of 
CTLA4+ Tregs in the draining lymph nodes of non-obese diabetic (NOD) mice, indicating 
the potential of helminth-derived molecules to upregulate the suppressive function of 
Tregs (38). Therefore, further studies are needed to elucidate the functional role of Tregs 
in WAT in the context of helminth infections and metabolic homeostasis.
DIRECTIONS FOR FUTURE RESEARCH 
Effects of deworming on type 2 and regulatory immune responses: Part II
Recent advances in cellular immunology methodologies and computational analysis 
approaches have now enabled detailed profiling of the immune system. However, mass 
cytometry is currently still limited by its slow throughput compared to flow cytometry. When 
considering large scale clinical trials, the application of this technique therefore provides 
the point of departure for larger studies. By using flow cytometry, future studies can further 
explore the findings described in chapter 8 in a larger subset of the study population, 
including placebo-treated individuals, to assess whether the observed effects can be 
truly attributed to the removal of helminths and to investigate if changes in the immune 
profile are reflected in clinical outcomes (e.g. changes in HOMA-IR). In addition, cellular 
assays can be performed to further investigate the function of particular cell populations. 
For example, suppression assays in which Tregs and T effector cells are co-cultured in 
the presence of blocking antibodies, can be used to evaluate the suppressive function of 
Tregs expressing CTLA4 and/or HLA-DR and/or CD38 and/or ICOS that were found to be 
expanded in STH-infected Indonesians. 
To assess the effect of deworming on the cytokine production of immune cells, 
cells need to be stimulated ex vivo. Whereas stimulation with PMA+ionomycin (used in 
chapter 8) is very strong, non-specific, and not even mediated via the T cell receptor 
complex, stimulation with helminth-antigens is more physiological and will provide insight 
into the function of antigen-specific T cells. For example, stimulation with schistosomal 
antigens (schistosome soluble egg (SEA) and adult worm antigens (AWA)) was previously 
used to investigate the adaptive immune responses in Schistosoma haematobium-infected 
schoolchildren (39, 40). However, up to now, it has been challenging to isolate STH-derived 
antigens which can induce detectable cytokine responses. 
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Controlled human infections 
Although longitudinal field studies in areas endemic for helminths provide a unique 
opportunity to study the real-life biological settings of infection, the interpretation of 
the results is complicated due to the presence of other infections that could be affected 
by treatment, the chance of reinfection and the observation that protective effects of 
helminths might persist long after treatment. Meanwhile, controlled human infections (CHI) 
in which healthy volunteers are experimentally infected with helminths, have generated 
much interest as a complementary approach to study the host-pathogen interaction in 
a very specific and controlled manner (41). CHI models will allow the characterization 
of the dynamics of immune responses that develop to helminth infections in a highly 
controlled setting, and will enable the assessment of helminth-induced effects on metabolic 
homeostasis. Moreover, these models can be used to study the therapeutic potential of 
helminth-derived molecules. 
Another advantage of the CHI model compared to a field setting where clinical 
resources are limited, is the possibility to obtain human adipose tissue biopsies from 
helminth-infected individuals. Although experimental infections with helminths or 
helminth-derived molecules have shown that the type 2 immune pathways in WAT have 
protective roles that support maintenance of metabolic homeostasis, little is known about 
the effects on the immune cell composition of human WAT. However, additional insights 
on tissue-resident cells might be more relevant for the control of metabolic homeostasis, 
compared to circulating immune cells which are most often studied in helminth-infected 
individuals. Previous work identified ILC2s in human adipose tissue and found that 
frequencies are lower in obese compared to non-obese individuals (42). The same was 
observed for Tregs, whose frequencies appear to decrease in obese individuals (13). 
It would be very interesting to study these immune cell frequencies in WAT of obese 
individuals in the setting of a controlled helminth infection, the hypothesis being that 
type 2 and regulatory immune cells will expand after infection, thereby promoting insulin 
sensitivity. Moreover, the use of WAT biopsies would allow the study of macrophages, cells 
that are absent in peripheral blood but have shown to play a key role in the association 
between helminths and metabolic homeostasis. 
Although white adipose tissue is the most studied organ in terms of immune-metabolic 
interactions in the context of obesity and metabolic disorders, it will also be interesting 
to explore the impact of helminths and helminth-derived molecules on other metabolic 
tissues such as brown adipose tissue, pancreas, liver, brain, muscle and intestine. These 
(predominantly rodent) studies will provide a deeper understanding of how the immune 
and metabolic systems interact to support metabolic homeostasis. To this end, novel 
technologies such as imaging mass cytometry (43), which couples high-density analysis 
by mass cytometry to conventional histology, could be used to study cell interactions in 
the context of the tissue microenvironment. 
Gut microbiome
Besides alteration of the immune response, changes in the composition of the gut 
microbiome might be another possible helminth-mediated mechanism associated with 
improved metabolic homeostasis. Although a recent study reported the impact of human 
gut microbiome on insulin sensitivity (44) and chronic Trichuris muris infection was shown 
to alter the host microbiota in vivo (45), there have been no studies specifically studying 
the interaction between helminth infections, gut microbiome and insulin resistance. 
Interestingly, in mice, helminth infections are associated with an increase of intestinal short-
chain fatty acids (SCFA) (46), the end products of dietary carbohydrates fermentation, 
which have been shown to play an important role in the control of body weight and 
insulin sensitivity (47). 
Despite the growing interest in the analysis of the composition of the human gut 
microbiome, sample collection, storage techniques and bacterial DNA extraction methods 
are key steps required for the accuracy of these studies (48). While immediate freezing 
of fecal samples at -20˚C or below is considered the gold standard for microbiome 
preservation, this approach is not feasible for many field studies in remote areas (49). 
Studies showed that long-term sample storage at room temperature or multiple freeze-
thaw cycles alters microbial community stability, while preservation methods improve 
stability but could alter community structure (50). Therefore, the microbiome field urgently 
needs a sampling method which can be readily applied outside of a clinical or well-
equipped environment and which produces an accurate representation of the microbiota 
composition (48). Recently developed commercial kits such as OMNIgene GUT (DNA 
Genotek), allowing storage of fecal samples at room temperature, are now available 
and these might be suitable for large-scale field studies since there is no need for 
cold-chain transportation. 
CONCLUDING REMARKS
This thesis has contributed to further understanding of immune modulation exerted by 
soil-transmitted helminths and how this can affect the development of type 2 diabetes. 
Every experimental study design has its pros and cons, and whereas this work has been 
based on a large-scale field study conducted in a rural area of Indonesia and an animal 
model of HFD-induced obese mice, the implementation of the controlled human infection 
model is expected to provide complementary insights into the mechanisms underlying 
the beneficial effects of helminths on metabolic homeostasis. Moreover, by investigating 
the effects of helminth-derived molecules on the immune response, future studies may 
offer new insights towards the development of novel therapeutics for the treatment of 
metabolic disorders. 
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Parasitaire worminfecties en het immuunsysteem
Naar schatting is een kwart van de wereldbevolking geïnfecteerd met parasitaire 
wormen. Deze infecties worden voornamelijk aangetroffen in tropische landen, in 
gebieden met slechte hygiënische omstandigheden. De meest voorkomende parasitaire 
wormen leven in het maag-darm kanaal, zoals mijnwormen (Necator, Ancylostoma), 
spoelwormen (Ascaris) en zweepwormen (Trichuris). Een geïnfecteerd persoon kan via 
zijn/haar ontlasting de bodem besmetten met wormeieren. Nieuwe personen worden 
vervolgens geïnfecteerd wanneer ze de wormeieren inslikken via besmet voedsel of 
vieze handen. Sommige wormlarven, zoals die van mijnworm, kunnen de intacte huid 
binnendringen. Zowel kinderen als volwassenen kunnen op deze wijze geïnfecteerd raken 
als zij bijvoorbeeld geen schoenen dragen. De levenscyclus van de wormen wordt in 
stand gehouden doordat de eieren en larven zich in de darmen van een geïnfecteerd 
persoon ontwikkelen tot volwassen wormen die weer nieuwe eieren produceren. Hoewel 
de wormen soms tot tien jaar in de darmen aanwezig blijven, verlopen de infecties vaak 
zonder klachten. 
Het afweersysteem, ook wel immuunsysteem genoemd, beschermt ons tegen 
ziekteverwekkers zoals virussen, bacteriën en parasitaire wormen. De ziekteverwekkers 
die het lichaam weten binnen te dringen worden opgewacht door een gemengde 
verzameling van witte bloedcellen (immuuncellen) met verschillende functies (bijv. 
T-helpercellen, B cellen, dendritische cellen, monocyten, macrofagen, ‘killercellen’, 
eosinofielen en neutrofielen). Het type ziekteverwekker bepaalt welke witte bloedcellen 
in actie komen. Virale of bacteriële infecties activeren veelal T-helper-1 (Th1) cellen, 
terwijl parasitaire wormen Th2 cellen activeren en een type 2-afweerreactie opwekken. 
Het is van groot belang dat de verschillende componenten van het afweersysteem in 
balans zijn en dit wordt aangestuurd door onder andere regulatoire T (Treg) cellen. Bij 
een worminfectie is deze immuunregulatie in het voordeel van zowel de geïnfecteerde 
persoon (de gastheer) als van de worm. In de gastheer zorgt immuunregulatie er namelijk 
voor dat de schade aan de omliggende weefsels die gepaard gaat met afweerreacties 
beperkt blijft, terwijl de worm niet wordt aangevallen door een sterke afweerreactie en 
dus langer kan overleven. 
Wormen en diabetes type 2
Studies hebben aangetoond dat de door een worminfectie geactiveerde type 2 en 
regulatoire afweercellen, mogelijk een beschermend effect hebben op de ontwikkeling 
van andere ziektes waarbij het immuunsysteem ontregeld is. Dit betreft bijvoorbeeld 
allergieën en auto-immuunziekten. Ook bij mensen met overtollig vetweefsel (obesitas) 
zijn de verschillende componenten van het afweersysteem uit balans en dit vergroot 
de kans op diabetes type 2. Patiënten met diabetes type 2 zijn minder gevoelig voor 




door lichaamscellen, zodat het gebruikt kan worden om energie van te maken. Als 
cellen echter niet meer reageren op insuline, oftewel insuline resistent zijn geworden, 
blijven bloedsuikerspiegels hoog en dit kan op lange termijn zenuwen en bloedvaten 
beschadigen. In muizen is aangetoond dat gezond vetweefsel wordt gekenmerkt door 
de aanwezigheid van type 2-afweercellen die de werking van insuline bevorderen. In 
het vetweefsel van muizen met overgewicht daarentegen, ontstaat een chronische 
ontsteking die gepaard gaat met een type 1-afweerreactie. Deze type 1-afweercellen 
belemmeren de werking van insuline. Zie figuur 2 in hoofdstuk 1 voor een illustratie 
waarin bovenstaande wordt samengevat.
Aangezien worminfecties een type 2-afweerreactie opwekken en geassocieerd 
worden met een versterkte immuunregulatie, hebben wij onderzocht of worminfecties, of 
moleculen afkomstig van wormen, een beschermend effect hebben op de ontwikkeling 
van diabetes type 2. Tevens is onderzocht hoe worminfecties de activatie van verschillende 
soorten witte bloedcellen beïnvloeden. Dit onderzoek is uitgevoerd in de vorm van een 
klinische studie en daarnaast is er gebruik gemaakt van een muismodel. 
Het effect van ontwormen op de ontwikkeling van diabetes type 2
Het effect van worminfecties op de ontwikkeling van diabetes type 2 kan worden onderzocht 
door de ene helft van een onderzoeksgroep te behandelen tegen worminfecties en de 
andere helft met een placebo. Dit hebben wij gedaan in een gebied waar veel mensen 
met wormen zijn besmet, in het ‘SugarSPIN’ project op Flores, Indonesië. Hoofdstuk 2 
beschrijft het studieprotocol dat is gebruikt om te onderzoeken of worminfecties een 
gunstig effect hebben op insuline resistentie, een veelgebruikte indicator en voorspeller 
voor de ontwikkeling van diabetes type 2. Gedurende 1 jaar is de onderzoeksgroep 
behandeld en deelnemers ontvingen hiervoor elke 3 maanden, 3 dagen achter elkaar 
medicatie tegen worminfecties (albendazole) of een placebo. Naast het uitvoeren van 
antropometrische metingen (lengte, gewicht, heup- en tailleomvang), zijn er voor en 
na de behandeling bloed, urine en feces monsters verzameld om veranderingen in 
insuline resistentie (en andere metabole parameters) en afweersysteem te kunnen meten. 
Hoofdstuk 3 beschrijft de onderzoeksresultaten van deze studie. De behandeling tegen 
wormen heeft ertoe heeft geleid dat het aantal worminfecties na 1 jaar sterk verlaagd 
was. Toen we het effect van de behandeling op insuline resistentie onderzochten, bleek 
dat er een kleine, maar significante toename in insuline resistentie was opgetreden in de 
groep mensen die voor aanvang van de behandeling geïnfecteerd waren. Dit resultaat is 
het eerste directe bewijs in mensen dat worminfecties een beschermend effect kunnen 
hebben op insuline resistentie, en dus op de ontwikkeling van diabetes type 2. Daarnaast 
bleek dat de toename in insuline resistentie voornamelijk was toe te wijzen aan een 
toename in Body Mass Index (BMI) en een afname in het aantal eosinofielen, een bepaald 
type witte bloedcellen dat betrokken is bij type 2-afweerreacties. 
Het mogelijk beschermende effect van parasitaire wormen op insuline resistentie is 
ook onderzocht in muizen met overgewicht. Ten opzichte van het SugarSPIN project, 
bieden deze experimenten meer mogelijkheden om het onderliggende mechanisme 
te onderzoeken. Het is bijvoorbeeld mogelijk om de compositie van immuuncellen in het 
vetweefsel te bekijken, iets wat in mensen een stuk lastiger is. Daarnaast is het muismodel 
erg geschikt om onderzoek te doen naar moleculen afkomstig van wormen, die in staat 
zijn om het gunstige effect van een worminfectie te reproduceren om de ontwikkeling van 
diabetes type 2 in obesitas tegen te gaan. Om die reden is in hoofdstuk 4 onderzocht of 
omega-1, een eiwit van Schistosoma-eitjes dat sterke Th2-sturende capaciteiten heeft, 
de insulinegevoeligheid in muizen met overgewicht kan bevorderen. Muizen op een 
hoog-vet-dieet die herhaaldelijk werden geïnjecteerd met omega-1 werden minder dik, 
de cellen in het lichaam namen glucose sneller op en de muizen waren gevoeliger voor 
insuline, in vergelijking met soortgenoten die niet met omega-1 werden behandeld. Dit 
ging gepaard met een type 2-afweerreactie in het vetweefsel. Om te onderzoeken of 
het positieve effect van omega-1 op insulinegevoeligheid echt veroorzaakt wordt door 
de type 2-afweerreactie, hebben we dit experiment ook uitgevoerd in zogenaamde STAT6-
knockout muizen op een hoog-vet-dieet. Deze muizen zijn genetisch gemanipuleerd 
waardoor er geen type 2-afweerreactie kan worden opgewekt. Tegen de verwachting 
in, bevorderde omega-1 de insulinegevoeligheid ook in deze muizen wat aantoont dat 
het effect onafhankelijk is van de type 2-afweerreactie. Zowel de normale als de STAT6-
knockout muizen, beide behandeld met omega-1, aten minder dan hun soortgenoten die 
niet met omega-1 werden behandeld. Dit resultaat suggereert dat dit eiwit mogelijk een 
effect heeft op de signalering in de hersenen die de voedselinname reguleert. Om deze 
hypothese te toetsen is echter verder onderzoek nodig.  
Zie figuur 1 in hoofdstuk 9 voor een illustratie die de resultaten van hoofdstuk 3 en 
4 samenvat.
Het effect van ontwormen op de verschillende componenten van het 
afweersysteem
In de volgende hoofdstukken hebben we het effect van worminfecties op de verschillende 
type witte bloedcellen in mensen verder onderzocht, omdat dit het positieve effect van 
wormen op insuline resistentie mogelijk zou kunnen verklaren. Tijdens een veldstudie 
zoals het SugarSPIN project zijn de onderzoeks-voorzieningen beperkt. Hierdoor zijn er 
methodes nodig waarmee we cellen kunnen invriezen zodat ze naar Nederland kunnen 
worden getransporteerd voor verder onderzoek. Hoofdstuk 5 beschrijft de ontwikkeling 
van de methode om bepaalde soorten witte bloedcellen, namelijk eosinofielen en 
neutrofielen, in te vriezen tijdens een veldstudie zodat de activatie status van deze 
cellen later gemeten kan worden. Het is bekend dat eosinofielen onderdeel uitmaken 
van de type 2-afweerreactie, terwijl neutrofielen over het algemeen meer betrokken 
zijn bij type 1-afweerreacties. Deze methode is toegepast tijdens het SugarSPIN project 
in Indonesië en hoofdstuk 6 beschrijft de studie waarin we in een deel van de totale 
onderzoeksgroep hebben onderzocht of worminfecties resulteren in een verhoogde 




bloed sterk afnam in de groep mensen die behandeld was tegen wormen, was er tegen 
de verwachting in geen verschil in de activatiestatus van de eosinofielen en neutrofielen. 
Dit kan worden verklaard door het feit dat dit type witte bloedcellen zich voornamelijk 
in de weefsels bevindt. Het is daarom mogelijk dat de activatiestatus van de cellen in 
het bloed geen goed beeld geeft van wat zich afspeelt in de weefsels. Daarnaast kan 
het zijn dat de activatiestatus toch nauwkeuriger kan worden bepaald in cellen die niet 
ingevroren zijn geweest. 
Naast Th2 cellen en eosinofielen, wordt de type 2-afweerreactie ook gekenmerkt 
door een toename van IgE, een antilichaam geproduceerd door B cellen, en bepaalde 
cytokines (eiwitten die belangrijk zijn voor de communicatie tussen cellen) zoals IL-4, IL-5 
en IL-13. Hoofdstuk 7 beschrijft dat de behandeling tegen wormen verschillende effecten 
kan hebben op de verschillende componenten van de type 2-afweerreactie. In vergelijking 
met de groep mensen die een placebo-behandeling kregen, resulteerde de behandeling 
tegen wormen namelijk in een afname in de concentratie van IgE, terwijl de productie 
van IL-5 niet significant veranderde en eerder leek toe te nemen. Het is de eerste keer 
dat deze verschillende effecten zijn aangetoond in één onderzoeksgroep. Het resultaat is 
een aanwijzing dat  men rekening moet houden met de verschillende effecten op de type 
2-afweerreactie in studies naar de invloed van parasitaire wormen op de ontwikkeling van 
ontstekingsziekten. 
Tot slot is er in hoofdstuk 8 gebruik gemaakt van een recentelijk ontwikkelde techniek 
genaamd ‘Massa cytometrie’ (CyTOF), waarmee het mogelijk is om de expressie van 37 
specifieke eiwitten (markers), cel voor cel, te bestuderen en zo de complexiteit van het 
afweersysteem in detail te onderzoeken. Door de cellen van Indonesische mensen met een 
worminfectie voor en na behandeling met elkaar te vergelijken, hebben we onderzocht 
welke specifieke cellen binnen de type 2-afweerreactie en de Treg cellen een rol spelen 
tijdens worminfecties. Daarnaast hebben we het afweersysteem van deze Indonesische 
mensen vergeleken met een groep gezonde Europeanen. De geconstateerde verschillen 
in het afweersysteem tussen Europeanen en Indonesiërs kunnen van belang zijn voor 
het begrip van de toenemende hoeveelheid mensen met diabetes type 2, en mogelijk 
bijdragen aan de ontwikkeling van oplossingen voor dit probleem. Daarnaast is deze 
kennis van belang voor de ontwikkeling van vaccins. Er zijn namelijk wereldwijd verschillen 
in de werkzaamheid van vaccins en dit wordt deels toegewezen aan veranderde 
levensomstandigheden (verbeterde hygiëne, minder blootstelling aan bacteriën en 
parasieten) in Westerse landen, waardoor er vermoedelijk plaatsgebonden verschillen in 
het afweersysteem zijn opgetreden.
Conclusie
Het onderzoek beschreven in dit proefschrift biedt nieuwe inzichten in de interactie tussen 
parasitaire wormen, het afweersysteem en de ontwikkeling van diabetes type 2. De studies 
laten zien dat zowel worminfecties in mensen, als de toediening van wormmoleculen in 
muizen met obesitas, een positief effect hebben op de insulinegevoeligheid en hierdoor het 
risico op diabetes type 2 verkleinen. Hoewel dit werk aantoont dat de type 2-afweerreactie 
en Treg cellen belangrijke en complexe onderdelen van ons afweersysteem vormen, zal 
toekomstig onderzoek moeten uitwijzen hoe cruciaal de rol van deze afweerreacties is 
in de ontwikkeling van ontstekingsziektes waarbij een type 2-afweerreactie wenselijk is, 
zoals diabetes type 2. De verwachting is dat studies waarbij gezonde proefpersonen 
onder gecontroleerde omstandigheden worden geïnfecteerd met parasitaire wormen 
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